2023년도 연구현황

2023

• 2023
• 2022
• 2021
• 2020
• 2019
• 2018
• 2017
• 2016
• 2015
• 2014
• 2013
• 2012
• 2011
• 2010
• 2009
• 2008
• 2007

국내학술지 연구논문

호흡기내과

• Kwon BS, Park JS, Shin JA, Kim ES, Lim SY, Song MJ, Kim YW, Kim HJ, Lee YJ, Park JS, Cho YJ, Yoon HI, Lee CT, Lee JH. A prospective study on the long-term storage of sputum and the recovery of nontuberculous mycobacteria. 2023 Jan-Dec:17:17534666231162244.
• Song MJ, Jang Y, Lee JH, Yoon JH, Kim DJ, Jung SY, Lim SY. Association of Dexmedetomidine With New-Onset Atrial Fibrillation in Patients With Critical Illness. 2023 Apr 3;6(4):e239955.
• Wook Kim Y, Kim HJ, Hyun Yoon S, Jin Song M, Soo Kwon B, Yoon Lim S, Joo Lee Y, Sun Park J, Cho YJ, Ho Lee J, Lee CT. Comparison of electromagnetic navigation bronchoscopy and transthoracic needle biopsy for diagnosing bronchus sign-positive pulmonary lesions. 2023 Jul:181:107234.
• Kim YW, Kim HJ, Yoon SH, Song MJ, Kwon BS, Lim SY, Lee YJ, Park JS, Cho YJ, Lee JH, Lee CT. Electromagnetic Navigation Bronchoscopy Versus Radial Endobronchial Ultrasound for Diagnosing Lung Cancer: A Propensity Score-Matched Analysis. 2023 Jun;59(6):356-363.
• Kim J, Kim YK, Kim H, Jung H, Koh S, Kim Y, Yoon D, Yi H, Kim HJ. Machine Learning Algorithms Predict Successful Weaning From Mechanical Ventilation Before Intubation: Retrospective Analysis From the Medical Information Mart for Intensive Care IV Database. 2023 Nov 14:7:e44763.
• Park S, Park SH, Kim Y, Lee GH, Kim HS, Lim SY, Choi SA. Optimal Nutritional Support Strategy Based on the Association between Modified NUTRIC Score and 28-Day Mortality in Critically Ill Patients: A Prospective Study. 2023 May 25;15(11):2465.
• Cho KJ, Kim JS, Lee DH, Lee SM, Song MJ, Lim SY, Cho YJ, Jo YH, Shin Y, Lee YJ. Prospective, multicenter validation of the deep learning-based cardiac arrest risk management system for predicting in-hospital cardiac arrest or unplanned intensive care unit transfer in patients admitted to general wards. 2023 Sep 5;27(1):346.
• Kim HJ, Lee YJ, Song MJ, Kwon BS, Kim YW, Lim SY, Lee YJ, Park JS, Cho YJ, Lee CT, Lee JH. Real-world experience of adverse reactions-necessitated rifampicin-sparing treatment for drug-susceptible pulmonary tuberculosis. 2023 Jul 12;13(1):11275. doi: 10.
• Lee H, Song MJ, Cho YJ, Kim DJ, Hong SB, Jung SY, Lim SY. Supervised machine learning model to predict mortality in patients undergoing venovenous extracorporeal membrane oxygenation from a nationwide multicentre registry. 2023 Dec 28;10(1):e002025.
• Lee YJ, Park YB. Inhaled Corticosteroids Is Not Associated with the Risk of Pneumonia in Asthma. 2023 Jul;86(3):151-157.
• Kim HJ, Lee YJ, Song MJ, Kwon BS, Kim YW, Lim SY, Lee YJ, Park JS, Cho YJ, Lee CT, Lee JH. Real-world experience of adverse reactions-necessitated rifampicin-sparing treatment for drug-susceptible pulmonary tuberculosis. 2023 Jul 12;13(1):11275.
• Shekar K, Abdul-Aziz MH, Cheng V, Burrows F, Buscher H, Cho YJ, Corley A, Diehl A, Gilder E, Jakob SM, Kim HS, Levkovich BJ, Lim SY, McGuinness S, Parke R, Pellegrino V, Que YA, Reynolds C, Rudham S, Wallis SC, Welch SA, Zacharias D, Fraser JF, Roberts JA. Antimicrobial Exposures in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation. 2023 Mar 15;207(6):704-720
• Ahn YH, Lee J, Oh DK, Lee SY, Park MH, Lee H, Lim CM, Lee SM, Lee HY; Korean Sepsis Alliance (KSA) Investigators. Association between the timing of ICU admission and mortality in patients with hospital-onset sepsis: a nationwide prospective cohort study. 2023 Apr 21;11(1):16.
• Kim TH, Kim HJ, Song MJ, Kwon BS, Kim YW, Lim SY, Lee YJ, Cho YJ, Lee JH, Chung JH, Park JS. Correlation of monocyte counts with clinical outcomes in idiopathic nonspecific interstitial pneumonia. 2023 Feb 16;13(1):2804.
• Kim JH, Kim YK, Oh DK, Jeon K, Ko RE, Suh GY, Lim SY, Lee YJ, Cho YJ, Park MH, Hong SB, Lim CM, Park S; Korean Sepsis Alliance (KSA) investigators. HYPOTENSION AT THE TIME OF SEPSIS RECOGNITION IS NOT ASSOCIATED WITH INCREASED MORTALITY IN SEPSIS PATIENTS WITH NORMAL LACTATE LEVELS. 2023 Mar 1;59(3):360-367.
• Hyun DG, Ahn JH, Huh JW, Hong SB, Koh Y, Oh DK, Lee SY, Park MH, Lee H, Lim CM; Korean Sepsis Alliance (KSA) Investigators. Impact of a cumulative positive fluid balance during the first three ICU days in patients with sepsis: a propensity score-matched cohort study. 2023 Oct 19;13(1):105.
• Lee KJ, Park JY, Jeon K, Ko RE, Suh GY, Lim SY, Lee YJ, Oh DK, Park MH, Lim CM, Park S. Impact of sepsis on Eastern Cooperative Oncology Group performance status among fully ambulatory patients: a prospective nationwide multicenter cohort. 2023 Sep 28;15(9):4681-4692.
• Ko RE, Kang D, Cho J, Na SJ, Chung CR, Lim SY, Lee YJ, Park S, Oh DK, Lee SY, Park MH, Lee H, Lim CM, Suh GY; Korean Sepsis Alliance (KSA) investigators. Influence of gender on age-associated in-hospital mortality in patients with sepsis and septic shock: a prospective nationwide multicenter cohort study. 2023 Jun 11;27(1):229.
• Park HJ, Kim JY, Kim HJ, Yim JJ, Kwak N. Lung function decline in non-tuberculous mycobacterial pulmonary disease according to disease severity. 2023 Jun 1;27(6):465-470.
• Kim TH, Ji E, Song MJ, Lim SY, Lee YJ, Cho YJ. Negative Conversion of Polymerase Chain Reaction and Clinical Outcomes according to the SARS-CoV-2 Variant in Critically Ill Patients with COVID-19. 2023 Apr;86(2):142-149.
• JAE HO LEE JIHANG KIM JUNGHOON KIM YE JIN LEE HYUNG-JUN KIM MYUNG JIN SONG SUNG YOON LIM BYOUNG SOO KWON YEON-JOO LEE JONG SUN PARK YOUNG-JAE CHO AND SUNG HYUN YOON. NONTUBERCULOUS MYCOBACTERIAL PULMONARY INFECTION PRESENTING AS BRONCHIOLITIS PATTERN ON CT SCAN WITHOUT CAVITY OR BRONCHIECTASIS. DOI:https://doi.org/10.1016/j.chest.2023.07.579
• Kim HJ, Lee YJ, Song MJ, Kwon BS, Kim YW, Lim SY, Lee YJ, Park JS, Cho YJ, Lee CT, Lee JH. Real-world experience of adverse reactions-necessitated rifampicin-sparing treatment for drug-susceptible pulmonary tuberculosis. 2023 Jul 12;13(1):11275.

순환기내과

• Park JJ, Jang SY, Adler E, Ahmad F, Campagnari C, Yagil A, Greenberg B. A machine learning-derived risk score predicts mortality in East Asian patients with acute heart failure. Eur J Heart Fail. 2023 Dec;25(12):2331-2333.
• Moon IT, Kim SH, Chin JY, Park SH, Yoon CH, Youn TJ, Chae IH, Kang SH. Accuracy of Artificial Intelligence-Based Automated Quantitative Coronary Angiography Compared to Intravascular Ultrasound: Retrospective Cohort Study. JMIR Cardio. 2023 Apr 26:7:e45299.
• Chu HW, Hwang IC, Kim HM, Park J, Choi H, Choi HM, Yoon YE, Cho GY. Age-dependent implications of left ventricular hypertrophy regression in patients with hypertension. Hypertens Res. 2024 May;47(5):1144-1156.
• Yoon M, Park JJ, Hur T, Hua CH, Hussain M, Lee S, Choi DJ. Application and Potential of Artificial Intelligence in Heart Failure: Past, Present, and Future. Int J Heart Fail. 2023 Nov 30;6(1):11-19.
• Han D, Kang SH, Yoon CH, Youn TJ, Chae IH. Author Correction: Attenuation of ischemia-reperfusion injury by intracoronary chelating agent administration. Sci Rep. 2023 Jul 3;13(1).
• Yoon CH, Kwun JS, Choi YJ, Park JJ, Kang SH, Kim SH, Suh JW, Youn TJ, Kim MK, Cha KS, Lee SH, Hong BK, Rha SW, Kang WC, Lee JH, Kim SH, Chae IH. BioMatrix Versus Orsiro Stents for Coronary Artery Disease: A Multicenter, Randomized, Open-Label Study. Circ Cardiovasc Interv. 2023 Jan;16(1).
• Park CS, Park JJ, Lee HY, Kang SM, Yoo BS, Jeon ES, Hong SK, Shin JH, Kim MA, Park DG, Kim EJ, Hong SJ, Kim SY, Kim JJ, Choi DJ. Clinical Characteristics and Outcome of Immediate-Release Versus SLOW-Release Carvedilol in Heart Failure Patient (SLOW-HF): a Prospective Randomized, Open-Label, Multicenter Study. Cardiovasc Drugs Ther. 2023 Jun;37(3):529-537.
• Kwun JS, Lee JH, Park BE, Park JS, Kim HJ, Kim SH, Jeon KH, Cho HW, Kang SH, Lee W, Youn TJ, Chae IH, Yoon CH. Diagnostic Value of a Wearable Continuous Electrocardiogram Monitoring Device (AT-Patch) for New-Onset Atrial Fibrillation in High-Risk Patients: Prospective Cohort Study. J Med Internet Res. 2023 Sep 18;25:e45760.
• Kim BJ, Cha KS, Cho WH, Kim EJ, Choi SH, Kim MH, Kim SH, Park JB, Park SM, Sohn IS, Ryu KH, Chae IH. Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial. J Cardiovasc Pharmacol Ther. 2023 Jan-Dec;28.
• Park J, Yoon YE, Chun EJ, Choi HM, Hwang IC, Lee HJ, Park JB, Lee SP, Kim HK, Kim YJ, Cho GY. Endocardial versus whole-myocardial tracking global longitudinal strain analysis in patients with hypertrophic cardiomyopathy: A preliminary comparative study. PLoS One. 2023 Jul 11;18(7):e0288421.
• Suh JW, Memtsas V, Gue YX, Cho HW, Lee W, Kang SH, Gorog DA. Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes: A Comparison of East Asian and White subjects. Thromb Haemost. 2023 Dec 29.
• Hahn D, Lee D, Hyun W, Cho Y, Yoon CH, Jeon KH, Kang SH, Youn TJ, Chae IH. Faster smooth muscle cell coverage in ultrathin-strut drug-eluting stent leads to earlier re-endothelialization. Front Bioeng Biotechnol. 2023 May 23:11:1207858.
• Park J, Yoon Y, Cho Y, Kim J. Feasibility of Artificial Intelligence–Based Electrocardiography Analysis for the Prediction of Obstructive Coronary Artery Disease in Patients With Stable Angina: Validation Study. JMIR Cardio 2023;7:e44791.
• Lee W, Kang SH, Kim SH, Lee SY, Myung W, Jheon KH, Yoon CH, Suh JW, Youn TJ, Chae IH. Impact of dementia and drug compliance on patients with acute myocardial infarction. Clin Cardiol. 2023 Oct;46(10):1253-1259.
• Hwang IC, Kim S, Boo D, Park C, Yoo S, Yoon YE, Cho GY. Impact of glycemic control on the progression of aortic stenosis: a single-center cohort study using a common data model. BMC Endocr Disord. 2023 Jul 10;23(1):143.
• Jeon KH, Jeong YH, Chae IH, Kim BK, Joo HJ, Chang K, Park Y, Song YB, Ahn SG, Lee SY, Cho JR, Her AY, Kim HS, Kim MH, Lim DS, Shin ES, Suh JW; PTRG-DES Consortium Investigators. Implication of diabetic status on platelet reactivity and clinical outcomes after drug-eluting stent implantation: results from the PTRG-DES consortium. Cardiovasc Diabetol. 2023 Sep 7;22(1):245.
• Park J, Ahn HB, Choi H, Choi HM, Hwang IC, Yoon YE, Cho GY. Integrative Assessment of Cardiopulmonary Fitness Using Cardiopulmonary Exercise Test With Supine Bicycle Echocardiography in Patients Presenting Dyspnea. J Am Heart Assoc. 2024;13:e033815.
• Choi YJ, Lee HJ, Park JS, Park CS, Rhee TM, Choi JY, Choi HM, Park JB, Yoon YE, Lee SP, Na JO, Cho GY, Kim YJ, Hwang IC, Kim HK. Left ventricular global longitudinal strain as a prognosticator in hypertrophic cardiomyopathy with a low-normal left ventricular ejection fraction. Eur Heart J Cardiovasc Imaging. 2023 Sep 26;24(10):1374-1383.
• Choi H, Kang SH, Jeong SW, Yoon CH, Youn TJ, Song WH, Jeon DW, Lim SW, Lee JH, Cho SW, Chae IH, Kim CH. Lipid-Lowering Efficacy of Combination Therapy With Moderate-Intensity Statin and Ezetimibe Versus High-Intensity Statin Monotherapy: A Randomized, Open-Label, Non-Inferiority Trial From Korea. J Lipid Atheroscler. 2023 Sep;12(3):277-289.
• Lee W, Kang J, Park JB, Seo WW, Lee SY, Lim WH, Jeon KH, Hwang IC, Kim HL. Long-term mortality and cardiovascular events of seven angiotensin receptor blockers in hypertensive patients: Analysis of a national real-world database: A retrospective cohort study. Health Sci Rep. 2023 Jan 31;6(2):e1056.
• Kim HM, Hwang IC, Yoon YE, Park JB, Lee SP, Kim HK, Kim YJ, Lim Y, Cho GY. Prediction of Deterioration of Left Ventricular Function Using 3-Dimensional Speckle-Tracking Echocardiography in Patients With Left Bundle-Branch Block. J Am Heart Assoc. 2023 Jan 3;12(1):e026194.
• Choi YJ, Kim HK, Hwang IC, Park CS, Rhee TM, Lee HJ, Park JB, Yoon YE, Lee SP, Cho GY, Kim YJ. Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction. Heart. 2023 Apr 25;109(10):771-778.
• Hwang IC, Kim CH, Kim JY, Choi HM, Yoon YE, Cho GY. Rate of Change in 10-Year Atherosclerotic Cardiovascular Disease Risk and Its Implications for Primary Prevention. Hypertension. 2023 Aug;80(8):1697-1706.
• M. Yoon, J. J. Park, T. Hur, C.-H. Hua, C. Y. Shim, B.-S. Yoo, et al. The ReInforcement of adherence via self-monitoring app orchestrating biosignals and medication of RivaroXaban in patients with atrial fibrillation and co-morbidities: a study protocol for a randomized controlled trial (RIVOX-AF). Front Cardiovasc Med. 2023 May 24:10:1130216.
• Park J, An SY, Choi HM, Hwang IC, Yoon YE, Park JH, Cho GY. The Risk of Heart Failure Progression in Patients With Patent Foramen Ovale: Differential Risk Associated With Device Closure. J Am Soc Echocardiogr. 2023 Aug;36(8):812-820.
• Park JJ, Greenberg B. Topping Off the Pill Box: Dapagliflozin, Heart Failure, and Polypharmacy. JACC Heart Fail. 2023 Oct;11(10):1394-1396.
• Park J, Yoon Y, Cho Y, Kim J. Feasibility of artificial intelligence-based ECG analysis for the prediction of obstructive coronary artery disease in patients with stable angina: A validation study. JMIR Cardio. 2023 May 2;7:e44791.
• Park CS, Kim H, Lee SR, Lee JH, Cho Y, Choi EK, Oh IY, Oh S. Prognostic implication of early recurrence after cryoballoon ablation in patients with atrial fibrillation. J. Interv. Card. J Interv Card Electrophysiol. 2024 Mar;67(2):285-292.
• Kim JY, Oh IY, Lee H, Lee JH, Cho Y, Gil Y, Jung S, Kim DI, Shin MG, Yoo JY, Kwak JY. The efficacy of detecting arrhythmia is higher with 7‐day continuous electrocardiographic patch monitoring than with 24‐h Holter monitoring. J Arrhythm. 2023 May 8;39(3):422-429.
• Kim MC, Ahn Y, Kim MH, Kim SY, Hong TJ, Rhee MY, Kim SH, Hong SJ, Kim H, Kim W, Chae IH, Kang DH, Kim BK, Kim HS. A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia. Am J Cardiovasc Drugs. 2023 Jul;23(4):441-454.
• Lee SH, Hyun D, Choi J, Yoon CH, Cha KS, Oh S, Seong IW, Jeong MH, Choi JH. Adherence to guideline-directed medical therapy and 3-year clinical outcome following acute myocardial infarction. Eur Heart J Open. 2023 Mar 17;3(2).
• Rhee TM, Bae JW, Park KW, Rha SW, Kang J, Lee H, Yang HM, Kwak SH, Chae IH, Shin WY, Kim DK, Oh JH, Jeong MH, Kim YH, Lee NH, Hur SH, Yoon J, Han JK, Shin ES, Koo BK, Kim HS; HOST-EXAM Investigators. Aspirin vs Clopidogrel for Long-term Maintenance After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the HOST-EXAM Trial. JAMA Cardiol. 2023 Jun 1;8(6):535-544.
• Kim D, Jeong H, Kim S, Shin HG, Park KI, Lee SP, Lee HS, Lee JY, Kim KI, Kang SH, Lee JH, Jang SY, Lee JH, Kim KH, Cho JY, Park JH, Park SK, Kim S, Kim K, Lee HY. Association between office visit intervals and long-term cardiovascular risk in hypertensive patients. J Clin Hypertens (Greenwich). 2023 Aug;25(8):748-756.
• Kwak S, Lim J, Yang S, Rhee TM, Choi YJ, Lee HJ, Hwang IC, Lee H, Yoon YE, Park HE, Lee SP, Kim HK, Choi SY, Kim YJ, Cho GY, Park JB. Atrial Functional Tricuspid Regurgitation: Importance of Atrial Fibrillation and Right Atrial Remodeling and Prognostic Significance. J Clin Hypertens (Greenwich). 2023 Aug;25(8):748-756.
• Negishi T, Thavendiranathan P, Penicka M, Lemieux J, Murbraech K, Miyazaki S, Shirazi M, Santoro C, Cho GY, Popescu BA, Kosmala W, Costello B, la Gerche A, Mottram P, Thomas L, Seldrum S, Hristova K, Bansal M, Kurosawa K, Fukuda N, Yamada H, Izumo M, Tajiri K, Sinski M, Vinereanu D, Shkolnik E, Banchs J, Kutty S, Negishi K, Marwick TH. Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy: 3-Year Results of the SUCCOUR Trial. JACC Cardiovasc Imaging. 2023 Mar;16(3):269-278.
• Yang S, Hwang D, Zhang J, Park J, Yun JP, Lee JM, Nam CW, Shin ES, Doh JH, Chen SL, Kakuta T, Toth GG, Piroth Z, Johnson NP, Hakeem A, Uretsky BF, Hokama Y, Tanaka N, Lim HS, Ito T, Matsuo A, Azzalini L, Leesar MA, Neleman T, van Mieghem NM, Diletti R, Daemen J, Collison D, Collet C, De Bruyne B, Koo BK. Clinical and Vessel Characteristics Associated With Hard Outcomes After PCI and Their Combined Prognostic Implications. J Am Heart Assoc. 2023 Sep 5;12(17).
• Kwon W, Lee JM, Yun KH, Choi KH, Lee SJ, Lee JY, Lee SY, Kim SM, Cho JY, Kim CJ, Ahn HS, Nam CW, Yoon HJ, Park YH, Lee WS, Jeong JO, Song PS, Doh JH, Jo SH, Yoon CH, Kang MG, Koh JS, Lee KY, Lim YH, Cho YH, Cho JM, Jang WJ, Chun KJ, Hong D, Park TK, Yang JH, Choi SH, Gwon HC, Hahn JY, Song YB; RENOVATE COMPLEX-PCI Investigators. Clinical Benefit of Intravascular Imaging Compared With Conventional Angiography in Left Main Coronary Artery Intervention. Circ Cardiovasc Interv. 2023 Dec;16(12).
• Baskaran L, Lee JK, Ko MSM, Al'Aref SJ, Neo YP, Ho JS, Huang W, Yoon YE, Han D, Nakanishi R, Tan SY, Al-Mallah M, Budoff MJ, Shaw LJ. Comparing the pooled cohort equations and coronary artery calcium scores in a symptomatic mixed Asian cohort. Front Cardiovasc Med. 2023 Jan 17.(10).
• Sung KC, Hong SJ, Rhee MY, Jeong MH, Kim DH, Lim SW, Park K, Lee JB, Kim SY, Cho JM, Cho GY, Heo JH, Kim SH, Lee HY, Kim W, Cho DK, Park S, Shin J, Pyun WB, Kwon K, Rha SW, Jung JA. Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertension. J Clin Hypertens (Greenwich). 2023 May;25(5):429-439.
• Chung SM, Moon JS, Hong JH, Hwang IC, Lim S. Comparison of the effects of gemigliptin versus glimepiride on cardiac function in patients with type 2 diabetes uncontrolled with metformin: The gemi-heart study. Diabetes Obes Metab. 2023 Aug;25(8):2181-2190.
• Kwak S, Lee SA, Lim J, Yang S, Hwang D, Lee HJ, Choi HM, Hwang IC, Lee S, Yoon YE, Park JB, Kim HK, Kim YJ, Song JM, Cho GY, Kang DH, Kim DH, Lee SP. Data-driven mortality risk prediction of severe degenerative mitral regurgitation patients undergoing mitral valve surgery. Eur Heart J Cardiovasc Imaging. 2023 Aug 23;24(9):1156-1165.
• Lee SJ, Lee HH, Ko YG, Ahn CM, Lee YJ, Kim JS, Kim BK, Hong MK, Chang Kim H, Yu CW, Lee JH, Lee SW, Youn YJ, Park JK, Yoon CH, Rha SW, Min PK, Choi SH, Chae IH, Choi D; K-VIS Investigators. Device Effectiveness for Femoropopliteal Artery Disease Treatment: An Analysis of K-VIS ELLA Registry. JACC Cardiovasc Interv. 2023 Jul 10;16(13):1640-1650.
• Cha JJ, Cho JY, Lim S, Kim JH, Joo HJ, Park JH, Hong SJ, Lim DS, Kook H, Lee SH, Ko YG, Min PK, Lee JH, Yoon CH, Chae IH, Lee SW, Lee SR, Choi SH, Koh YS, Yu CW. Effect of Cilostazol on Patients With Diabetes Who Underwent Endovascular Treatment for Peripheral Artery Disease. J Am Heart Assoc. 2023 Jun 20;12(12):e027334.
• Song ZY, Kim MH, Lee HC, Park SJ, Rhee MY, Choi JI, Kim SH, Chae IH, Hong YJ, Lee NH, Hwang GS, Hur SH, Son JW, Chae JK, Kim HS. Efficacy and Safety of Coadministered Ezetimibe-Rosuvastatin plus Telmisartan in South Korean Patients with Dyslipidemia and Hypertension: A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase III Trial. J Clin Med. 2023 Mar 19;12(6):2377
• Lee S, Yoon CH, Oh DH, Anh TQ, Jeon KH, Chae IH, Park KD. Gelatin microgel-coated balloon catheter with enhanced delivery of everolimus for long-term vascular patency. Acta Biomater. 2024 Jan 1:173:314-324.
• Brann A, Miller J, Eshraghian E, Park JJ, Greenberg B. Global longitudinal strain predicts clinical outcomes in patients with heart failure with preserved ejection fraction. Eur J Heart Fail. 2023 Oct;25(10):1755-1765.
• Rhee TM, Kim HK, Kim BS, Han KD, Lee HJ, Hwang IC, Lee H, Park JB, Yoon YE, Kim YJ, Cho GY. Impact of coronary artery revascularization on long-term outcome in hypertrophic cardiomyopathy patients: a nationwide population-based cohort study. Sci Rep. 2023 Apr 19;13(1):6412.
• Lee Y, Shin JH, Seo SM, Choi IJ, Lee JY, Lee JW, Park MW, Kang TS, Choi WG, Jeon KH, Lim HS, Joo HJ, Rhee SJ, Seo JB, Park MS, Park SH, Lim YH. Influence of early dose reduction of ticagrelor on clinical outcomes following percutaneous coronary intervention for complex lesions. Sci Rep. 2023 Sep 19;13(1):15481.
• Kwon W, Choi KH, Song YB, Park YH, Lee JM, Lee JY, Lee SJ, Lee SY, Kim SM, Yun KH, Cho JY, Kim CJ, Ahn HS, Nam CW, Yoon HJ, Lee WS, Jeong JO, Song PS, Doh JH, Jo SH, Yoon CH, Hong D, Park TK, Yang JH, Choi SH, Gwon HC, Hahn JY; RENOVATE COMPLEX-PCI Investigators. Intravascular Imaging in Patients With Complex Coronary Lesions and Chronic Kidney Disease. JAMA Netw Open. 2023 Nov 1;6(11):e2345554.
• Kwak S, Lee SA, Lim J, Yang S, Choi HM, Hwang IC, Lee S, Yoon YE, Park JB, Kim HK, Kim YJ, Song JM, Cho GY, Kim KH, Kang DH, Kim DH, Lee SP. Long-term outcomes in distinct phenogroups of patients with primary mitral regurgitation undergoing valve surgery. Heart. 2023 Jan 27;109(4):305-313.
• Lee SJ, Cha JJ, Choi WG, Lee WS, Jeong JO, Choi S, Cho YH, Park W, Yoon CH, Lee YJ, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y, Hong SJ, Kim JS; RACING Investigators. Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial. JAMA Cardiol. 2023 Sep 1;8(9):853-858.
• Lin FY, Goebel BP, Lee BC, Lu Y, Baskaran L, Yoon YE, Maliakal GT, Gianni U, Bax AM, Sengupta PP, Slomka PJ, Dey DS, Rozanski A, Han D, Berman DS, Budoff MJ, Miedema MD, Nasir K, Rumberger J, Whelton SP, Blaha MJ, Shaw LJ. Mortality impact of low CAC density predominantly occurs in early atherosclerosis: explainable ML in the CAC consortium. J Cardiovasc Comput Tomogr. 2023 Jan-Feb;17(1):28-33.
• Ahn HJ, Kang J, Lee SR, Park JJ, Lee HY, Choi DJ, Cho HJ. Neutrophil-to-lymphocyte ratio as a predictor of in-hospital complications and overall mortality in Takotsubo syndrome preceded by physical triggers. BMC Cardiovasc Disord. 2023 Jan 27;23(1):51.
• Yun JP, Kang J, Park KW, Park K, Hwang D, Han JK, Yang HM, Kang HJ, Koo BK, Chae IH, Moon KW, Park HW, Won KB, Jeon DW, Han KR, Choi SW, Ryu JK, Jeong MH, Kim HS. Prasugrel-Based De-Escalation in Patients With Acute Coronary Syndrome According to Renal Function. JACC Asia. 2023 Jan 10;3(1):51-61.
• Jin G, Seong SW, Kim MJ, Ahn KT, Jin SA, Hahn JY, Gwon HC, Hur SH, Rha SW, Yoon CH, Jeong MH, Bae JW, Song PS, Jeong JO; KAMIR-NIH Investigators. Prevalence and Prognostic Implications of Worsening Renal Function After Acute Myocardial Infarction. Am J Cardiol. 2023 Aug 1;200:40-46.
• Kim SB, Kim N, Park J, Hwang IC, Lim SH, Song DH, Choi Y, Yoon H, Shin CM, Park YS, Lee DH, Ahn S. Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow-up of 51 months. Helicobacter. 2023 Aug;28(4):e12969.
• Ahn JM, Kang DY, Lee PH, Ahn YK, Kim WJ, Nam CW, Jeong JO, Chae IH, Shiomi H, Kao PHL, Hahn JY, Her SH, Lee BK, Ahn TH, Chang K, Chae JK, Smyth D, Stone GW, Park DW, Park SJ; PREVENT Investigators. Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: Rationale and design of the randomized, controlled PREVENT trial. Am Heart J. 2023 Oct;264:83-96.
• Hong D, Kim SM, Lee SY, Choi KH, Song YB, Lee JY, Lee SJ, Yun KH, Cho JY, Kim CJ, Ahn HS, Nam CW, Yoon HJ, Park YH, Lee WS, Jeong JO, Song PS, Doh JH, Jo SH, Yoon CH, Kang MG, Koh JS, Lee KY, Lim YH, Cho YH, Cho JM, Jang WJ, Chun KJ, Park TK, Yang JH, Choi SH, Gwon HC, Hahn JY, Lee JM; RENOVATE-COMPLEX-PCI Investigators. Prognostic Impact of Intravascular Imaging-Guided Percutaneous Coronary Intervention in Chronic Total Occlusion. Circulation. 2023 Sep 12;148(11):903-905.
• Sa YK, Hwang BH, Chung WB, Lee KY, Lee J, Kang D, Ko YG, Yu CW, Kim J, Choi SH, Bae JW, Chae IH, Choi YS, Park CS, Yoo KD, Jeon DS, Kim HS, Chung WS, Chang K. Real-World Comparison of Transcatheter Versus Surgical Aortic Valve Replacement in the Era of Current-Generation Devices. J Clin Med. 2023 Jan 10;12(2):571.
• Park JB, Yun JY, Kim B, Rhee TM, Lee HJ, Lee H, Hwang IC, Yoon YE, Park HE, Lee SP, Choi SY, Kim YJ, Cho GY, Han K, Kim HK. Risk of incident mental disorders in hypertrophic cardiomyopathy: a nationwide propensity-matched study. Eur J Prev Cardiol. 2023 Jan 11;30(1):85-94.
• Shin ES, Jun EJ, Han JK, Kong MG, Kang J, Zheng C, Garg S, Choi YJ, Bae JW, Chun KJ, Kim DI, Rha SW, Lee SY, Rhew JY, Woo SI, Lee HC, Jeong JO, Yang HM, Park KW, Kang HJ, Koo BK, Chae IH, Kim HS. Sex-related impact on clinical outcomes of patients treated with drug-eluting stents according to clinical presentation: Patient-level pooled analysis from the GRAND-DES registry. Cardiol J. 2023;30(1):105-116.
• Kim YS, Jeong HG, Hwang IC, Kim BJ, Kwon JM, Bae HJ, Han MK. Tricuspid regurgitation: a hidden risk factor for atrial fibrillation related stroke? Front Cardiovasc Med. 2023 Jul 18;10:1135069.
• Jin U, Yoon M, Ha J, Lee SH, Yun D, Kim JS, Oh J, Park S, Lee SH, Kang SM, Lee CJ. Association between frailty and physical performance in older patients with heart failure. Clin Cardiol. 2023 Dec;46(12):1530-1537.
• H. J. Ahn, M. J. Cha, E. Lee, S. R. Lee, E. K. Choi, S. Han, et al. The higher recurrence rate after catheter ablation in younger patients with atrial fibrillation suggesting different pathophysiology. J Interv Card Electrophysiol. 2023 Oct;66(7):1609-1619.
• Jeong JH, Lee HS, Choi YY, Kim YG, Choi JI, Kim YH, Lim HE, Oh IY, Cha MJ, Lee SR, Kim JY, Kwon CH, Lee SH, Park J, Kim KH, Yang PS, Kim JH, Shim J. Association of typical atrial flutter and cavotricuspid isthmus ablation on clinical recurrence after cryoballoon ablation for atrial fibrillation. Front Cardiovasc Med. 2023 Dec 15;10:1303635
• Song MJ, Jang Y, Lee JH, Yoon JH, Kim DJ, Jung SY, Lim SY. Association of Dexmedetomidine With New-Onset Atrial Fibrillation in Patients With Critical Illness. JAMA Netw Open. 2023 Apr 3;6(4):e239955.

소화기내과

• Lee JW, Kim N, Choi SI, Jang JY, Song CH, Nam RH, Lee DH. Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea. Helicobacter. Helicobacter. 2023 Feb;28(1):e12939.
• Song CH, Kim N, Nam RH, Choi SI, Jang JY, Lee H. Changes in gut microbiome upon orchiectomy and testosterone administration in AOM/DSS-induced colon cancer mouse model. Cancer Res Treat. 2023 Jan;55(1):196-218.
• Kim SB, Kim N, Park J, Hwang IC, Lim SH, Song DH, Choi Y, Yoon H, Shin CM, Park YS, Lee DH, Ahn S. Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow-up of 51 months. Helicobacter. 2023 Aug;28(4):e12969.
• Song CH, Kim N, Nam RH, Choi SI, Jang JY, Choi J, Lee HN. Anti-PD-L1 antibody and/or 17β-estradiol treatment induces changes in the gut microbiome in MC38 colon tumor model. Cancer Res Treat. 2023 Jul;55(3):894-909.
• Lee HD, Nam KH, Shin CM, Lee HS, Chang YH, Yoon H, Park YS, Kim N, Lee DH, Ahn SH, Kim HH. Development and Validation of Models to Predict Lymph Node Metastasis in Early Gastric Cancer Using Logistic Regression and Gradient Boosting Machine Methods.Cancer Res Treat. 2023;55(4):1240-1249
• Choi J, Kim N, Nam RH, Kim JW, Song CH, Na HY, Kang GH. Influence of location-dependent sex difference on PD-L1, MMR/MSI, and EGFR in colorectal carcinogenesis. PLoS. 2023;18(2):e0282017
• Kim N. Sex/gender differences in gastrointestinal endoscopy from the perspective of patients and gastroenterologists. Clin Endosc. 2023 May;56(3):268-282.
• Choi Y, Choi SI, Kim N, Nam RH, Jang JY, Na HY, Shin CM, Lee DH, Min H, Kim YR, Seok YJ. Effect of Clostridium butyricum on high-fat diet-induced intestinal inflammation and production of short-chain fatty acids. Dig Dis Sci. 2023 Jun;68(6):2427-2440.
• Kim SB, Kim N, Park J, Hwang IC, Lim SH, Song DH, Choi Y, Yoon H, Shin CM, Park YS, Lee DH, Ahn S. Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow-up of 51 months. Helicobacter. 2023 Aug;28(4):e12969.
• Kim J, Choi GH, Jang OJ, Chon Y, Cho SN, Kwon D, Jeong SH. Hepatitis C Virus Seroprevalence in Persons Who Inject Drugs in Korea, 2012-2022: A Multicenter, Retrospective Study. J Korean Med Sci. 2023 Dec 11;38(48):e357
• Ahn S, Choi J, Jeong SH. The First Korean Adult Case of Progressive Familial Intrahepatic Cholestasis Type 7 with Novel USP53 Splicing Variants by Next Generation Sequencing. Yonsei Med J. 2023 Dec;64(12):745-749
• Shin YC, Cho EJ, Na HY, Cho JY, Han HS, Lee YJ, Kim H, Jang S, Choi GH, Jang ES, Kim JW, Jeong SH.Hepatic hemangioma: proportion and predictor of surgical treatment with emphasis on its growth rate. Korean J Intern Med. 2023 Nov;38(6):818-830
• Jeong CY, Choi GH, Jang ES, Kim YS, Lee YJ, Kim IH, Cho SB, Yoon JH, Kim KA, Choi DH, Chung WJ, Cho HJ, Na SK, Kim YT, Lee BS, Jeong SH.A Silent Outbreak of Hepatitis E Virus (HEV) Infection or False-Positive Reaction of Anti-HEV IgM after COVID-19 Vaccination? Epidemiological Investigation of an Outbreak in a Korean Factory Complex in 2022. Sci Rep. 2023 Aug 31;13(1):14271
• Jang ES, Choi GH, Kim YS, Kim IH, Lee YJ, Cho SB, Kim YT, Jeong SH.Prevalence, incidence, and outcomes of hepatitis E virus coinfection in patients with chronic hepatitis C.Sci Rep. 2023 Aug 21;13(1):13632
• Lee CH, Choi GH, Choi HY, Han S, Jang ES, Chon YE, Chang Y, Kim KA, Kim DY, Yim HJ, Kim HL, Jeong SH, Kim IH.Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study. Clin Mol Hepatol. 2023 Jul;29(3):779-793
• Kim KA, Lee S, Park HJ, Jang ES, Lee YJ, Cho SB, Kim YS, Kim IH, Lee BS, Chung WJ, Ahn SH, Kim S, Jeong SH. Next-generation sequencing analysis of hepatitis C virus resistance-associated substitutions in direct-acting antiviral failure in South Korea. Clin Mol Hepatol. 2023 Apr;29(2):496-509
• Jaehyung Park, Nayoung Kim, Won Seok Kim, Seon Hee Lim, Yonghoon Choi, Hyeong Ho Jo, Eunjeong Ji, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee. Long-term effects of the eradication of Helicobacter pylori on metabolic parameters depending on sex, in South Korea. Gut and Liver. 2023 Jan;17(1):58-68.
• Jihye Park, Jaeyoung Chun, Hyuk Yoon, Jae Hee Cheon, Feasibility of a clinical decision support tool for ustekinumab to predict clinical remission and relapse in patients with Crohn’s disease: A multicenter, observational study, Inflammatory Bowel Disease, 2023 Apr;29(4):548-554
• Yu Kyung Jun, Hyuk Yoon, Seong-Joon Koh, A Hyeon Kim, Kwang Woo Kim, Jun Won Park, Hyun Jung Lee, Hyoun Woo Kang, Jong Pil Im, Young Soo Park, Joo Sung Kim.Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease. 2024 Apri;21(2)244-251
• Jihye Park, Jaeyoung Chun, Soo Jung Park, Jae Jun Park, Tae Il Kim, Hyuk Yoon, Jae Hee CheonEffectiveness and tolerability of methotrexate monotherapy in Crohn’s disease patients: A multicenter observational study. Therapeutic Advances in Gastroenterology. 2023 Aug;16:1-11
• Hee Moon Koo, Yu Kyung Jun, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Young Kee Shin, Hyuk Yoon. 10 Years of Biologic Use Patterns in Patients with Inflammatory Bowel Disease: Treatment Persistence, Switching, and Dose-Intensification - A Nationwide Population-based Study. Therapeutic Advances in Gastroenterology. 2023Sep ;16:1–16
• Jin Park, Hae Young Kim, Yoon Jin Lee, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee. Distribution of Small Bowel Involvement and its Association with Clinical Outcomes in Patients with Crohn’s disease. Medicine (Baltimore). 2023 Oct 6;102(40)
• Hyuk Yoon, Young Soo Park, Jeong Eun Shin, Byong Duk Ye, Chang Soo Eun, Soon Man Yoon, Jae Myung Cha, You Sun Kim, Kyu Chan Huh, Young Sook Park, Jae Hee Cheon, Eun Suk Jung, Youngdoe Kim, Su Young Jung. Clinical importance of weight gain and associated factors in patients with moderate to severe ulcerative colitis: Results from the MOSAIK cohort in Korea. BMC Gastroenterology. 2023 Nov 21;23(1):405.
• Hyuk Yoon, Sunghyouk Park, Yu Kyung Jun, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee. Evaluation of Bacterial and Fungal Biomarkers for Differentiation and Prognosis of Patients with Inflammatory Bowel Disease. 2023 Nov 29;11(12):2882.
• Yu Kyung Jun, Hee Tae Yoon 2, So Hyun Kwon 2, Ui Hyeon Jo 3, Ji Eun Kim 4, Yoo Min Han 2 5, Min-Seon Kim 6, Jong Pil Im 2, Dong Ho Lee 1, Joo Sung Kim 2, Seong-Joon Koh, Hyunsun Park. Regulation of psoriasis, colitis, and the intestinal microbiota by clusterin. SCIENTIFIC. 2023 Sep 16;13(1):15405.
• Jun, YK/Yu, DA/Han, YM/Lee, SR/Koh, SJ/Park, H. The relationship between rosacea and inflammatory bowel disease: A systematic review and meta-analysis. DERMATOLOGY AND THERAPY. 2023 Jul;13(7):1465-1475.
• Jun, YK/Koh, SJ/Myung, DS/Park, SH/Ooi, CJ/Sood, A/Im, JP, Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting. INTESTINAL RESEARCH. 2023 Jul;21(3):353-362.
• Jun, YK/Yoon, H/Koh, SJ/Kim, AH/Kim, KW/Park, JW/Lee, HJ/Kang, HW/Im, JP/Park, YS/Kim, JS. Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease. INTESTINAL RESEARCH. 2023 Apr;21(2):244-251.
• Ho-Kyoung Lee, Nam-Eun Kim, Cheol Min Shin, Tae Jung Oh, Hyuk Yoon, Young Soo Park, Nayoung Kim, Sungho Won, Dong Ho Lee. Gut microbiome signature of metabolically healthy obese individuals according to anthropometric, metabolic and inflammatory parameters. Scientific Reports. 2024 Feb 11;14(1):3449.
• Kim E, Lee HW, Kim SS, Yoon E, Jang ES, Chang JI, Cho YY, Seo GH, Kim HJ. Tenofovir disoproxil fumarate versus tenofovir alafenamide on risk of osteoporotic fracture in patients with chronic hepatitis B: A nationwide claims study in South Korea. Aliment Pharmacol Ther. 2023 Dec;58(11-12):1185-1193.
• Shin YC, Cho EJ, Na HY, Cho JY, Han HS, Lee YJ, Kim H, Jang S, Choi GH, Jang ES, Kim JW, Jeong SH. Hepatic hemangioma: proportion and predictor of surgical treatment with emphasis on its growth rate. Korean J Intern Med. 2023 Nov;38(6):818-830.
• Park GC, Chung JW, Jang ES, Kim JW. Association between adverse outcomes of hepatitis A and acetaminophen use: A population-based cohort study. Sci Rep. 2023 Aug 31;13(1):14271.
• Jeong CY, Choi GH, Jang ES, Kim YS, Lee YJ, Kim IH, Cho SB, Yoon JH, Kim KA, Choi DH, Chung WJ, Cho HJ, Na SK, Kim YT, Lee BS, Jeong SH. Etiology and clinical characteristics of acute viral hepatitis in South Korea during 2020-2021: a prospective multicenter study. Sci Rep. 2023 Aug 31;13(1):14271.
• Park SB, Khan M, Chiliveri SC, Hu X, Irvin P, Leek M, Grieshaber A, Hu Z, Jang ES, Bax A, Liang TJ. SARS-CoV-2 omicron variants harbor spike protein mutations responsible for their attenuated fusogenic phenotype. Commun Biol. 2023 May 24;6(1):556.
• Kim, KW/Koh,SJ/Kang, HW/Park, H/Ha, H/Park, J/Kim, K/Jun, Y/Han, YM/Lee, HJ/Yoon, H/Im, JP/Park, YS/Kin, JW/Kim, JS. Atopic dermatitis is associated with the clinical course of inflammatory bowel disease. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2023 Jul-Dec;58(10):1115-1121.
• Jaehyung Park, Nayoung Kim, Won Seok Kim, Seon Hee Lim, Yonghoon Choi, Hyeong Ho Jo, Eunjeong Ji, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee. Long-term effects of the eradication of Helicobacter pylori on metabolic parameters depending on sex, in South Korea.
• Kyunghwan Oh, Hee Seung Hong, Nam Seok Ham, Jungbok Lee, Sang Hyoung Park, Suk-Kyun Yang, Hyuk Yoon, You Sun Kim, Chang Hwan Choi, Byong Duk Ye. Real-World Effectiveness and Safety of Ustekinumab Induction Therapy for Korean Patients with Crohn’s Disease: A KASID Prospective Multicenter Study. Intestinal Research. Intestinal Research. 2023 Jan;21(1):137-147.
• Eun Soo Kim, Sung Kook Kim, Dong Il Park, Hyo Jong Kim, Yoo Jin Lee, Ja Seol Koo, Eun Sun Kim, Hyuk Yoon, Ji Hyun Lee, Ji Won Kim, Sung Jae Shin, Hyung Wook Kim, Hyun-Soo Kim, Young Sook Park, You Sun Kim, Tae Oh Kim, Jun Lee, Chang Hwan Choi, Dong Soo Han, Jaeyoung Chun, Hyun Soo Kim. Comparison of the Pharmacokinetics of CT-P13 Between Crohn’s Disease and Ulcerative Colitis. 2023 Jul 1;57(6):601-609.
• Kwang Woo Ki, Seong-Joon Koh, Hyoun Woo Kang, Hyunsun Park, Hyeonjin Ha, Jin Park, Kyunghoon Kim, Yukyung Jun, Yoo Min Han, Hyun Jung Lee, Hyuk Yoon, Jong Pil Im, Young Soo Park, Ji Won Kim, Joo Sung Kim. Atopic dermatitis is associated with the clinical course of inflammatory bowel disease. Scandinavian Journal of Gastroenterology. 2023 Jul-Dec;58(10):1115-1121.
• Kim KA, Choi HY, Ki M, Jang ES, Jeong SH. Epidemiological trends and outcomes of primary biliary cholangitis in South Korea between 2009 and 2019 J Gastroenterol. 2023 Jul;58(7):682-692.
• Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, Kremer AE, Zigmond E, Andreone P, Gordon SC, Bowlus CL, Lawitz EJ, Aspinall RJ, Pratt DS, Raikhelson K, Gonzalez-Huezo MS, Heneghan MA, Jeong SH, Ladrón de Guevara AL, Mayo MJ, Dalekos GN, Drenth JPH, Janczewska E, Leggett BA, Nevens F, Vargas V, Zuckerman E, Corpechot C, Fassio E, Hinrichsen H, Invernizzi P, Trivedi PJ, Forman L, Jones DEJ, Ryder SD, Swain MG, Steinberg A, Boudes PF, Choi YJ, McWherter CA; ENHANCE Study Group*. Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. Hepatology.
• Heo J, Kim YJ, Lee SW, Lee YJ, Yoon KT, Byun KS, Jung YJ, Tak WY, Jeong SH, Kwon KM, Suri V, Wu P, Jang BK, Lee BS, Cho JY, Jang JW, Yang SH, Paik SW, Kim HJ, Kwon JH, Park NH, Kim JH, Kim IH, Ahn SH, Lim YS. Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study. Korean J Intern Med. 2023 Jul;38(4):504-513.
• Cho YK, Kim JH, Kim HS, Kim TO, Oh JH, Choi SC, Moon JS, Lee SK, Jung SW, Kim SS, Jung HK, Lee SP, Cheon GJ, Park MI, Jung HY, Ko KH, Sung IK, Lee SH, Lee JY, Lee ST, Rhee PL, Kim N, Hong SJ, Kim HJ, Kim GH, Lee KJ, Kim SK, Shin WG, Lee OY. Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitis. Aliment Pharmacol Ther. 2023;57(1):72-80.
• Lim H, Park JK, Chung H, Lee SH, Park JM, Park JH, Kim GH, Shin SK, Hong SJ, Lee KJ, Park MI, Jung HK, Kim HS, Sung JK, Jeon SW, Choi SC, Moon JS, Kim N, Park JJ, Hong SH, Kim NY, Jung HY. Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study. BMC Gastroenterol. 2023 Dec 18;23(1):447.
• Park SM, Kim KB, Han JH, Kim N, Kang TU, Swan H, Kim HJ. Incidence and risk of pancreatic cancer in patients with acute or chronic pancreatitis: a population-based cohort study. Sci Rep. 2023 Nov 2;13(1):18930.
• Park J, Kim HY, Lee YJ, Yoon H, Shin CM, Park YS, Kim N, Lee DH. Distribution of small bowel involvement and its association with clinical outcomes in patients with Crohn's disease. Medicine (Baltimore). 2023 Oct 6;102(40):e35040.
• Koo HM, Jun YK, Choi Y, Shin CM, Park YS, Kim N, Lee DH, Shin YK, Yoon H. 10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification - a nationwide population-based study. Therap Adv Gastroenterol. 2023 Sep 29:16:17562848231201728.
• Yoon H, Park S, Jun YK, Choi Y, Shin CM, Park YS, Kim N, Lee DH. Evaluation of bacterial and fungal biomarkers for differentiation and prognosis of patients with inflammatory bowel disease. Microorganisms. 2023 Nov 29;11(12):2882.
• Lee HD, Nam KH Shin CM, Lee HS, Chang YH, Yoon H, Park YS, Kim N, Lee DH, Ahn SH, Kim HH. Development and Validation of Models to Predict Lymph Node Metastasis in Early Gastric Cancer Using Logistic Regression and Gradient Boosting Machine Methods. Cancer Res Treat. 2023 Oct;55(4):1240-1249.

혈액종양내과

• Seo J, Koh J, Lee DW, Kim J, Ryu HS, Lee KH, Kim TY, Im SA. HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless of HER2 IHC results. Breast Cancer Res. 2023 Dec 14;25(1):154.
• Yang J, Kim SH, Jung EH, Kim SA, Suh KJ, Lee JY, Kim JW, Kim JW, Lee JO, Kim YJ, Lee KW, Kim JH, Bang SM, Lee JS. The effect of metformin or dipeptidyl peptidase 4 inhibitors on clinical outcomes in metastatic non-small cell lung cancer treated with immune checkpoint inhibitors. Thorac Cancer. 2023 Jan;14(1):52-60.
• Kim K, Kim H, Shin I, Noh SJ, Kim JY, Suh KJ, Kim YN, Lee JY, Cho DY, Kim SH, Kim JH, Lee SH, Choi JK. Genomic hypomethylation in cell-free DNA predicts responses to checkpoint blockade in lung and breast cancer. Sci Rep. 2023 Dec 18;13(1):22482.
• Kim S, Kim S, Kim SH, Jung EH, Suh KJ, Kim YJ, Kwon NJ, Kim H, Chung JH, Lee JS. Clinical validity of oncogenic driver genes detected from circulating tumor DNA in the blood of lung cancer patients. Transl Lung Cancer Res. 2023 Jun 30;12(6):1185-1196.
• Kim SH, Im SA, Suh KJ, Lee KH, Kim MH, Sohn J, Park YH, Kim JY, Jeong JH, Lee KE, Choi IS, Park KH, Kim HJ, Cho EK, Park SY, Kim M, Kim JH. Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16). Eur J Cancer. 2023 Dec;195:113386.
• Yhim HY, Lee J, Kim KH, Kim SA, Lee JY, Hwang HG, Hong J, Lee JO, Bang SM. Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximab-based combination chemotherapy: A population-based study in Korea. Thromb Res. 2023 Nov;231:50-57.
• Hwang HG, Lee JH, Bang SM. Incidence of Pregnancy-Associated Venous Thromboembolism: Second Nationwide Study. Thromb Haemost. 2023 Sep;123(9):904-910.
• Yoon D, Jeong HE, Choi S, Lee D, Shin JY, Bang SM. Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study. Cancer Med. 2023 Nov;12(21):20538-20543.
• Noh S, Kim SA, Lee JY, Lee JO, Bang SM. A case report of thrombotic thrombocytopenic purpura-like syndrome after Coronavirus disease 2019 vaccination. Blood Res. 2023 Jun 30;58(2):116-117.
• Jung EH, Byun JM, Shin DY, Do YR, Jo JC, Lee SM, Yoon SS. Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122). Cancer Med. 2023 Apr;12(8):9186-9193.
• Lee SW, Jung EH, Kim HJ, Min C, Yoo SH, Kim YJ, Rha SY, Yon DK, Kang B. Risk factors for delirium among patients with advanced cancer in palliative care: a multicenter, patient-based registry cohort in South Korea. Eur Rev Med Pharmacol Sci. 2023 Mar;27(5):2068-2076.
• Kim YJ, Kim SH. Advance Care Planning in South Korea. Z Evid Fortbild Qual Gesundhwes. 2023 Aug;180:68-73.
• Lim Y, Choi S, Oh HJ, Kim C, Song S, Kim S, Song H, Park S, Kim JW, Kim JW, Kim JH, Kang M, Kang SB, Kim DW, Oh HK, Lee HS, Lee KW. Artificial intelligence- powered spatial analysis of tumor-infiltrating lymphocytes for prediction of prognosis in resected colon cancer. NPJ Precis Oncol. 2023 Nov 20;7(1):124.
• Suh KJ, Ryu MH, Zang DY, Bae WK, Lee HS, Oh HJ, Kang M, Kim JW, Kim BJ, Mortimer PGS, Kim HJ, Lee KW. AZD8186 in Combination With Paclitaxel in Patients With Advanced Gastric Cancer: Results From a Phase Ib/II Study (KCSG ST18-20). Oncologist. 2023 Sep 7;28(9):e823-e834.
• Won SH, Hiratsuka Y, Suh SY, Bae H, Choi SE, Kim YJ, Kang B, Lee SW, Suh KJ, Kim JW, Kim SH, Kim JW, Lee KW. Mid-upper Arm Circumference as an Indicator of Quality of Life of Patients with Advanced Cancer. J Palliat Care. 2023 Jan;38(1):24-29.
• Lee KW, Zang DY, Ryu MH, Han HS, Kim KH, Kim MJ, Koh SA, Lee SS, Koo DH, Ko YH, Sohn BS, Kim JW, Park JH, Nam BH, Choi IS. A Phase 3 Randomized Clinical Trial to Compare Efficacy and Safety between Combination Therapy and Monotherapy in Elderly Patients with Advanced Gastric Cancer (KCSG ST13-10). Cancer Res Treat. 2023 Oct;55(4):1250-1260.
• Yeo M, Seo J, Lim J. The impact of the COVID-19 pandemic and the expansion of free vaccination policy on influenza vaccination coverage: An analysis of vaccination behavior in South Korea. PLoS One. 2023 Feb 15;18(2):e0281812.
• Park J, Kim HY, Na HY, Lee JS, Lee JC, Kim JW, Yoon YS, Hwang JH, Han HS, Kim J. Continued adjuvant FOLFIRINOX for BRPC or LAPC after neoadjuvant FOLFIRINOX. J Cancer Res Clin Oncol. 2023 May;149(5):1765-1775.
• Ryu H, Song C, Kim JS, Jeon JH, Cho S, Kim K, Jheon S, Kim SH, Kim YJ, Lee JS. Role of prognostic nutritional index in postoperative radiotherapy for non- small cell lung cancer. Thorac Cancer. 2023 Oct;14(28):2859-2868.
• Jung JJ, Kim EK, Kang E, Kim JH, Kim SH, Suh KJ, Kim SM, Jang M, Yun B, Park SY, Lim C, Han W, Shin HC. Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer. J Breast Cancer. 2023 Aug;26(4):353-362.
• Kim SW, Ohn JH, Kim NH, Kim ES, Lim Y, Lee J, Kim HW, Ryu J, Park HS, Suh KJ, Kim JW, Kim JW, Kim SH, Kim YJ, Lee KW, Kim JH, Lee JS, Jang HC. The Hospitalist-Oncologist co-ManagemEnt (HOME) system improves hospitalization outcomes of patients with cancer. BMC Health Serv Res. 2023 Dec 6;23(1):1367.
• Turpie AGG, Farjat AE, Haas S, Ageno W, Weitz JI, Goldhaber SZ, Goto S, Angchaisuksiri P, Kayani G, Lopes RD, Chiang CE, Gibbs H, Tse E, Verhamme P, Ten Cate H, Muntaner J, Schellong S, Bounameaux H, Prandoni P, Maheshwari U, Kakkar AK; GARFIELD-VTE investigators. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE. Thromb Res. 2023 Feb;222:31-39.
• Verstovsek S, Gerds AT, Vannucchi AM, Al-Ali HK, Lavie D, Kuykendall AT, Grosicki S, Iurlo A, Goh YT, Lazaroiu MC, Egyed M, Fox ML, McLornan D, Perkins A, Yoon SS, Gupta V, Kiladjian JJ, Granacher N, Lee SE, Ocroteala L, Passamonti F, Harrison CN, Klencke BJ, Ro S, Donahue R, Kawashima J, Mesa R; MOMENTUM Study Investigators. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study. Lancet. 2023 Jan 28;401(10373):269-280.
• Fu W, Bang SM, Huang H, Kim K, Li W, An G, Lee JJ, Cai Z, Jin J, Wang Y, Lin TL, Chim CS, Qi M, Wang J, Lu X, Song Y, Jia B, Yang X, Liu W, Zhou T, Yin L, Li Y, Zhang R, Hou J, Wang J. Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS Study. Clin Lymphoma Myeloma Leuk. 2023 Jun;23(6):446-455.e4.
• Candeloro M, Valeriani E, Monreal M, Ageno W, Riva N, Schulman S, Bang SM, Mellado M, Díaz-Peromingo JA, Moisés J, Díaz-Brasero AM, Garcia-Pagan JC, Perez- Campuzano V, Senzolo M, De Gottardi A, Di Nisio M. Clinical course and treatment of incidentally detected splanchnic vein thrombosis: an individual patient data meta-analysis. J Thromb Haemost. 2023 Jun;21(6):1592-1600.
• Yoon D, Jeong HE, Park S, You SC, Bang SM, Shin JY. Real-world data emulating randomized controlled trials of non-vitamin K antagonist oral anticoagulants in patients with venous thromboembolism. BMC Med. 2023 Sep 29;21(1):375.
• Ha H, Ko YH, Kim K, Hong J, Lee GW, Jeong SH, Bang SM, Yoon SS. Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy. Thromb J. 2023 Jun 5;21(1):63.
• Jung J, Kim K, Jung SH, Yoon SS, Lee JH, Kim JS, Shin HJ, Bang SM, Sohn SK, Suh C, Yoon DH, Kong SY, Min CK, Eom HS; Korean Multiple Myeloma Working Party. Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study. Cancer Res Treat. 2023 Apr;55(2):693-703.
• Byun JM, Shin J, Kim SA, Park H, Lee J, Shin DY, Hong J, Lee JO, Bang SM, Kim I, Yoon SS, Koh Y. A Phase II Study to Evaluate the Efficacy of Bortezomib in Combination with Thalidomide in Treatment-Naïve Waldenstrom Macroglobulinemia Patients. Cancer Res Treat. 2024 Apr;56(2):675-680.
• Kim SJ, Do YR, Lee HS, Lee WS, Kong JH, Kwak JY, Eom HS, Moon JH, Yi JH, Lee JO, Jo JC, Yang DH. A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study. Blood Res. 2023 Dec 31;58(4):194-200.
• Yhim HY, Lee J, Kim KH, Kim SA, Lee JY, Hwang HG, Hong J, Lee JO, Bang SM. Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximab-based combination chemotherapy: A population-based study in Korea. Thromb Res. 2023 Nov;231:50-57.
• Baek DW, Moon JH, Lee JH, Kang KW, Lee HS, Eom HS, Lee E, Lee JH, Lee JO, Park SK, Kim SJ, Yoo KH, Yoon SS, Koh Y, Kang HJ, Won JH, Lyu CJ, Hahn SM, Lee JH, Park JS, Jo JC, Mun YC, Yang DH, Song GY, Lim SN, Sohn SK; Korean Society of Blood and Marrow Transplantation. Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation. Blood Cancer J. 2023 Jun 26;13(1):95.
• Kim DY, Kim YR, Suh C, Yoon DH, Yang DH, Park Y, Eom HS, Lee JO, Kwak JY, Kang HJ, Hyun SY, Jo JC, Chang MH, Yoo KH, Lim SN, Shin HJ, Kim WS, Kim IH, Kim MK, Kim HJ, Lee WS, Mun YC, Kim JS. A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone. Am J Gastroenterol. 2023 Aug 1;118(8):1373-1380.
• Kim DW, Byun JM, Lee JO, Kim JK, Koh Y. Chemotherapy delivery time affects treatment outcomes of female patients with diffuse large B cell lymphoma. JCI Insight. 2023 Jan 24;8(2):e164767.
• Paik JH, Koh J, Han B, Kim S, Lee KR, Lee S, Lee JO, Kim TM, Kim WY, Jeon YK. Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression. Hum Pathol. 2023 Jan;131:47-60.
• Lee SW, Jung EH, Kim HJ, Min C, Yoo SH, Kim YJ, Rha SY, Yon DK, Kang B. Risk factors for delirium among patients with advanced cancer in palliative care: a multicenter, patient-based registry cohort in South Korea. Eur Rev Med Pharmacol Sci. 2023 Mar;27(5):2068-2076.
• Yoon WS, Chang JH, Kim JH, Kim YJ, Jung TY, Yoo H, Kim SH, Ko YC, Nam DH, Kim TM, Kim SH, Park SH, Lee YS, Yim HW, Hong YK, Yang SH. Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study). Discov Oncol. 2023 Jun 6;14(1):90.
• Galffy G, Lugowska I, Poddubskaya EV, Cho BC, Ahn MJ, Han JY, Su WC, Hauke RJ, Dyar SH, Lee DH, Serwatowski P, Estelles DL, Holden VR, Kim YJ, Vladimirov V, Horvath Z, Ghose A, Goldman A, di Pietro A, Wang J, Murphy DA, Alhadab A, Laskov M. A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer. ESMO Open. 2023 Jun;8(3):101173.
• Lee HB, Lee KH, Song SH, Kim K, Kim HK, Moon HG, Han W, Lee DW, Im SA, Jang BS, Kim YB, Yu J, Kim JH, Park YH, Shin KH, Chang JH. A Survey of Practice Patterns for Clinical Nodal Staging Prior to Neoadjuvant Chemotherapy in Breast Cancer. Oncologist. 2023 Dec 11;28(12):e1142-e1151.
• Lee K, Lee J, Choi J, Sim SH, Kim JE, Kim MH, Park YH, Kim JH, Koh SJ, Park KH, Kang MJ, Ahn MS, Lee KE, Kim HJ, Ahn HK, Kim HJ, Park KU, Park IH. Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer. Sci Rep. 2023 Jun 19;13(1):9928.
• Hwang S, Park S, Kim JH, Bang SB, Kim HJ, Ka NL, Ko Y, Kim SS, Lim GY, Lee S, Shin YK, Park SY, Kim S, Lee MO. Targeting HMG-CoA synthase 2 suppresses tamoxifen-resistant breast cancer growth by augmenting mitochondrial oxidative stress-mediated cell death. Life Sci. 2023 Sep 1;328:121827.
• Kim JS, Kim K, Jung W, Shin KH, Im SA, Kim HJ, Kim YB, Chang JS, Kim JH, Choi DH, Park YH, Kim DY, Kim TH, Choi BO, Lee SW, Kim S, Kwon J, Kang KM, Chung WK, Kim KS, Yoon WS, Kim JH, Cha J, Oh YK, Kim IA. Comparison of initial and sequential salvage brain-directed treatment in patients with 1-4 vs. 5-10 brain metastases from breast cancer (KROG 16-12). Breast Cancer Res Treat. 2023 Jul;200(1):37-45.
• Im SA, Gennari A, Park YH, Kim JH, Jiang ZF, Gupta S, Fadjari TH, Tamura K, Mastura MY, Abesamis-Tiambeng MLT, Lim EH, Lin CH, Sookprasert A, Parinyanitikul N, Tseng LM, Lee SC, Caguioa P, Singh M, Naito Y, Hukom RA, Smruti BK, Wang SS, Kim SB, Lee KH, Ahn HK, Peters S, Kim TW, Yoshino T, Pentheroudakis G, Curigliano G, Harbeck N. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer. ESMO Open. 2023 Jun;8(3):101541.
• Lee DW, Keam B, Lee KS, Ahn JH, Sohn J, Ahn JS, Lee MH, Kim JH, Lee KE, Kim HJ, Kim SY, Park YH, Ock CY, Lee KH, Han SW, Kim SB, Im YH, Chung HC, Oh DY, Im SA. A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03). Cancer Res Treat. 2023 Apr;55(2):523-530.
• Nakamura Y, Mizuno N, Sunakawa Y, Canon JL, Galsky MD, Hamilton E, Hayashi H, Jerusalem G, Kim ST, Lee KW, Kankeu Fonkoua LA, Monk BJ, Nguyen D, Oh DY, Okines A, O'Malley DM, Pohlmann P, Reck M, Shin SJ, Sudo K, Takahashi S, Van Marcke C, Yu EY, Groisberg R, Ramos J, Tan S, Stinchcombe TE, Bekaii-Saab T. Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study. J Clin Oncol. 2023 Dec 20;41(36):5569-5578.
• Kim DH, Lim Y, Ock CY, Park G, Park S, Song H, Ma M, Mostafavi M, Kang EJ, Ahn MJ, Lee KW, Kwon JH, Yang Y, Choi YH, Kim MK, Ji JH, Yun T, Kim SB, Keam B. Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma. Head Neck. 2023 Dec;45(12):3086-3095.
• Oh DY, Maqueda MA, Quinn DI, O'Dwyer PJ, Chau I, Kim SY, Duran I, Castellano D, Berlin J, Mellado B, Williamson SK, Lee KW, Marti F, Mathew P, Saif MW, Wang D, Chong E, Hilger-Rolfe J, Dean JP, Arkenau HT. Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase1b/2 study. BMC Cancer. 2023 Nov 3;23(1):1056.
• Lam LL, Pavlakis N, Shitara K, Sjoquist KM, Martin AJ, Yip S, Kang YK, Bang YJ, Chen LT, Moehler M, Bekaii-Saab T, Alcindor T, O'Callaghan CJ, Tebbutt NC, Hague W, Chan H, Rha SY, Lee KW, Gebski V, Jaworski A, Zalcberg J, Price T, Simes J, Goldstein D. INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG). BMC Cancer. 2023 Feb 22;23(1):180.
• Lee J, Park S, Jung HA, Lee SH, Seo S, Kim SB, Kim JW, Lee KW, Kang EJ, Kim JW, Choi YJ, Shim BY, An HJ, Park LC, Shin SH, Kim JJ, Oh SY, Kim MK, Ahn MJ. A phase 2 multicenter study of docetaxel-PM and trastuzumab-pkrb combination therapy in recurrent or metastatic salivary gland carcinomas. Cancer. 2023 Oct 1;129(19):2966-2974.
• Klempner SJ, Lee KW, Shitara K, Metges JP, Lonardi S, Ilson DH, Fazio N, Kim TY, Bai LY, Moran D, Yang J, Arozullah A, Park JW, Raizer JJ, Bang YJ, Shah MA. ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma. Clin Cancer Res. 2023 Oct 2;29(19):3882-3891.
• Choi Y, Kim N, Yun CY, Choi YJ, Yoon H, Shin CM, Park YS, Ahn SH, Joong Park D, Lee HS, Kim JW, Kim JW, Lee KW, Chang W, Park JH, Lee YJ, Lee KH, Kim YH, Lee DH, Kim HH. Correction: Effect of Helicobacter pylori eradication after subtotal gastrectomy on the survival rate of patients with gastric cancer: follow-up for up to 15 years. Gastric Cancer. 2023 Sep;26(5):843-845.
• Kwon HJ, Park Y, Nam SK, Kang E, Kim KK, Jeong I, Kwak Y, Yoon J, Kim TY, Lee KW, Oh DY, Im SA, Kong SH, Park DJ, Lee HJ, Kim HH, Yang HK, Lee HS. Genetic and immune microenvironment characterization of HER2-positive gastric cancer: Their association with response to trastuzumab-based treatment. Cancer Med. 2023 May;12(9):10371-10384.
• Catenacci DV, Kang YK, Uronis HE, Lee KW, Ng MC, Enzinger PC, Park SH, Gold PJ, Lacy J, Hochster HS, Oh SC, Kim YH, Marrone KA, Kelly RJ, Juergens RA, Kim JG, Alcindor T, Sym SJ, Song EK, Chee CE, Chao Y, Kim S, Oh DY, Yen J, Odegaard JI, Lagow E, Li D, Sun J, Kaminker P, Moore PA, Rosales MK, Park H. Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma. Oncology (Williston Park). 2023 Apr 25;37(4):176-183.
• Satake H, Lee KW, Chung HC, Lee J, Yamaguchi K, Chen JS, Yoshikawa T, Amagai K, Yeh KH, Goto M, Chao Y, Lam KO, Han SR, Shiratori S, Shah S, Shitara K. Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062. Jpn J Clin Oncol. 2023 Mar 7;53(3):221-229.
• Yamaguchi K, Bang YJ, Iwasa S, Sugimoto N, Ryu MH, Sakai D, Chung HC, Kawakami H, Yabusaki H, Lee J, Shimoyama T, Lee KW, Saito K, Kawaguchi Y, Kamio T, Kojima A, Sugihara M, Shitara K. Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Factor Receptor 2 Treatment-Naive Patients With Human Epidermal Growth Factor Receptor 2-Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial. J Clin Oncol. 2023 Feb 1;41(4):816-825.
• Lee YG, Kang EJ, Keam B, Choi JH, Kim JS, Park KU, Lee KE, Lee KW, Kim MK, Ahn HK, Shin SH, Kim HR, Kim SB, Kim HJ, Yun HJ. Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01). Cancers (Basel). 2023 Jan 12;15(2):471.
• Kim TH, Kwak Y, Song C, Lee HS, Kim DW, Oh HK, Kim JW, Lee KW, Kang SB, Kim JS. GLUT-1 may predict metastases and death in patients with locally advanced rectal cancer. Front Oncol. 2023 Mar 9;13:1094480.
• Oh DY, He AR, Qin S, Chen LT, Okusaka T, Vogel A, Kim JW, Suksombooncharoen T, Lee MA, Kitano M, Burris H, Bouattour M, Tanasanvimon S, McNamara MG, Zaucha R, Avallone A, Tan B, Cundom J, Lee CK, Takahashi H, Ikeda M, Chen JS, Wang J, Makowsky M, Rokutanda N, Żotkiewicz M, Kurland JF, Cohen G, Valle JW. Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer. Future Oncol. 2023 Nov;19(34):2277-2289.
• Yoo C, Javle MM, Verdaguer Mata H, de Braud F, Trojan J, Raoul JL, Kim JW, Ueno M, Lee CK, Hijioka S, Cubillo A, Furuse J, Azad N, Sato M, Vugmeyster Y, Machl A, Bajars M, Bridgewater J, Oh DY, Borad MJ. Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers. Hepatology. 2023 Sep 1;78(3):758-770.
• Harding JJ, Fan J, Oh DY, Choi HJ, Kim JW, Chang HM, Bao L, Sun HC, Macarulla T, Xie F, Metges JP, Ying J, Bridgewater J, Lee MA, Tejani MA, Chen EY, Kim DU, Wasan H, Ducreux M, Bao Y, Boyken L, Ma J, Garfin P, Pant S; HERIZON-BTC-01 study group. Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study. Lancet Oncol. 2023 Jul;24(7):772-782.
• Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, Yau T, Klümpen HJ, Chan SL, Ozaka M, Verslype C, Bouattour M, Park JO, Barajas O, Pelzer U, Valle JW, Yu L, Malhotra U, Siegel AB, Edeline J, Vogel A; KEYNOTE-966 Investigators. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023 Jun 3;401(10391):1853-1865. doi: 10.1016/S0140-6736(23)00727-4. Epub 2023 Apr 16. Erratum in: Lancet. 2023 Sep 16;402(10406):964.
• Choi J, Kim N, Nam RH, Kim JW, Song CH, Na HY, Kang GH. Influence of location-dependent sex difference on PD-L1, MMR/MSI, and EGFR in colorectal carcinogenesis. PLoS One. 2023 Feb 21;18(2):e0282017.
• Lee CK, Chon HJ, Cheon J, Lee MA, Im HS, Jang JS, Kim MH, Park S, Kang B, Hong M, Kim JW, Park HS, Kang MJ, Park YN, Choi HJ. Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14). Lancet Gastroenterol Hepatol. 2023 Jan;8(1):56-65.

내분비내과

• Lim S, Sohn M. How to cope with emerging viral diseases: lessons from South Korea's strategy for COVID-19, and collateral damage to cardiometabolic health. Lancet Reg Health West Pac. 2023 Jan;30:100581
• Kong SH, Kim JH, Park MY, Kim SW, Shin CS. Residual risks of comorbidities after parathyroidectomy in a nationwide cohort of patients with primary hyperparathyroidism. Endocrine. 2023 Jan;79(1):190-199
• Lim S, Sohn M, Florez JC, Nauck MA, Ahn J. Effects of Initial Combinations of Gemigliptin Plus Metformin Compared with Glimepiride Plus Metformin on Gut Microbiota and Glucose Regulation in Obese Patients with Type 2 Diabetes: The INTESTINE Study. Nutrients. 2023 Jan 3;15(1):248.
• Kong SH, Lee JH, Bae JM, Hong N, Kim H, Park SY, Choi YJ, Lee S, Rhee Y, KimSW, Han D, Kim JH, Shin CS. In-depth proteomic signature of parathyroid carcinoma. Eur J Endocrinol. 2023 Apr 5;188(4):385-394
• Kong SH, Jo AJ, Park CM, Park KI, Yun JE, Kim JH. Chronic airway disease as a major risk factor for fractures in osteopenic women: Nationwide cohort study. Front Endocrinol (Lausanne). 2023 Mar 21;14:1085252
• Moon JH, Jang Y, Oh TJ, Jung SY. The Risk of Type 2 Diabetes Mellitus according to Changes in Obesity Status in Late Middle-Aged Adults: A Nationwide Cohort Study of Korea. Diabetes Metab J. 2023 Jul;47(4):514-522
• Kong SH, Kim S, Kim Y, Kim JH, Kim K, Shin CS. Development and validation of common data model-based fracture prediction model using machine learning algorithm. Osteoporos Int. 2023 Aug;34(8):1437-1451
• Kim MJ, Song H, Koh Y, Lee H, Park HE, Choi SH, Yoon JW, Choi SY. Clonal hematopoiesis as a novel risk factor for type 2 diabetes mellitus in patients with hypercholesterolemia. Front Public Health. 2023 Jun 28;11:1181879
• Moon JH, Kim Y, Oh TJ, Moon JH, Kwak SH, Park KS, Jang HC, Choi SH, Cho NH. Triglyceride-Glucose Index Predicts Future Atherosclerotic Cardiovascular Diseases: A 16-Year Follow-up in a Prospective, Community-Dwelling Cohort Study. Endocrinol Metab (Seoul). 2023 Aug;38(4):406-417
• Jang HN, Oh TJ. Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy. Diabetes Metab J. 2023 Nov;47(6):743-756
• Moon JH, Lee J, Kim KH, Kim HJ, Kim H, Cha HN, Park J, Lee H, Park SY, Jang HC, Kim H. Multiparity increases the risk of diabetes by impairing the proliferative capacity of pancreatic β cells. Exp Mol Med. 2023 Oct;55(10):2269-2280
• Moon JH, Jeong S, Jang H, Koo BK, Kim W. Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study. EClinicalMedicine. 2023 Oct 28;65:102292
• Sohn M, Jung H, Lee WS, Kim TH, Lim S. Effect of Lactobacillus plantarum LMT1-48 on Body Fat in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Metab J. 2023 Jan;47(1):92-103
• Ahn CH, Oh TJ, Min SH, Cho YM. Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes. Endocrinol Metab (Seoul). 2023 Feb;38(1):1-9
• Lim LL, Lau ESH, Cheung JTK, Chan SP, Ji L, Lim S, Sirinvaravong S,Unnikrishnan AG, Luk AOY, Cortese V, Durocher A, Chan JCN. Real-world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation (JADE) register. Diabetes Obes Metab. 2023 Jan;25(1):208-221
• Koo HY, Cho EB, Kong SH, Han K, Lee KN, Yoo JE, Min JH, Chun S, Shin DW. Fracture risk in Parkinson's disease according to its severity and duration. Osteoporos Int. 2023 Jan;34(1):81-89
• Suh B, Yu H, Kim H, Lee S, Kong S, Kim JW, Choi J. Interpretable Deep-Learning Approaches for Osteoporosis Risk Screening and Individualized Feature Analysis Using Large Population-Based Data: Model Development and Performance Evaluation. J Med Internet Res. 2023 Jan 13;25:e40179
• Golfetto Miskiewicz IC, Cho HC, Lee JI, Lee J, Lee Y, Lee YK, Choi SH. Effect of atorvastatin on lipoxygenase pathway-related gene expression in an in vitro model of lipid accumulation in hepatocytes. FEBS Open Bio. 2023 Apr;13(4):606-616
• Choi JH, Yu HW, Lee JK, Kim W, Choi JY, Na HY, Park SY, Ahn CH, Moon JH, Choi SI, Lee HY, Lee WW, Cha W, Jeong WJ. BRAF^V600E and TERT promoter C228T mutations on ThyroSeq v3 analysis of delayed skin metastasis from papillary thyroid cancer: a case report and literature review. World J Surg Oncol. 2023 Feb 17;21(1):49
• Jung SY, Cho EB, Han KD, Jung JH, Yeo Y, Kong SH, Shin DW, Min JH. Risk of fracture in neuromyelitis optica spectrum disorder and multiple sclerosis: a nationwide cohort study in South Korea. Osteoporos Int. 2023 May;34(5):925-933
• Kwak SH, Han KA, Kim KS, Yu JM, Kim E, Won JC, Kang JG, Chung CH, Oh S, Choi SH, Won KC, Kim SG, Cho SA, Cho BY, Park KS. Efficacy and safety of enavogliflozin, a novel SGLT2 inhibitor, in Korean people with type 2 diabetes: A 24-week, multicentre, randomized, double-blind, placebo-controlled, phase III trial. Diabetes Obes Metab. 2023 Jul;25(7):1865-1873
• Kim KS, Han KA, Kim TN, Park CY, Park JH, Kim SY, Kim YH, Song KH, Kang ES, Kim CS, Koh G, Kang JG, Kim MK, Han JM, Kim NH, Mok JO, Lee JH, Lim S, Kim SS, Kim TH, Won KC, Lee KY, Cho JH, Han JY, Kim SH, Nah JJ, Song HR, Lee SE, Kim S;ENHANCE-D Investigators. Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study. Diabetes Metab. 2023 Jul;49(4):101440
• Kim HS, Yu JM, Jang HC, Choi EK, Park JH, Shon HS, Chung CH, Park KG, Cho JH, Kim W, Lee KH, Lee JH, Yoo SJ. Real-World Analysis of Rapid-Acting Insulin Analog Use and Its Blood Glucose Lowering Effect in Patients with Type 2 Diabetes Mellitus: Results from PASSION Disease Registry in Korea. Diabetes Metab Syndr Obes 2022;15:1495-503.
• Hwang H, Choi JY, Yu HW, Moon JH, Kim JH, Lee EK, Kim YK, Lee CY, Cho SW, Chung EJ, Ryu CH, Ryu J, Yi KH, Park DJ, Lee KE, Park YJ, Kim SJ, Jung YS. Surgical Outcomes in Patients With Low-risk Papillary Thyroid Microcarcinoma From MAeSTro Study: Immediate Operation Versus Delayed Operation After Active SurveillanceA Multicenter Prospective Cohort Study. Ann Surg. 2023 Nov 1;278(5):e1087-e1095
• Kang SM, Yun HM, Sohn M, Lim S. Vascular and metabolic effects of ipragliflozin versus sitagliptin (IVS) in type 2 diabetes treated with sulphonylurea and metformin: IVS study. Diabetes Obes Metab. 2023 Jul;25(7):1922-1931
• Lim JY, Kim YY, Kim JW, Hong S, Min K, Beom J, Yoon BH, Lee SY, Kong SH, Yoo JI, Park MS, Nho JH, Ko S, Joo MW, Kim DH, Park CH, Kim TY, Sohn S, Park SY, Hong AR, Kwon YJ, Park SB, Lee YK, Moon NH, Kim BR, Park Y, Cha Y, Ha YC. Fracture Liaison Service in Korea: 2022 Position Statement of the Korean Society for Bone and Mineral Research. J Bone Metab. 2023 Feb;30(1):31-36
• LBae JH, Lim H, Lim S. The Potential Cardiometabolic Effects of Long-Chain ω-3 Polyunsaturated Fatty Acids: Recent Updates and Controversies. Adv Nutr. 2023 Jul;14(4):612-628
• Luo Y, Xia J, Zhao Z, Chang Y, Bee YM, Nguyen KT, Lim S, Yabe D, McGill M, Kong APS, Chan SP, Deodat M, Deerochanawong C, Suastika K, Xu C, Chen L, Chen W, Li X, Zhao W, Yao X, Ji L. Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta-analysis. J Diabetes. 2023 May;15(5):419-435
• Chung SM, Moon JS, Hong JH, Hwang IC, Lim S. Comparison of the effects of gemigliptin versus glimepiride on cardiac function in patients with type 2 diabetes uncontrolled with metformin: The gemi-heart study. Diabetes Obes Metab. 2023 Aug;25(8):2181-2190
• Ji L, Luo Y, Bee YM, Xia J, Nguyen KT, Zhao W, Chen L, Chan SP, Deerochanawong C, Lim S, Yabe D, McGill M, Suastika K, Li X, Kong APS, Chen W, Zhao Z, Xu C, Deodat M, Yao X. Use of basal insulin in the management of adults with type 2 diabetes: An Asia-Pacific evidence-based clinical practice guideline. J Diabetes. 2023 Jun;15(6):474-487
• Moon S, Lee J, Yu JM, Choi H, Choi S, Park J, Choi K, Kim E, Kim H, Kim MJ, Park YJ. Association between environmental cadmium exposure and increased mortality in the U.S. National Health and Nutrition Examination Survey (1999-2018). J Expo Sci Environ Epidemiol. 2023 Nov;33(6):874-882
• Twigg S, Lim S, Yoo SH, Chen L, Bao Y, Kong A, Yeoh E, Chan SP, Robles J, Mohan V, Cohen N, McGill M, Ji L. Asia-Pacific Perspectives on the Role of Continuous Glucose Monitoring in Optimizing Diabetes Management. J Diabetes SciTechnol. 2023 May 26:19322968231176533
• Kim I, Cho HJ, Lim S, Seok SH, Lee HY. Comparison of the effects of empagliflozin and sotagliflozin on a zebrafish model of diabetic heart failure with reduced ejection fraction. Exp Mol Med. 2023 Jun;55(6):1174-1181
• Chung GE, Cho EJ, Kim MJ, Yoo JJ, Cho Y, Lee KN, Han K, Kim YJ, Yoon JH, Shin DW, Yu SJ. Association between the fatty liver index and the risk of fractureamong individuals over the age of 50 years: a nationwide population-based study. Front Endocrinol (Lausanne). 2023 May 16;14:1156996
• Davies MJ, Ahmad E, Lim S, Lamptey R, Webb DR. Cancer is becoming the leading cause of death in diabetes - Authors' reply. Lancet. 2023 Jun 3;401(10391):1849-1850
• Lee JS, Sohn M, Kim K, Yoon YS, Lim S. Glucose Regulation after Partial Pancreatectomy: A Comparison of Pancreaticoduodenectomy and Distal Pancreatectomy in the Short and Long Term. Diabetes Metab J. 2023 Sep;47(5):703-714
• Sohn M, Dietrich JW, Nauck MA, Lim S. Characteristics predicting the efficacy of SGLT-2 inhibitors versus GLP-1 receptor agonists on major adverse cardiovascular events in type 2 diabetes mellitus: a meta-analysis study. Cardiovasc Diabetol. 2023 Jun 28;22(1):153
• Park D, Shin MJ, Després JP, Eckel RH, Tuomilehto J, Lim S. 20-Year Trends in Metabolic Syndrome Among Korean Adults From 2001 to 2020. JACC Asia. 2023 Jun 20;3(3):491-502
• Lee H, Kang BG, Jo J, Park HE, Yoon S, Choi SY, Kim MJ. Deep learning-based prediction for significant coronary artery stenosis on coronary computed tomography angiography in asymptomatic populations. Front Cardiovasc Med. 2023 Jun 21;10:1167468
• Luo Y, Chang Y, Zhao Z, Xia J, Xu C, Bee YM, Li X, Sheu WH, McGill M, Chan SP, Deodat M, Suastika K, Thy KN, Chen L, Shan Kong AP, Chen W, Deerochanawong C, Yabe D, Zhao W, Lim S, Yao X, Ji L. Device-supported automated basal insulin titration in adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Lancet Reg Health West Pac. 2023 Mar 24;35:100746
• Jeong SI, Kim W, Yu HW, Choi JY, Ahn CH, Moon JH, Choi SI, Cha W, Jeong WJ, Park SY, Na HY. Incidence and Clinicopathological Features of Differentiated High-Grade Thyroid Carcinomas: An Institutional Experience. Endocr Pathol. 2023 Sep;34(3):287-297
• Lim LL, S H Lau E, Pheng Chan S, Ji L, Lim S, Sirinvaravong S, Unnikrishnan AG, O Y Luk A, Cortese V, Durocher A, C N Chan J. Real-world evidence on health-related quality of life in patients with type 2 diabetes mellitus using sulphonylureas: An analysis of the Joint Asia Diabetes Evaluation (JADE) Register. Diabetes Res Clin Pract. 2023 Sep;203:110855
• Lee YK, Oh TJ, Lee JI, Choi BY, Cho HC, Jang HC, Choi SH. Complementary effects of dapagliflozin and lobeglitazone on metabolism in a diet-induced obese mouse model. Eur J Pharmacol. 2023 Oct 15;957:175946
• Hong JH, Moon JS, Seong K, Lim S. Comparison of therapeutic efficacy and safety of sitagliptin, dapagliflozin, or lobeglitazone adjunct therapy in patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea and metformin: Third agent study. Diabetes Res Clin Pract. 2023 Sep;203:110872
• Song J, Oh TJ, Song Y. Individual Postprandial Glycemic Responses to Meal Types by Different Carbohydrate Levels and Their Associations with Glycemic Variability Using Continuous Glucose Monitoring. Nutrients. 2023 Aug13;15(16):3571
• Choi KS, Hwang I, Moon JH, Kim M. Progressive reduction in basal ganglia explains and predicts cerebral structural alteration in type 2 diabetes. J Cereb Blood Flow Metab. 2023 Dec;43(12):2096-2104
• Kim GA, Moon JH, Kim W. Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity. Clin Mol Hepatol. 2023 Oct;29(4):831-843
• Sohn M, Frias JP, Lim S. Cardiovascular efficacy and safety of antidiabetic agents: A network meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2023 Dec;25(12):3560-3577
• Oh J, Kim W, Kim GH, Kim HL, Park SD, Min KW, Hyun D, Hong JH, Lim S, Shin J; RESOLVE-INT Investigators. Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors. Adv Ther. 2023 Nov;40(11):4817-4835
• Ko HY, Bea S, Jeong HE, Park S, Cho YM, Kong SH, Shin JY. Sodium-Glucose Cotransporter 2 Inhibitors vs Incretin-Based Drugs and Risk of Fractures for Type 2 Diabetes. JAMA Netw Open. 2023 Sep 5;6(9):e2335797
• Choi JH, Lee KA, Moon JH, Chon S, Kim DJ, Kim HJ, Kim NH, Seo JA, Kim MK, Lim JH, Song Y, Yang YS, Kim JH, Lee YB, Noh J, Hur KY, Park JS, Rhee SY, Kim HJ, Kim HM, Ko JH, Kim NH, Kim CH, Ahn J, Oh TJ, Kim SK, Kim J, Han E, Jin SM, Choi WS, Moon MK. 2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association. Diabetes Metab J. 2023 Sep;47(5):575-594
• Lee JY, Kim JH, Kim YK, Lee CY, Lee EK, Moon JH, Choi HS, Yul H, Cho SW, Kim SJ, Lee KE, Park DJ, Park YJ. US Predictors of Papillary Thyroid Microcarcinoma Progression at Active Surveillance. Radiology. 2023 Oct;309(1):e230006
• Shin K, Kim J, Park J, Oh TJ, Kong SH, Ahn CH, Moon JH, Kim MJ, Moon JH. A machine learning-assisted system to predict thyrotoxicosis using patients' heart rate monitoring data: a retrospective cohort study. Sci Rep. 2023 Nov 30;13(1):21096
• Han SM, Park ES, Park J, Nahmgoong H, Choi YH, Oh J, Yim KM, Lee WT, Lee YK, Jeon YG, Shin KC, Huh JY, Choi SH, Park J, Kim JK, Kim JB. Unique adipose tissue invariant natural killer T cell subpopulations control adipocyte turnover in mice. Nat Commun. 2023 Dec 21;14(1):8512
• Kim Buomsoo,Srinivasan Karthik,Kong Sung Hye,Kim Jung Hee,Shin Chan Soo,Ram Sudha. ROLEX: A NOVEL METHOD FOR INTERPRETABLE MACHINE LEARNING USING ROBUST LOCAL EXPLANATIONS, MIS Quarterly. Sep2023, Vol. 47 Issue 3, p1303-1332. 30p

신장내과

• Park S, Yi J, Lee YJ, Kwon EJ, Yun G, Jeong JC, Chin HJ, Na KY, Kim S. Electronic alert outpatient protocol improves the quality of care for the risk of postcontrast acute kidney injury following computed tomography. Kidney Res Clin Pract. 2023 Sep;42(5):606-616.
• Yadav SK, Park S, Lee YM, Hurh S, Kim D, Min S, Kim S, Yan JJ, Kang BC, Kim S, Yang J, Jeong JC. Application of microphysiologic system to assess neutrophil extracellular trap in xenotransplantation. J Immunol Methods. 2023 Oct;521:113537.
• Samantasinghar A, Ahmed F, Rahim CSA, Kim KH, Kim S, Choi KH. Artificial intelligence-assisted repurposing of lubiprostone alleviates tubulointerstitial fibrosis. Transl Res. 2023 Dec;262:75-88.
• Jeong HG, Kim T, Hong JE, Kim HJ, Yun SY, Kim S, Yoo J, Lee SH, Thomas RJ, Yun CH. Automated deep neural network analysis of lateral cephalogram data can aid in detecting obstructive sleep apnea. J Clin Sleep Med. 2023 Feb 1;19(2):327-337.
• Kim JH, Kang M, Kang E, Ryu H, Jeong Y, Kim J, Park SK, Jeong JC, Yoo TH, Kim Y, Kim YC, Han SS, Lee H, Oh KH. Comparison of cardiovascular event predictability between the 2009 and 2021 Chronic Kidney Disease Epidemiology Collaboration equations in a Korean chronic kidney disease cohort: the KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease. Kidney Res Clin Pract. 2023 Nov;42(6):700-711.
• Ryu J, Baek E, Son HE, Ryu JY, Jeong JC, Kim S, Na KY, Chae DW, Kim SP, Kim SH, Jhee JH, Chang TI, Choi BS, Chin HJ. Comparison of dominant and nondominant C3 deposition in primary glomerulonephritis. Kidney Res Clin Pract. 2023 Jan;42(1):98-108.
• Ryu H, Hong Y, Kang E, Kang M, Kim J, Park HC, Oh YK, Chin HJ, Park SK, Jung JY, Hyun YY, Sung SA, Ahn C, Oh KH; KNOW-CKD Study Group. Comparison of outcomes of chronic kidney disease based on etiology: a prospective cohort study from KNOW-CKD. Sci Rep. 2023 Mar 2;13(1):3570.
• Hwang JH, Oh S, Chin HJ, Kim S, Kim DK, Kim S, Park JH, Shin SJ, Lee SH, Choi BS, Lim CS. Comparison of the performance of currently used estimated glomerular filtration rate equations with 24-hour urine creatinine clearance: sampleanalysis of randomised controlled trial participants. BMJ Open. 2023 Aug 23;13(8):e067398.
• Ryu JY, Baek SH, Kim S. Correspondence on Letter regarding "Evidence-based hyponatremia management in liver disease". Clin Mol Hepatol. 2023 Oct;29(4):1048-1049.
• Choi JY, Chin HJ, Lee H, Jeon Y, Lim JH, Jung HY, Cho JH, Kim CD, Kim YL, Park SH. Effect of immunosuppressive agents on clinical outcomes in idiopathic membranous nephropathy. Kidney Res Clin Pract. 2023 Sep 8.
• Huh H, Kim YS, Chung W, Kim YL, Kim Y, Han S, Jung Y, Na KY, Lee KB, Oh YK, Park HC, Han SH, Yoo TH, Kim YH, Kim SW, Lee KW, Park HC, Kim SG, Kim H, Lee CH,Bae KT, Oh KH, Ahn C, Ryu HJ, Kim YC. Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period. Kidney Res Clin Pract. 2023 Mar;42(2):216-228.
• Yun G, Baek SH, Kim S. Evaluation and management of hypernatremia in adults: clinical perspectives. Korean J Intern Med. 2023 May;38(3):290-302
• Ryu JY, Baek SH, Kim S. Evidence-based hyponatremia management in liver disease. Clin Mol Hepatol. 2023 Oct;29(4):924-944.
• Han M, Wong G, Kute VB, Nakagawa Y, Wang HH, Arakama MH, Jeong JC, Cho YY, Thwin KT, Chapman J, Sapir-Pichhadze R, Mannon RB, Ahn C, Kim YH; Steering Committee Members of ASTREG-WIT-KT. Gender Disparity in Asian-Pacific Countries: An Analysis of the ASTREG-WIT-KT Registry. Transplantation. 2023 Jan 1;107(1):1-5.
• Fang X, Kim JH, Cui S, Shin YJ, Lee H, Ko EJ, Cheong HI, Kim S, Kim HS, Kim M, Yang CW, Lim SW, Chung BH. Generation of a human induced pluripotent stem cell line from a patient with dent disease. Stem Cell Res. 2023 Sep;71:103140.
• Kwon S, Kim YC, Kwon H, Cho JH, Kim CD, Son HE, Jeong JC, Jung IM, Yoo KD, Kim Y, Lee W, Lee JS, Lee H, Lim CS, Kim YS, Kim YH, Lee JP. Metformin Use and Long-term Clinical Outcomes in Kidney Transplant Recipients. Am J Kidney Dis. 2023 Sep;82(3):290-299.e1.
• Son HE, Yun G, Kwon EJ, Park S, Jeong JC, Kim S, Na KY, Paik JH, Chin HJ. Outcomes of minimal change disease without nephrotic range proteinuria. PLoS One. 2023 Aug 17;18(8):e0289870.
• Shin DJ, Li L, Cho A, Lee J, Oh S, Kwon S, Kim DK, Kim S, Oh YK, Lim CS, Kim YS, Lee JP; VENUS study investigators. Plasma Circulating Tumor Necrosis Factor Receptors at Multiple Time Points Can Predict the Outcome of Severe Acute Kidney Injury. Blood Purif. 2023;52(3):285-295.
• Yoo KD, Noh J, Bae W, An JN, Oh HJ, Rhee H, Seong EY, Baek SH, Ahn SY, Cho JH, Kim DK, Ryu DR, Kim S, Lim CS, Lee JP; Korean Association for the Study of Renal Anemia and Artificial Intelligence (KARAI). Predicting outcomes of continuous renal replacement therapy using body composition monitoring: a deep-learning approach. Sci Rep. 2023 Mar 21;13(1):4605.
• Kim H, Hyun YY, Yun HR, Joo YS, Kim Y, Jung JY, Jeong JC, Kim J, Park JT, Yoo TH, Kang SW, Oh KH, Han SH. Predictive performance of the new race-free Chronic Kidney Disease Epidemiology Collaboration equations for kidney outcome in Korean patients with chronic kidney disease. Kidney Res Clin Pract. 2023 Jul;42(4):501-511.
• Joo L, Jeong HY, Bae DH, Jee JH, Choi WH, Kim HY, Kim S, Yang DH, Gee HY, Jeon S, Roh YG, Yoo J. Prostaglandin F2α analogue, bimatoprost ameliorates colistin-induced nephrotoxicity. Biomed Pharmacother. 2023 Dec;168:115446.
• Kim M, Sohn H, Choi S, Kim S. Requirements for Trustworthy Artificial Intelligence and its Application in Healthcare. Healthc Inform Res. 2023 Oct;29(4):315-322.
• Koh HB, Kim HW, Jung CY, Lee Y, Park JT, Yoo TH, Kang SW, Lee J, Kim YH, Chae DW, Chung WK, Oh KH, Han SH; KoreaN cohort study for Outcomes in patients With Chronic Kidney Disease (KNOW-CKD) Investigators. Risk improvement and adverse kidney outcomes in patients with chronic kidney disease: findings from KNOW-CKD. J Nephrol. 2023 Apr;36(3):767-776.
• Han M, Jeong JC, Cho YY, Ahn C, Kim YH. Sex disparity in dialysis and kidney transplantation over 20 years in Korea. Kidney Res Clin Pract. 2023Jul;42(4):512-518.
• Chang JH, Kim YC, Song SH, Kim S, Jo MW, Kim S. Shared Decision Making for Choosing renAl Replacement Therapy in Chronic Kidney Disease Patients (SDM-ART trial): study protocol for randomized clinical trial. Kidney Res Clin Pract. 2023 Nov;42(6):751-761.
• Lee YK, Kim YH, Kim DH, Kim JH, Lee JH, Park JH, Ko GJ, Hwang WM, Gil HW, Kang YS, Jin KB, Do JY, Kim SJ, Kim BS, Shin HS. Shared decision-making intervention regarding dialysis modality in patients with CKD stage 5. Medicine (Baltimore). 2023 May 12;102(19):e33695.
• Park CH, Kim HW, Park JT, Chang TI, Yoo TH, Park SK, Kim Y, Jung JY, Jeong JC, Oh KH, Kang SW, Han SH; KNOW-CKD (KoreaN Cohort Study for Outcomes in Patients with Chronic Kidney Disease) Investigators. The 2021 KDIGO blood pressure target and the progression of chronic kidney disease: Findings from KNOW-CKD. J Intern Med. 2023 Nov;294(5):653-664.
• Lee Y, Kim J, Kwon S, Jeong JC, Joo KW, Oh KH. The need for prophylactic hemodialysis to protect against nephrogenic systemic fibrosis in patients withend-stage renal disease receiving gadolinium-based contrast agents. Acta Radiol. 2023 Aug;64(8):2492-2496.
• Kwon EJ, Hwang SH, Seo S, Park J, Park S, Kim S. Efficacy of Mesenchymal-Stromal-Cell-Derived Extracellular Vesicles in Ameliorating Cisplatin Nephrotoxicity, as Modeled Using Three-Dimensional, Gravity-Driven, Two-Layer Tubule-on-a-Chip (3D-MOTIVE Chip). Int J Mol Sci. 2023 Oct 29;24(21):15726.

알레르기내과

• Shim JS, Kim H, Kwon JW, Park SY, Kim S, Kim BK, Nam YH, Yang MS, Kim MY, Kim SH, Lee BJ, Lee T, Kim SH, Park SY, Cho YJ, Park CS, Jung JW, Park HK, Kim JH,Choi JH, Moon JY, Adcock I, Chung KF, Kim MH, Kim TB; Precision Intervention in Severe Asthma (PRISM) study investigatorsa. A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM study. World Allergy Organ J. 2023 Dec 12;16(12):100848.
• Shim JS, Kim BK, Kim SH, Kwon JW, Ahn KM, Kang SY, Park HK, Park HW, Yang MS, Kim MH, Lee SM. A smartphone-based application for cough counting in patients with acute asthma exacerbation. J Thorac Dis. 2023 Jul 31;15(7):4053-4065.
• Gu BH, Choi JP, Park T, Kim AS, Jung HY, Choi DY, Lee SJ, Chang YS, Kim M, Park HK. Adult asthma with symptomatic eosinophilic inflammation is accompanied by alteration in gut microbiome. Allergy. 2023 Jul;78(7):1909-1921.
• Shim JS, Kim MH, Lee SM, Kim SH, Kwon JW, Song C, Ahn KM, Kang SY, Park HK, Park HW, Kim BK, Yang MS. An artificial intelligence algorithm-based smartphone application for daily cough monitoring. Allergy. 2023 May;78(5):1378-1380.
• Moon JY, Lee H, Kim MH, Song WJ, Lee SM, Kim SH, Kim SH, Lee BJ, Yoon HJ, Kim SH; on the behalf of Work Group for Chronic Cough, the Korean Academy of Asthma, Allergy and Clinical Immunology. Bacterial Etiology in Subacute Cough. Allergy Asthma Immunol Res. 2023 Sep;15(5):673-681.
• Jo EJ, Lee JH, Won HK, Kang N, Kang SY, Lee SE, Lee JH, Kim MY, Shim JS, An J, Yoo Y, Park SY, Kim BK, Moon JY, Park HK, Kim MH, Kwon HS, Kim SH, Kim SH, Chang YS, Kim SH, Birring SS, Lee BJ, Song WJ. Baseline Cohort Profile of the Korean Chronic Cough Registry: A Multicenter, Prospective, Observational Study. Lung. 2023 Oct;201(5):477-488.
• Losol P, Ji MH, Kim JH, Choi JP, Yun JE, Seo JH, Kim BK, Chang YS, Kim SH. Bronchial epithelial cells release inflammatory markers linked to airway inflammation and remodeling in response to TLR5 ligand flagellin. World Allergy Organ J. 2023 Jun 10;16(6):100786.
• Tomaszewski EL, Atkinson MJ, Janson C, Karlsson N, Make B, Price D, Reddel HK, Vogelmeier CF, Müllerová H, Jones PW; NOVELTY Scientific Community; NOVELTY study investigators. Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD. Respir Res. 2023 Apr 8;24(1):106.
• Kim MH, Kang DY, Nam YH, Sim DW, Kim S, Lee JK, Park JW, Park HK, Jung JW, Kim CW, Yang MS, Kim JH, Ye YM, Koh YI, Kang HR, Park SJ, Kim SH. Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR registry. World Allergy Organ J. 2023 Jan 12;16(1):100738.
• Kim MJ, Kim BR, Kim SH, Chang YS, Youn SW. Clinical Response to Low-dose Omalizumab Treatment in Chronic Spontaneous Urticaria: A Retrospective Study of 179 Patients. Acta Derm Venereol. 2023 Aug 30;103:adv11627.
• Hughes R, Rapsomaniki E, Bansal AT, Vestbo J, Price D, Agustí A, Beasley R, Fageras M, Alacqua M, Papi A, Müllerová H, Reddel HK; NOVELTY Scientific Community; NOVELTY study investigators. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum. J Allergy Clin Immunol Pract. 2023 Sep;11(9):2803-2811.
• Koh J, Woo YD, Yoo HJ, Choi JP, Kim SH, Chang YS, Jung KC, Kim JH, Jeon YK, Kim HY, Chung DH. De novo fatty-acid synthesis protects invariant NKT cells from cell death, thereby promoting their homeostasis and pathogenic roles in airway hyperresponsiveness. Elife. 2023 Nov 2;12:RP87536.

감염내과

• Choi S, Moon SM, Kwon JS, Kim SH, Park SY. Diagnostic Usefulness of Varicella Zoster Virus-Specific Immunoglobulin (Ig) A and IgG in Patients With Herpes Zoster. J Korean Med Sci. 2023 Jan 9;38(2):e7
• HChoi SJ, Koh JY, Rha MS, Seo IH, Lee H, Jeong S, Park SH, Shin EC. KIR⁺CD8⁺ and NKG2A⁺CD8⁺ T cells are distinct innate-like populations in humans. Cell Rep. 023 Mar 28;42(3):112236.
• Park SY, Moon SM, Kim B, Lee MJ, Song KH, Kim ES, Kim TH, Kim HB; Korea Study Group for Antimicrobial Stewardship (KOSGAP). Applicability and limitations of quality indicator-based assessment of appropriateness in antimicrobial use: a comparison with expert opinion. J Hosp Infect. 2023 Sep;139:93-98
• Jung J, Moon SM, Kim DY, Kim SH, Lee WJ, Heo ST, Park JY, Bae S, Lee MJ, Kim B, Park SY, Jeong HW, Kim Y, Kwak YG, Song KH, Park KH, Park SH, Kim YK, Kim ES, Kim HB; Korea Study Group for Antimicrobial Stewardship. Appropriateness of antibiotic use for patients with asymptomatic bacteriuria or urinary tract infection with positive urine culture: a retrospective observational multi-centre study in Korea. J Hosp Infect. 2023 Oct;140:79-86
• Kim B, Hwang S, Heo E, Kim HS, Jung J, Kim ES, Kim HB, Lee K, Park JS, Song J, Lee JH, Chung JY, Song KH, Yoon S. Evaluation of Vancomycin TDM Strategies: Prediction and Prevention of Kidney Injuries Based on Vancomycin TDM Results. J Korean Med Sci. 2023 Apr 10;38(14):e101
• Kang CK, Choi B, Kim S, Sun CH, Yoon SH, Kim K, Chang E, Jung J, Choe PG, Park WB, Kim ES, Kim HB, Kim NJ, Oh MD, Im H, Kim J, Lee YH, Lee J, Chun H, Koh Y, Lee JY, Moon JH, Song KH, Jung I. Clinical impact of clonal hematopoiesis on severe COVID- 19 patients without canonical risk factors. Haematologica. 2023 Jan 1;108(1):257-260
• Escrihuela-Vidal F, Kaasch AJ, Von Cube M, Rieg S, Kern WV, Seifert H, Song KH, Liao CH, Tilley R, Gott H, Scarborough M, Gordon C, Llewelyn MJ, Kuehl R, Morata L, Soriano A, Edgeworth J, De Gopegui ER, Nsutebu E, Cisneros JM, Fowler VG, Thwaites G, López-Contreras J, Barlow G, Ternavasio-De La Vega HG, Rodríguez-Baño J, López-Cortés LE; International Staphylococcus Aureus Collaboration Study Group, The European Society of Clinical Microbiology and Infectious Diseases Study Group For Bloodstream Infections, Endocarditis And Sepsis. Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort. Clin Microbiol Infect. 2023 Apr;29(4):498-505
• Heo E, Choi Y, Kim HS, Namgung HW, Lee E, Lee E, Lee JY, Jung J, Kim ES, Kim HB, Song KH. Current Status of Outpatient Parenteral Antimicrobial Therapy in Korea: Experience of a Single 6DNJFUniversity-Affiliated Acute-Care Hospital. Infect Chemother. 2023 Jun;55(2):185-193
• Noh H, Yoon S, Kim SH, Kim J, Seo JS, Kim JJ, Park IH, Oh J, Bae JY, Lee GE, Woo SJ, Seo SM, Kim NW, Lee YW, Jang HJ, Hong SM, An SH, Lyoo KS, Yeom M, Lee H, Jung B, Yoon SW, Kang JA, Seok SH, Lee YJ, Kim SY, Kim YB, Hwang JY, On D, Lim SY, Kim SP, Jang JY, Lee H, Kim K, Lee HJ, Kim HB, Kim SB, Park JW, Jeong DG, Song D, Choi KS, Lee HY, Choi YK, Choi JA, Song M, Park MS, Seo JY, Shin JS, Yun JW, Nam KT, Seong JK. Establishment of multicenter COVID-19 therapeutics
• Bang E, Oh S, Cho HW, Park DH, Chang HE, Park JS, Lee H, Song KH, Kim ES, Kim HB, Suh YH, Park KU. Development of diagnostic tests for pathogen identification and detection of antimicrobial resistance on WHO global priority pathogens using modular real-time nucleic acid amplification test. Int Microbiol. 2023 Aug;26(3):563-577
• Choi Y, Jeon EB, Kim T, Choi SJ, Moon SM, Song KH, Kim HB, Kim ES. Case Report and Literature Review of Occupational Transmission of Monkeypox Virus to Healthcare Workers, South Korea. Emerg Infect Dis. 2023 May;29(5):997-1001
• Cheong HS, Park KH, Kim B, Eun BW, Kim HS, Kim YC, Lee H, Jeong SJ, Moon C, Kim SW, Yoon YK, Hwang IS, Park CS, Lee MS, Kim HB, Shin JY, Kwon KT. Developing Core Elements and Checklist Items for Implementing Antimicrobial Stewardship Programs in Korean General Hospitals: A Modified Delphi Survey. Infect Chemother. 2023 Mar;55(1):59-68. doi: 10.3947/ic.2022.0169. Epub 2023 Feb 15
• Kang J, Kim HS, Yi HJ, Lee Y, Lee SH, Song KH, Park HY, Oh HS, Yoon D, Choe PG, Lee EJ, Choi CH, Sim M, Yu ES, Paik JW, Park HY. Causing trouble and being transmissible: COVID-19 survivors' experiences of stigma and discrimination in South Korea. Front Psychiatry. 2023 Mar 14;14:1103572
• Lee CM, Choe PG, Kang CK, Lee E, Song KH, Bang JH, Kim ES, Kim HB, Kim NJ, Kim HR, Kim Y, Lee CH, Shin HM, Park SW, Park WB, Oh MD. Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19. Front Immunol. 2023 Mar 22;14:1106664
• Kim B, Hwang S, Heo E, Kim HS, Jung J, Kim ES, Kim HB, Lee K, Park JS, Song J, Lee JH, Chung JY, Song KH, Yoon S. Evaluation of Vancomycin TDM Strategies: Prediction and Prevention of Kidney Injuries Based on Vancomycin TDM Results. J Korean Med Sci. 2023 Apr 10;38(14):e101
• Kim NH, Choi Y, Kwon K, Park JS, Park KU, Moon SM, Song KH, Kim ES, Park WB, Kim HB. Anti-Alpha-Toxin Antibody Responses and Clinical Outcomes of Staphylococcus aureus Bacteremia. J Korean Med Sci. 2023 Apr 24;38(16):e129
• Kim DM, Yu BJ, Kim DY, Seo JW, Yun NR, Kim CM, Kim YK, Jung SI, Kim UJ, Kim SE, Kim HA, Kim ES, Hur J, Lee SH, Jeong HW, Heo JY, Jung DS, Kim J, Park SH, Kwak YG, Lee S, Lim S, Chatterjee S. Clinically differential diagnosis of human granulocytic anaplasmosis and severe fever with thrombocytopenia syndrome. Sci Rep. 2023 Apr 26;13(1):6837
• Choi JP, Ayoub G, Ham J, Huh Y, Choi SE, Hwang YK, Noh JY, Kim SH, Song JY, Kim ES, Chang YS. Exercise With a Novel Digital Device Increased Serum Anti- influenza Antibody Titers After Influenza Vaccination. Immune Netw. 2023 Feb 27;23(2):e18
• Choi Y, Kang M, Shin DH, Jung J, Choi SJ, Kim NH, Moon SM, Song KH, Kim ES, Jung J, Kim HB. Antibiotic Prescription in Patients With Coronavirus Disease 2019: Analysis of National Health Insurance System Data in the Republic of Korea. J Korean Med Sci. 2023 Jun 26;38(25):e189
• Wiboonchutikula C, Kim HB, Honda H, Xin Loo AY, Chi-Chung Cheng V, Camins B, Jantarathaneewat K, Apisarnthanarak P, Rutjanawech S, Apisarnthanarak A. Antibiotic prescribing behavior among physicians in Asia: a multinational survey. Antimicrob Steward Healthc Epidemiol. 2023 Jun 29;3(1):e112
• Park HY, Lee H, Lee JY, Song KH, Kim Y, Lee SH. How Can We Deal with Psychosocial Issues in an Emerging Infectious Disease Outbreak? Lessons from a Qualitative Study for the MERS Outbreak in Korea. Infect Chemother. 2023 Sep;55(3):355-367
• Ahn JY, Ko JH, Peck KR, Bae S, Kim SH, Lee KH, Song YG, Kim YC, Park YS, Song KH, Kim ES, Jeong HW, Kim SW, Kwon KT, Choi WS, Choi JY. Immune Response Kinetics Following a Third Heterologous BNT162b2 Booster Dose After Primary 2-Dose ChAdOx1 Vaccination in Relation to Omicron Breakthrough Infection: A Prospective Nationwide Cohort Study in South Korea. Open Forum Infect Dis. 2023 Jul 13;10(7):ofad363
• Lee M, Park WB, Kim ES, Kim Y, Park SW, Lee E, Oh MD, Kim NJ, Kim HB, Song KH, Choe PG, Kang CK, Lee CM, Choi Y, Moon SM, Choi SJ, Jeon J, Bang J. Possibility of Decreasing Incidence of Human Immunodeficiency Virus Infection in Korea. Infect Chemother. 2023 Dec;55(4):451-459
• Worldwide Antimicrobial Resistance National/International Network Group (WARNING) Collaborators. Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action. World J Emerg Surg. 2023 Oct 16;18(1):50
• Park SY, Kim YC, Moon SM, Kim B, Lee R, Kim HB; Korea Study Group for Antimicrobial Stewardship (KOSGAP). Developing a framework for regular and sustainable qualitative assessment of antibiotic use in Korean medicalinstitutions: a Delphi study. Antimicrob Resist Infect Control. 2023 Oct 18;12(1):114
• Chatterjee S, Kim CM, Kim DM, Seo JW, Kim DY, Yun NR, Jung SI, Kim UJ, Kim SE, Kim HA, Kim ES, Hur J, Kim YK, Jeong HW, Heo JY, Jung DS, Lee H, Park SH, Kwak YG, Lee S, Chatterjee RP. Coinfection With Severe Fever With Thrombocytopenia Syndrome and Scrub Typhus in Korea. Open Forum Infect Dis. 2023 Oct 17;10(10):ofad377
• Kim J, Youn D, Choi S, Lee YW, Sumberzul D, Yoon J, Lee H, Bae JW, Noh H, On D, Hong SM, An SH, Jang HJ, Kim SY, Kim YB, Hwang JY, Lee HJ, Bin Kim H, Park JW, Yun JW, Shin JS, Seo JY, Nam KT, Choi KS, Lee HY, Chang H, Seong JK, Cho J. SARS-CoV-2 infection engenders heterogeneous ribonucleoprotein interactions to impede translation elongation in the lungs. Exp Mol Med. 2023 Dec;55(12):2541-2552
• Kim IS, Kang CK, Lee SJ, Lee CH, Kim M, Seo C, Kim G, Lee S, Park KS, Chang E, Jung J, Song KH, Choe PG, Park WB, Kim ES, Bin Kim H, Kim NJ, Oh MD, Lee JE, Shin HM, Kim HR. Tracking antigen-specific TCR clonotypes in SARS-CoV-2 infection reveals distinct severity trajectories. J Med Virol. 2023 Nov;95(11):e29199
• Lee B, Ko JH, Kim YC, Baek JY, Park YS, Song KH, Kim ES, Lee KH, Song YG, Ahn JY, Choi JY, Choi WS, Bae S, Kim SH, Jeong HW, Lee YJ, Kim HJ, Choi JY, Kim B, Kim SW, Kwon KT, Peck KR, Kang ES. Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants. J Med Virol. 2023 Dec;95(12):e29329

류마티스내과

• Choi SR, Shin JY, Shin A, Choung H, Woo SJ, Park SJ, Ha YJ, Lee YJ, Lee EB, Park JK, Kang EH. Comparative risk of blindness and vision-threatening ocular comorbidities in patients with Behçet's disease versus the general population. 2023 May 2;62(5):1895-1902.
• Park EH, Kang EH, Lee YJ, Ha YJ. Impact of early age at menopause on disease outcomes in postmenopausal women with rheumatoid arthritis: a large observational cohort study of Korean patients with rheumatoid arthritis. 2023 Feb;9(1):e002722.
• Yeo J, Yoon SH, Kim JY, Lee JS, Lee EY, Goo JM, Pourzand L, Goldin JG, Kim GJ, Ha YJ. Quantitative interstitial lung disease scores in idiopathic inflammatory myopathies: longitudinal changes and clinical implications. 2023 Nov 2;62(11):3690-3699.
• Chang SH, Choi SR, Choi YS, Go DJ, Park JW, Ha YJ, Park JK, Kang EH, Lee EY, Shin K, Lee EB, Song YW, Lee YJ. Performance of cut-offs adjusted with positive control band intensity in line-blot assays for myositis-specific antibodies. 2023 Aug;43(8):1507-1513.
• Park JK, Lee YJ, Shin K, Kang EH, Ha YJ, Park JW, Kim MJ, Kim MH, Choi SR, Jung Y, Lee JH, In Jung J, Kim JY, Winthrop KL, Lee EB. A Multicenter, Prospective, Randomized, Parallel-Group Trial on the Effects of Temporary Methotrexate Discontinuation for One Week Versus Two Weeks on Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis. 2023 Feb;75(2):171-177.
• Kim HS, Park JW, Park JW, Ha YJ, Lee YK, Lee YJ, Koo KH. Anterior and Lateral Femoroacetabular Excursion Angles Are Helpful for Assessing Femoroacetabular Impingement Syndrome: A Cross-Sectional Cohort Study. 2023 Sep;39(9):2012-2022.e1.
• Park JK, Lee YJ, Kang EH, Shin K, Kim MJ, Ha YJ, Choi SR, Park JW, Kim MH, Kim JY, Jung JI, Choi Y, Winthrop KL, Lee EB. Choi SR, Shin A, Ha YJ, Lee YJ, Lee EB, Kang EH. Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study. 2023 Jul 26;25(1):129.
• Park JK, Lee YJ, Kang EH, Shin K, Kim MJ, Ha YJ, Choi SR, Park JW, Kim MH, Kim JY, Jung JI, Choi Y, Winthrop KL, Lee EB. Effect of the methotrexate discontinuation for 1 versus 2 weeks on vaccine response to seasonal influenza vaccine in rheumatoid arthritis: a noninferiority randomized controlled trial. 2023 Jul 6. doi: 10.1002/art.42644.
• Chang SH, Lee JS, Ha YJ, Kim MU, Park CH, Lee JS, Kim JW, Chung SW, Pyo JY, Lee SW, Kang EH, Lee YA, Park YB, Choe JY, Lee EY. Lung function trajectory of rheumatoid arthritis-associated interstitial lung disease. 2023 Sep 1;62(9):3014-3024.
• Kim JW, Chung SW, Pyo JY, Chang SH, Kim MU, Park CH, Lee JS, Lee JS, Ha YJ, Kang EH, Lee YA, Park YB, Lee EY, Choe JY. Methotrexate, leflunomide and tacrolimus use and the progression of rheumatoid arthritis-associated interstitial lung disease. 2023 Jul 5;62(7):2377-2385.
• Yang MK, Kim HW, Kang EH, Kim N, Choung H, Khwarg SI. Ophthalmic manifestations and visual outcomes of granulomatosis with polyangiitis: a retrospective multicentre study in Korea. 2023 May;37(7):1302-1307.
• Chung SW, Lee JH, Ha YJ, Kang EH, Lee YJ. Recurrent focal myofasciitis of Behçet syndrome mimics infectious myofasciitis: a case report. 2023 Oct 1;30(4):268-271.
• Park JW, Curtis JR, Choi SR, Kim MJ, Ha YJ, Kang EH, Lee YJ, Lee EB. Risk-Benefit Analysis of Primary Prophylaxis Against Pneumocystis Jirovecii Pneumonia in Patients With Rheumatic Diseases Receiving Rituximab. 2023 Nov;75(11):2036-2044.
• Yoo WH, Kang YM, Kim DW, Kang EH, Lee YA, Suh CH, Sung YK, Lee SH, Gu DH, Lee J, Choe JY. Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data. 2023 Apr;10(2):329-341.

노인병내과

• Kim KI. Risk Stratification of Cardiovascular Disease according to Age Groups In New Prevention Guidelines: A Review. J Lipid Atheroscler. 2023May;12(2):96-105
• Kim D, Jeong H, Kim S, Shin HG, Park KI, Lee SP, Lee HS, Lee JY, Kim KI, Kang SH, Lee JH, Jang SY, Lee JH, Kim KH, Cho JY, Park JH, Park SK, Kim S, Kim K, Lee HY. Association between office visit intervals and long-term cardiovascular risk in hypertensive patients. J Clin Hypertens (Greenwich). 2023 Aug;25(8):748-756.
• Heo KN, Seok JY, Ah YM, Kim KI, Lee SB, Lee JY. Development and validation of a machine learning-based fall-related injury risk prediction model using nationwide claims database in Korean community-dwelling older population. BMC Geriatr. 2023 Dec 11;23(1):830.
• Huh Y, Son KY, Lee JE, Kim KI, Cho B, Won CW. Health-Related Unmet Needs of Community-Dwelling Older Adults: A Nationwide Representative Descriptive Study in Korea. Ann Geriatr Med Res. 2023 Mar;27(1):66-72.
• Jung MH, Kim KI, Lee JH, Sung KC. Relative importance of potential risk factors for dementia in patients with hypertension. PLoS One. 2023 Mar 15;18(3):e0281532.

종합내과

• Kim SW, Ohn JH, Kim NH, Kim ES, Lim Y, Lee J, Kim HW, Ryu J, Park HS, Suh KJ, Kim JW, Kim JW, Kim SH, Kim YJ, Lee KW, Kim JH, Lee JS, Jang HC. The Hospitalist-Oncologist co-ManagemEnt (HOME) system improves hospitalization outcomes of patients with cancer. BMC Health Serv Res. 2023 Dec 6;23(1):1367.
• Ryu J, Park Y, Kim HW, Kim NH, Kim SH, Lee SM, Bae YS, Yoon HJ. Association between higher variability in kidney function and long-term mortality. Nephrology (Carlton). 2022 Jun;27(6):519-527.
• Ryu J, Baek E, Son HE, Ryu JY, Jeong JC, Kim S, Na KY, Chae DW, Kim SP, Kim SH, Jhee JH, Chang TI, Choi BS, Chin HJ. Comparison of dominant and nondominant C3 deposition in primary glomerulonephritis. Kidney Res Clin Pract. 2023 Jan;42(1):98-108.
• Kim SW, Ohn JH, Kim NH, Kim ES, Lim Y, Lee J, Kim HW, Ryu J, Park HS, Suh KJ, Kim JW, Kim JW, Kim SH, Kim YJ, Lee KW, Kim JH, Lee JS, Jang HC. The Hospitalist-Oncologist co-ManagemEnt (HOME) system improves hospitalization outcomes of patients with cancer. BMC Health Serv Res. 2023 Dec 6;23(1):1367.
• Ohn JH. Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis (Diabetes Metab J 2023;47:356-65). Diabetes Metab J. 2023 Sep;47(5):715-716.
• Lee S, Kim J, Ohn JH. Exploring quantitative traits-associated copy number deletions through reanalysis of UK10K consortium whole genome sequencing cohorts. BMC Genomics. 2023 Dec 18;24(1):787.
• Kim SP, Ryu J, Kim SH, Yoon HJ. Low-dose aspirin in the primary prevention of cardiovascular diseases: A retrospective, propensity score matched study. Atherosclerosis. 2023 Apr;371:54-60.
• Yang MK, Kim HW, Kang EH, Kim N, Choung H, Khwarg SI. Ophthalmic manifestations and visual outcomes of granulomatosis with polyangiitis: a retrospective multicentre study in Korea. Eye (Lond). 2023 May;37(7):1302-1307.
• Seo MR, Yeo J, Park JW, Lee YA, Lee JH, Kang EH, Ji SM, Kwon SR, Kim SK, Kim TJ, Kim TH, Kim HW, Park MC, Shin K, Lee SH, Lee EY, Cha HS, Shim SC, Yoon Y, Lee SH, Lim JH, Baek HJ; Korean Society of Spondyloarthritis Research. Korean treatment recommendations for patients with axial spondyloarthritis. J Rheum Dis. 2023 Jul 1;30(3):151-169.
• Kim HJ, Kim J, Ohn JH, Kim NH. Impact of hospitalist care model on patient outcomes in acute medical unit: a retrospective cohort study. BMJ Open. 2023 Aug 3;13(8):e069561.
• Lee SW, Park J, Kim H, Jung YW, Baek YS, Lim Y, Kim K. Atopic dermatitis and risk of gastroesophageal reflux disease: A nationwide population-based study. PLoS One. 2023 Feb 17;18(2):e0281883.
• Kim J, Han K, Jung JH, Ha J, Jeong C, Heu JY, Lee SW, Lee J, Lim Y, Kim MK, Kwon HS, Song KH, Baek KH. Physical activity and reduced risk of fracture in thyroid cancer patients after thyroidectomy - a nationwide cohort study. Front Endocrinol (Lausanne). 2023 Jul 20;14:1173781
• Jeong C, Kim J, Lee J, Lim Y, Lim DJ, Baek KH, Ha J; Catholic Medical Center Bone Research Group. Effect of Denosumab on Bone Density in Postmenopausal Osteoporosis: A Comparison with and without Calcium Supplementation in Patients on Standard Diets in Korea. J Clin Med. 2023 Nov 2;12(21):6904.

해외학술지 연구논문

호흡기내과

• Kwon BS, Park JS, Shin JA, Kim ES, Lim SY, Song MJ, Kim YW, Kim HJ, Lee YJ, Park JS, Cho YJ, Yoon HI, Lee CT, Lee JH. A prospective study on the long-term storage of sputum and the recovery of nontuberculous mycobacteria. 2023 Jan-Dec:17:17534666231162244.
• Song MJ, Jang Y, Lee JH, Yoon JH, Kim DJ, Jung SY, Lim SY. Association of Dexmedetomidine With New-Onset Atrial Fibrillation in Patients With Critical Illness. 2023 Apr 3;6(4):e239955.
• Wook Kim Y, Kim HJ, Hyun Yoon S, Jin Song M, Soo Kwon B, Yoon Lim S, Joo Lee Y, Sun Park J, Cho YJ, Ho Lee J, Lee CT. Comparison of electromagnetic navigation bronchoscopy and transthoracic needle biopsy for diagnosing bronchus sign-positive pulmonary lesions. 2023 Jul:181:107234.
• Kim YW, Kim HJ, Yoon SH, Song MJ, Kwon BS, Lim SY, Lee YJ, Park JS, Cho YJ, Lee JH, Lee CT. Electromagnetic Navigation Bronchoscopy Versus Radial Endobronchial Ultrasound for Diagnosing Lung Cancer: A Propensity Score-Matched Analysis. 2023 Jun;59(6):356-363.
• Kim J, Kim YK, Kim H, Jung H, Koh S, Kim Y, Yoon D, Yi H, Kim HJ. Machine Learning Algorithms Predict Successful Weaning From Mechanical Ventilation Before Intubation: Retrospective Analysis From the Medical Information Mart for Intensive Care IV Database. 2023 Nov 14:7:e44763.
• Park S, Park SH, Kim Y, Lee GH, Kim HS, Lim SY, Choi SA. Optimal Nutritional Support Strategy Based on the Association between Modified NUTRIC Score and 28-Day Mortality in Critically Ill Patients: A Prospective Study. 2023 May 25;15(11):2465.
• Cho KJ, Kim JS, Lee DH, Lee SM, Song MJ, Lim SY, Cho YJ, Jo YH, Shin Y, Lee YJ. Prospective, multicenter validation of the deep learning-based cardiac arrest risk management system for predicting in-hospital cardiac arrest or unplanned intensive care unit transfer in patients admitted to general wards. 2023 Sep 5;27(1):346.
• Kim HJ, Lee YJ, Song MJ, Kwon BS, Kim YW, Lim SY, Lee YJ, Park JS, Cho YJ, Lee CT, Lee JH. Real-world experience of adverse reactions-necessitated rifampicin-sparing treatment for drug-susceptible pulmonary tuberculosis. 2023 Jul 12;13(1):11275. doi: 10.
• Lee H, Song MJ, Cho YJ, Kim DJ, Hong SB, Jung SY, Lim SY. Supervised machine learning model to predict mortality in patients undergoing venovenous extracorporeal membrane oxygenation from a nationwide multicentre registry. 2023 Dec 28;10(1):e002025.
• Lee YJ, Park YB. Inhaled Corticosteroids Is Not Associated with the Risk of Pneumonia in Asthma. 2023 Jul;86(3):151-157.
• Kim HJ, Lee YJ, Song MJ, Kwon BS, Kim YW, Lim SY, Lee YJ, Park JS, Cho YJ, Lee CT, Lee JH. Real-world experience of adverse reactions-necessitated rifampicin-sparing treatment for drug-susceptible pulmonary tuberculosis. 2023 Jul 12;13(1):11275.
• Kim HJ, Song MJ, Kwon BS, Kim YW, Lim SY, Lee YJ, Park JS, Cho YJ, Lee CT, Lee JH. Usefulness of the BACES score in nontuberculous mycobacterial pulmonary disease for various clinical outcomes. 2023 May 9;13(1):7495.
• Shekar K, Abdul-Aziz MH, Cheng V, Burrows F, Buscher H, Cho YJ, Corley A, Diehl A, Gilder E, Jakob SM, Kim HS, Levkovich BJ, Lim SY, McGuinness S, Parke R, Pellegrino V, Que YA, Reynolds C, Rudham S, Wallis SC, Welch SA, Zacharias D, Fraser JF, Roberts JA. Antimicrobial Exposures in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation. 2023 Mar 15;207(6):704-720.
• Ahn YH, Lee J, Oh DK, Lee SY, Park MH, Lee H, Lim CM, Lee SM, Lee HY; Korean Sepsis Alliance (KSA) Investigators. Association between the timing of ICU admission and mortality in patients with hospital-onset sepsis: a nationwide prospective cohort study. 2023 Apr 21;11(1):16.
• Kim TH, Kim HJ, Song MJ, Kwon BS, Kim YW, Lim SY, Lee YJ, Cho YJ, Lee JH, Chung JH, Park JS. Correlation of monocyte counts with clinical outcomes in idiopathic nonspecific interstitial pneumonia. 2023 Feb 16;13(1):2804.
• Kim JH, Kim YK, Oh DK, Jeon K, Ko RE, Suh GY, Lim SY, Lee YJ, Cho YJ, Park MH, Hong SB, Lim CM, Park S; Korean Sepsis Alliance (KSA) investigators. HYPOTENSION AT THE TIME OF SEPSIS RECOGNITION IS NOT ASSOCIATED WITH INCREASED MORTALITY IN SEPSIS PATIENTS WITH NORMAL LACTATE LEVELS. 2023 Mar 1;59(3):360-367.
• Hyun DG, Ahn JH, Huh JW, Hong SB, Koh Y, Oh DK, Lee SY, Park MH, Lee H, Lim CM; Korean Sepsis Alliance (KSA) Investigators. Impact of a cumulative positive fluid balance during the first three ICU days in patients with sepsis: a propensity score-matched cohort study. 2023 Oct 19;13(1):105.
• Lee KJ, Park JY, Jeon K, Ko RE, Suh GY, Lim SY, Lee YJ, Oh DK, Park MH, Lim CM, Park S. Impact of sepsis on Eastern Cooperative Oncology Group performance status among fully ambulatory patients: a prospective nationwide multicenter cohort. 2023 Sep 28;15(9):4681-4692.
• Ko RE, Kang D, Cho J, Na SJ, Chung CR, Lim SY, Lee YJ, Park S, Oh DK, Lee SY, Park MH, Lee H, Lim CM, Suh GY; Korean Sepsis Alliance (KSA) investigators. Influence of gender on age-associated in-hospital mortality in patients with sepsis and septic shock: a prospective nationwide multicenter cohort study. 2023 Jun 11;27(1):229.
• Park HJ, Kim JY, Kim HJ, Yim JJ, Kwak N. Lung function decline in non-tuberculous mycobacterial pulmonary disease according to disease severity. 2023 Jun 1;27(6):465-470.
• Kim TH, Ji E, Song MJ, Lim SY, Lee YJ, Cho YJ. Negative Conversion of Polymerase Chain Reaction and Clinical Outcomes according to the SARS-CoV-2 Variant in Critically Ill Patients with COVID-19. 2023 Apr;86(2):142-149.
• Kim TH, Ji E, Song MJ, Lim SY, Lee YJ, Cho YJ. Negative Conversion of Polymerase Chain Reaction and Clinical Outcomes according to the SARS-CoV-2 Variant in Critically Ill Patients with COVID-19. 2023 Apr;86(2):142-149.
• JAE HO LEE JIHANG KIM JUNGHOON KIM YE JIN LEE HYUNG-JUN KIM MYUNG JIN SONG SUNG YOON LIM BYOUNG SOO KWON YEON-JOO LEE JONG SUN PARK YOUNG-JAE CHO AND SUNG HYUN YOON. NONTUBERCULOUS MYCOBACTERIAL PULMONARY INFECTION PRESENTING AS BRONCHIOLITIS PATTERN ON CT SCAN WITHOUT CAVITY OR BRONCHIECTASIS. DOI:https://doi.org/10.1016/j.chest.2023.07.579.
• Kim HJ, Lee YJ, Song MJ, Kwon BS, Kim YW, Lim SY, Lee YJ, Park JS, Cho YJ, Lee CT, Lee JH. Real-world experience of adverse reactions-necessitated rifampicin-sparing treatment for drug-susceptible pulmonary tuberculosis. 2023 Jul 12;13(1):11275.

순환기내과

• Park JJ, Jang SY, Adler E, Ahmad F, Campagnari C, Yagil A, Greenberg B. A machine learning-derived risk score predicts mortality in East Asian patients with acute heart failure. Eur J Heart Fail. 2023 Dec;25(12):2331-2333.
• Moon IT, Kim SH, Chin JY, Park SH, Yoon CH, Youn TJ, Chae IH, Kang SH. Accuracy of Artificial Intelligence-Based Automated Quantitative Coronary Angiography Compared to Intravascular Ultrasound: Retrospective Cohort Study. JMIR Cardio. 2023 Apr 26:7:e45299.
• Chu HW, Hwang IC, Kim HM, Park J, Choi H, Choi HM, Yoon YE, Cho GY. Age-dependent implications of left ventricular hypertrophy regression in patients with hypertension. Hypertens Res. 2024 May;47(5):1144-1156.
• Yoon M, Park JJ, Hur T, Hua CH, Hussain M, Lee S, Choi DJ. Application and Potential of Artificial Intelligence in Heart Failure: Past, Present, and Future. Int J Heart Fail. 2023 Nov 30;6(1):11-19.
• Han D, Kang SH, Yoon CH, Youn TJ, Chae IH. Author Correction: Attenuation of ischemia-reperfusion injury by intracoronary chelating agent administration. Sci Rep. 2023 Jul 3;13(1).
• Yoon CH, Kwun JS, Choi YJ, Park JJ, Kang SH, Kim SH, Suh JW, Youn TJ, Kim MK, Cha KS, Lee SH, Hong BK, Rha SW, Kang WC, Lee JH, Kim SH, Chae IH. BioMatrix Versus Orsiro Stents for Coronary Artery Disease: A Multicenter, Randomized, Open-Label Study. Circ Cardiovasc Interv. 2023 Jan;16(1).
• Park CS, Park JJ, Lee HY, Kang SM, Yoo BS, Jeon ES, Hong SK, Shin JH, Kim MA, Park DG, Kim EJ, Hong SJ, Kim SY, Kim JJ, Choi DJ. Clinical Characteristics and Outcome of Immediate-Release Versus SLOW-Release Carvedilol in Heart Failure Patient (SLOW-HF): a Prospective Randomized, Open-Label, Multicenter Study. Cardiovasc Drugs Ther. 2023 Jun;37(3):529-537.
• Kwun JS, Lee JH, Park BE, Park JS, Kim HJ, Kim SH, Jeon KH, Cho HW, Kang SH, Lee W, Youn TJ, Chae IH, Yoon CH. Diagnostic Value of a Wearable Continuous Electrocardiogram Monitoring Device (AT-Patch) for New-Onset Atrial Fibrillation in High-Risk Patients: Prospective Cohort Study. J Med Internet Res. 2023 Sep 18;25:e45760.
• Kim BJ, Cha KS, Cho WH, Kim EJ, Choi SH, Kim MH, Kim SH, Park JB, Park SM, Sohn IS, Ryu KH, Chae IH. Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial. J Cardiovasc Pharmacol Ther. 2023 Jan-Dec;28.
• Park J, Yoon YE, Chun EJ, Choi HM, Hwang IC, Lee HJ, Park JB, Lee SP, Kim HK, Kim YJ, Cho GY. Endocardial versus whole-myocardial tracking global longitudinal strain analysis in patients with hypertrophic cardiomyopathy: A preliminary comparative study. PLoS One. 2023 Jul 11;18(7):e0288421.
• Suh JW, Memtsas V, Gue YX, Cho HW, Lee W, Kang SH, Gorog DA. Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes: A Comparison of East Asian and White subjects. Thromb Haemost. 2023 Dec 29.
• Hahn D, Lee D, Hyun W, Cho Y, Yoon CH, Jeon KH, Kang SH, Youn TJ, Chae IH. Faster smooth muscle cell coverage in ultrathin-strut drug-eluting stent leads to earlier re-endothelialization. Front Bioeng Biotechnol. 2023 May 23:11:1207858.
• Park J, Yoon Y, Cho Y, Kim J. Feasibility of Artificial Intelligence–Based Electrocardiography Analysis for the Prediction of Obstructive Coronary Artery Disease in Patients With Stable Angina: Validation Study. JMIR Cardio 2023;7:e44791.
• Lee W, Kang SH, Kim SH, Lee SY, Myung W, Jheon KH, Yoon CH, Suh JW, Youn TJ, Chae IH. Impact of dementia and drug compliance on patients with acute myocardial infarction. Clin Cardiol. 2023 Oct;46(10):1253-1259.
• Hwang IC, Kim S, Boo D, Park C, Yoo S, Yoon YE, Cho GY. Impact of glycemic control on the progression of aortic stenosis: a single-center cohort study using a common data model. BMC Endocr Disord. 2023 Jul 10;23(1):143.
• Jeon KH, Jeong YH, Chae IH, Kim BK, Joo HJ, Chang K, Park Y, Song YB, Ahn SG, Lee SY, Cho JR, Her AY, Kim HS, Kim MH, Lim DS, Shin ES, Suh JW; PTRG-DES Consortium Investigators. Implication of diabetic status on platelet reactivity and clinical outcomes after drug-eluting stent implantation: results from the PTRG-DES consortium. Cardiovasc Diabetol. 2023 Sep 7;22(1):245.
• Park J, Ahn HB, Choi H, Choi HM, Hwang IC, Yoon YE, Cho GY. Integrative Assessment of Cardiopulmonary Fitness Using Cardiopulmonary Exercise Test With Supine Bicycle Echocardiography in Patients Presenting Dyspnea. J Am Heart Assoc. 2024;13:e033815.
• Choi YJ, Lee HJ, Park JS, Park CS, Rhee TM, Choi JY, Choi HM, Park JB, Yoon YE, Lee SP, Na JO, Cho GY, Kim YJ, Hwang IC, Kim HK. Left ventricular global longitudinal strain as a prognosticator in hypertrophic cardiomyopathy with a low-normal left ventricular ejection fraction. Eur Heart J Cardiovasc Imaging. 2023 Sep 26;24(10):1374-1383.
• Choi H, Kang SH, Jeong SW, Yoon CH, Youn TJ, Song WH, Jeon DW, Lim SW, Lee JH, Cho SW, Chae IH, Kim CH. Lipid-Lowering Efficacy of Combination Therapy With Moderate-Intensity Statin and Ezetimibe Versus High-Intensity Statin Monotherapy: A Randomized, Open-Label, Non-Inferiority Trial From Korea. J Lipid Atheroscler. 2023 Sep;12(3):277-289.
• Lee W, Kang J, Park JB, Seo WW, Lee SY, Lim WH, Jeon KH, Hwang IC, Kim HL. Long-term mortality and cardiovascular events of seven angiotensin receptor blockers in hypertensive patients: Analysis of a national real-world database: A retrospective cohort study. Health Sci Rep. 2023 Jan 31;6(2):e1056.
• Kim HM, Hwang IC, Yoon YE, Park JB, Lee SP, Kim HK, Kim YJ, Lim Y, Cho GY. Prediction of Deterioration of Left Ventricular Function Using 3-Dimensional Speckle-Tracking Echocardiography in Patients With Left Bundle-Branch Block. J Am Heart Assoc. 2023 Jan 3;12(1):e026194.
• Choi YJ, Kim HK, Hwang IC, Park CS, Rhee TM, Lee HJ, Park JB, Yoon YE, Lee SP, Cho GY, Kim YJ. Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction. Heart. 2023 Apr 25;109(10):771-778.
• Hwang IC, Kim CH, Kim JY, Choi HM, Yoon YE, Cho GY. Rate of Change in 10-Year Atherosclerotic Cardiovascular Disease Risk and Its Implications for Primary Prevention. Hypertension. 2023 Aug;80(8):1697-1706.
• Yoon M, Park JJ, Hur T, Hua CH, Shim CY, Yoo BS, et al. The ReInforcement of adherence via self-monitoring app orchestrating biosignals and medication of RivaroXaban in patients with atrial fibrillation and co-morbidities: a study protocol for a randomized controlled trial (RIVOX-AF). Front Cardiovasc Med. 2023 May 24:10:1130216.
• Park J, An SY, Choi HM, Hwang IC, Yoon YE, Park JH, Cho GY. The Risk of Heart Failure Progression in Patients With Patent Foramen Ovale: Differential Risk Associated With Device Closure. J Am Soc Echocardiogr. 2023 Aug;36(8):812-820.
• Park JJ, Greenberg B. Topping Off the Pill Box: Dapagliflozin, Heart Failure, and Polypharmacy. JACC Heart Fail. 2023 Oct;11(10):1394-1396.
• Park J, Yoon Y, Cho Y, Kim J. Feasibility of artificial intelligence-based ECG analysis for the prediction of obstructive coronary artery disease in patients with stable angina: A validation study. JMIR Cardio. 2023 May 2;7:e44791.
• Park CS, Kim H, Lee SR, Lee JH, Cho Y, Choi EK, Oh IY, Oh S. Prognostic implication of early recurrence after cryoballoon ablation in patients with atrial fibrillation. J. Interv. Card. J Interv Card Electrophysiol. 2024 Mar;67(2):285-292.
• Kim JY, Oh IY, Lee H, Lee JH, Cho Y, Gil Y, Jung S, Kim DI, Shin MG, Yoo JY, Kwak JY. The efficacy of detecting arrhythmia is higher with 7‐day continuous electrocardiographic patch monitoring than with 24‐h Holter monitoring. J Arrhythm. 2023 May 8;39(3):422-429.
• Kim MC, Ahn Y, Kim MH, Kim SY, Hong TJ, Rhee MY, Kim SH, Hong SJ, Kim H, Kim W, Chae IH, Kang DH, Kim BK, Kim HS. A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia. Am J Cardiovasc Drugs. 2023 Jul;23(4):441-454.
• Lee SH, Hyun D, Choi J, Yoon CH, Cha KS, Oh S, Seong IW, Jeong MH, Choi JH. Adherence to guideline-directed medical therapy and 3-year clinical outcome following acute myocardial infarction. Eur Heart J Open. 2023 Mar 17;3(2).
• Rhee TM, Bae JW, Park KW, Rha SW, Kang J, Lee H, Yang HM, Kwak SH, Chae IH, Shin WY, Kim DK, Oh JH, Jeong MH, Kim YH, Lee NH, Hur SH, Yoon J, Han JK, Shin ES, Koo BK, Kim HS; HOST-EXAM Investigators. Aspirin vs Clopidogrel for Long-term Maintenance After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the HOST-EXAM Trial. JAMA Cardiol. 2023 Jun 1;8(6):535-544.
• Kim D, Jeong H, Kim S, Shin HG, Park KI, Lee SP, Lee HS, Lee JY, Kim KI, Kang SH, Lee JH, Jang SY, Lee JH, Kim KH, Cho JY, Park JH, Park SK, Kim S, Kim K, Lee HY. Association between office visit intervals and long-term cardiovascular risk in hypertensive patients. J Clin Hypertens (Greenwich). 2023 Aug;25(8):748-756.
• Kwak S, Lim J, Yang S, Rhee TM, Choi YJ, Lee HJ, Hwang IC, Lee H, Yoon YE, Park HE, Lee SP, Kim HK, Choi SY, Kim YJ, Cho GY, Park JB. Atrial Functional Tricuspid Regurgitation: Importance of Atrial Fibrillation and Right Atrial Remodeling and Prognostic Significance. J Clin Hypertens (Greenwich). 2023 Aug;25(8):748-756.
• Negishi T, Thavendiranathan P, Penicka M, Lemieux J, Murbraech K, Miyazaki S, Shirazi M, Santoro C, Cho GY, Popescu BA, Kosmala W, Costello B, la Gerche A, Mottram P, Thomas L, Seldrum S, Hristova K, Bansal M, Kurosawa K, Fukuda N, Yamada H, Izumo M, Tajiri K, Sinski M, Vinereanu D, Shkolnik E, Banchs J, Kutty S, Negishi K, Marwick TH. Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy: 3-Year Results of the SUCCOUR Trial. JACC Cardiovasc Imaging. 2023 Mar;16(3):269-278.
• Yang S, Hwang D, Zhang J, Park J, Yun JP, Lee JM, Nam CW, Shin ES, Doh JH, Chen SL, Kakuta T, Toth GG, Piroth Z, Johnson NP, Hakeem A, Uretsky BF, Hokama Y, Tanaka N, Lim HS, Ito T, Matsuo A, Azzalini L, Leesar MA, Neleman T, van Mieghem NM, Diletti R, Daemen J, Collison D, Collet C, De Bruyne B, Koo BK. Clinical and Vessel Characteristics Associated With Hard Outcomes After PCI and Their Combined Prognostic Implications. J Am Heart Assoc. 2023 Sep 5;12(17).
• Kwon W, Lee JM, Yun KH, Choi KH, Lee SJ, Lee JY, Lee SY, Kim SM, Cho JY, Kim CJ, Ahn HS, Nam CW, Yoon HJ, Park YH, Lee WS, Jeong JO, Song PS, Doh JH, Jo SH, Yoon CH, Kang MG, Koh JS, Lee KY, Lim YH, Cho YH, Cho JM, Jang WJ, Chun KJ, Hong D, Park TK, Yang JH, Choi SH, Gwon HC, Hahn JY, Song YB; RENOVATE COMPLEX-PCI Investigators. Clinical Benefit of Intravascular Imaging Compared With Conventional Angiography in Left Main Coronary Artery Intervention. Circ Cardiovasc Interv. 2023 Dec;16(12).
• Baskaran L, Lee JK, Ko MSM, Al'Aref SJ, Neo YP, Ho JS, Huang W, Yoon YE, Han D, Nakanishi R, Tan SY, Al-Mallah M, Budoff MJ, Shaw LJ. Comparing the pooled cohort equations and coronary artery calcium scores in a symptomatic mixed Asian cohort. Front Cardiovasc Med. 2023 Jan 17;(10).
• Sung KC, Hong SJ, Rhee MY, Jeong MH, Kim DH, Lim SW, Park K, Lee JB, Kim SY, Cho JM, Cho GY, Heo JH, Kim SH, Lee HY, Kim W, Cho DK, Park S, Shin J, Pyun WB, Kwon K, Rha SW, Jung JA. Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertension. J Clin Hypertens (Greenwich). 2023 May;25(5):429-439.
• Chung SM, Moon JS, Hong JH, Hwang IC, Lim S. Comparison of the effects of gemigliptin versus glimepiride on cardiac function in patients with type 2 diabetes uncontrolled with metformin: The gemi-heart study. Diabetes Obes Metab. 2023 Aug;25(8):2181-2190.
• Kwak S, Lee SA, Lim J, Yang S, Hwang D, Lee HJ, Choi HM, Hwang IC, Lee S, Yoon YE, Park JB, Kim HK, Kim YJ, Song JM, Cho GY, Kang DH, Kim DH, Lee SP. Data-driven mortality risk prediction of severe degenerative mitral regurgitation patients undergoing mitral valve surgery. Eur Heart J Cardiovasc Imaging. 2023 Aug 23;24(9):1156-1165.
• Lee SJ, Lee HH, Ko YG, Ahn CM, Lee YJ, Kim JS, Kim BK, Hong MK, Chang Kim H, Yu CW, Lee JH, Lee SW, Youn YJ, Park JK, Yoon CH, Rha SW, Min PK, Choi SH, Chae IH, Choi D; K-VIS Investigators. Device Effectiveness for Femoropopliteal Artery Disease Treatment: An Analysis of K-VIS ELLA Registry. JACC Cardiovasc Interv. 2023 Jul 10;16(13):1640-1650.
• Cha JJ, Cho JY, Lim S, Kim JH, Joo HJ, Park JH, Hong SJ, Lim DS, Kook H, Lee SH, Ko YG, Min PK, Lee JH, Yoon CH, Chae IH, Lee SW, Lee SR, Choi SH, Koh YS, Yu CW. Effect of Cilostazol on Patients With Diabetes Who Underwent Endovascular Treatment for Peripheral Artery Disease. J Am Heart Assoc. 2023 Jun 20;12(12):e027334.
• Song ZY, Kim MH, Lee HC, Park SJ, Rhee MY, Choi JI, Kim SH, Chae IH, Hong YJ, Lee NH, Hwang GS, Hur SH, Son JW, Chae JK, Kim HS. Efficacy and Safety of Coadministered Ezetimibe-Rosuvastatin plus Telmisartan in South Korean Patients with Dyslipidemia and Hypertension: A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase III Trial. J Clin Med. 2023 Mar 19;12(6):2377.
• Lee S, Yoon CH, Oh DH, Anh TQ, Jeon KH, Chae IH, Park KD. Gelatin microgel-coated balloon catheter with enhanced delivery of everolimus for long-term vascular patency. Acta Biomater. 2024 Jan 1:173:314-324.
• Brann A, Miller J, Eshraghian E, Park JJ, Greenberg B. Global longitudinal strain predicts clinical outcomes in patients with heart failure with preserved ejection fraction. Eur J Heart Fail. 2023 Oct;25(10):1755-1765.
• Rhee TM, Kim HK, Kim BS, Han KD, Lee HJ, Hwang IC, Lee H, Park JB, Yoon YE, Kim YJ, Cho GY. Impact of coronary artery revascularization on long-term outcome in hypertrophic cardiomyopathy patients: a nationwide population-based cohort study. Sci Rep. 2023 Apr 19;13(1):6412.
• Lee Y, Shin JH, Seo SM, Choi IJ, Lee JY, Lee JW, Park MW, Kang TS, Choi WG, Jeon KH, Lim HS, Joo HJ, Rhee SJ, Seo JB, Park MS, Park SH, Lim YH. Influence of early dose reduction of ticagrelor on clinical outcomes following percutaneous coronary intervention for complex lesions. Sci Rep. 2023 Sep 19;13(1):15481.
• Kwon W, Choi KH, Song YB, Park YH, Lee JM, Lee JY, Lee SJ, Lee SY, Kim SM, Yun KH, Cho JY, Kim CJ, Ahn HS, Nam CW, Yoon HJ, Lee WS, Jeong JO, Song PS, Doh JH, Jo SH, Yoon CH, Hong D, Park TK, Yang JH, Choi SH, Gwon HC, Hahn JY; RENOVATE COMPLEX-PCI Investigators. Intravascular Imaging in Patients With Complex Coronary Lesions and Chronic Kidney Disease. JAMA Netw Open. 2023 Nov 1;6(11):e2345554.
• Kwak S, Lee SA, Lim J, Yang S, Choi HM, Hwang IC, Lee S, Yoon YE, Park JB, Kim HK, Kim YJ, Song JM, Cho GY, Kim KH, Kang DH, Kim DH, Lee SP. Long-term outcomes in distinct phenogroups of patients with primary mitral regurgitation undergoing valve surgery. Heart. 2023 Jan 27;109(4):305-313.
• Lee SJ, Cha JJ, Choi WG, Lee WS, Jeong JO, Choi S, Cho YH, Park W, Yoon CH, Lee YJ, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y, Hong SJ, Kim JS; RACING Investigators. Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial. JAMA Cardiol. 2023 Sep 1;8(9):853-858.
• Lin FY, Goebel BP, Lee BC, Lu Y, Baskaran L, Yoon YE, Maliakal GT, Gianni U, Bax AM, Sengupta PP, Slomka PJ, Dey DS, Rozanski A, Han D, Berman DS, Budoff MJ, Miedema MD, Nasir K, Rumberger J, Whelton SP, Blaha MJ, Shaw LJ. Mortality impact of low CAC density predominantly occurs in early atherosclerosis: explainable ML in the CAC consortium. J Cardiovasc Comput Tomogr. 2023 Jan-Feb;17(1):28-33.
• Ahn HJ, Kang J, Lee SR, Park JJ, Lee HY, Choi DJ, Cho HJ. Neutrophil-to-lymphocyte ratio as a predictor of in-hospital complications and overall mortality in Takotsubo syndrome preceded by physical triggers. BMC Cardiovasc Disord. 2023 Jan 27;23(1):51.
• Yun JP, Kang J, Park KW, Park K, Hwang D, Han JK, Yang HM, Kang HJ, Koo BK, Chae IH, Moon KW, Park HW, Won KB, Jeon DW, Han KR, Choi SW, Ryu JK, Jeong MH, Kim HS. Prasugrel-Based De-Escalation in Patients With Acute Coronary Syndrome According to Renal Function. JACC Asia. 2023 Jan 10;3(1):51-61.
• Jin G, Seong SW, Kim MJ, Ahn KT, Jin SA, Hahn JY, Gwon HC, Hur SH, Rha SW, Yoon CH, Jeong MH, Bae JW, Song PS, Jeong JO; KAMIR-NIH Investigators. Prevalence and Prognostic Implications of Worsening Renal Function After Acute Myocardial Infarction. Am J Cardiol. 2023 Aug 1;200:40-46.
• Kim SB, Kim N, Park J, Hwang IC, Lim SH, Song DH, Choi Y, Yoon H, Shin CM, Park YS, Lee DH, Ahn S. Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow-up of 51 months. Helicobacter. 2023 Aug;28(4):e12969.
• Ahn JM, Kang DY, Lee PH, Ahn YK, Kim WJ, Nam CW, Jeong JO, Chae IH, Shiomi H, Kao PHL, Hahn JY, Her SH, Lee BK, Ahn TH, Chang K, Chae JK, Smyth D, Stone GW, Park DW, Park SJ; PREVENT Investigators. Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: Rationale and design of the randomized, controlled PREVENT trial. Am Heart J. 2023 Oct;264:83-96.
• Hong D, Kim SM, Lee SY, Choi KH, Song YB, Lee JY, Lee SJ, Yun KH, Cho JY, Kim CJ, Ahn HS, Nam CW, Yoon HJ, Park YH, Lee WS, Jeong JO, Song PS, Doh JH, Jo SH, Yoon CH, Kang MG, Koh JS, Lee KY, Lim YH, Cho YH, Cho JM, Jang WJ, Chun KJ, Park TK, Yang JH, Choi SH, Gwon HC, Hahn JY, Lee JM; RENOVATE-COMPLEX-PCI Investigators. Prognostic Impact of Intravascular Imaging-Guided Percutaneous Coronary Intervention in Chronic Total Occlusion. Circulation. 2023 Sep 12;148(11):903-905.
• Sa YK, Hwang BH, Chung WB, Lee KY, Lee J, Kang D, Ko YG, Yu CW, Kim J, Choi SH, Bae JW, Chae IH, Choi YS, Park CS, Yoo KD, Jeon DS, Kim HS, Chung WS, Chang K. Real-World Comparison of Transcatheter Versus Surgical Aortic Valve Replacement in the Era of Current-Generation Devices. J Clin Med. 2023 Jan 10;12(2):571.
• Park JB, Yun JY, Kim B, Rhee TM, Lee HJ, Lee H, Hwang IC, Yoon YE, Park HE, Lee SP, Choi SY, Kim YJ, Cho GY, Han K, Kim HK. Risk of incident mental disorders in hypertrophic cardiomyopathy: a nationwide propensity-matched study. Eur J Prev Cardiol. 2023 Jan 11;30(1):85-94.
• Shin ES, Jun EJ, Han JK, Kong MG, Kang J, Zheng C, Garg S, Choi YJ, Bae JW, Chun KJ, Kim DI, Rha SW, Lee SY, Rhew JY, Woo SI, Lee HC, Jeong JO, Yang HM, Park KW, Kang HJ, Koo BK, Chae IH, Kim HS. Sex-related impact on clinical outcomes of patients treated with drug-eluting stents according to clinical presentation: Patient-level pooled analysis from the GRAND-DES registry. Cardiol J. 2023;30(1):105-116.
• Kim YS, Jeong HG, Hwang IC, Kim BJ, Kwon JM, Bae HJ, Han MK. Tricuspid regurgitation: a hidden risk factor for atrial fibrillation related stroke? Front Cardiovasc Med. 2023 Jul 18;10:1135069.
• Jin U, Yoon M, Ha J, Lee SH, Yun D, Kim JS, Oh J, Park S, Lee SH, Kang SM, Lee CJ. Association between frailty and physical performance in older patients with heart failure. Clin Cardiol. 2023 Dec;46(12):1530-1537.
• H. J. Ahn, M. J. Cha, E. Lee, S. R. Lee, E. K. Choi, S. Han, et al. The higher recurrence rate after catheter ablation in younger patients with atrial fibrillation suggesting different pathophysiology. J Interv Card Electrophysiol. 2023 Oct;66(7):1609-1619.
• Jeong JH, Lee HS, Choi YY, Kim YG, Choi JI, Kim YH, Lim HE, Oh IY, Cha MJ, Lee SR, Kim JY, Kwon CH, Lee SH, Park J, Kim KH, Yang PS, Kim JH, Shim J. Association of typical atrial flutter and cavotricuspid isthmus ablation on clinical recurrence after cryoballoon ablation for atrial fibrillation. Front Cardiovasc Med. 2023 Dec 15;10:1303635
• Song MJ, Jang Y, Lee JH, Yoon JH, Kim DJ, Jung SY, Lim SY. Association of Dexmedetomidine With New-Onset Atrial Fibrillation in Patients With Critical Illness. JAMA Netw Open. 2023 Apr 3;6(4):e239955.

소화기내과

• Lee JW, Kim N, Choi SI, Jang JY, Song CH, Nam RH, Lee DH. Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea. Helicobacter. 2023 Feb;28(1):e12939.
• Song CH, Kim N, Nam RH, Choi SI, Jang JY, Lee H. Changes in gut microbiome upon orchiectomy and testosterone administration in AOM/DSS-induced colon cancer mouse model. Cancer Res Treat. 2023 Jan;55(1):196-218.
• Kim SB, Kim N, Park J, Hwang IC, Lim SH, Song DH, Choi Y, Yoon H, Shin CM, Park YS, Lee DH, Ahn S. Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow-up of 51 months. Helicobacter. 2023 Aug;28(4):e12969.
• Song CH, Kim N, Nam RH, Choi SI, Jang JY, Choi J, Lee HN. Anti-PD-L1 antibody and/or 17β-estradiol treatment induces changes in the gut microbiome in MC38 colon tumor model. Cancer Res Treat. 2023 Jul;55(3):894-909.
• Lee HD, Nam KH, Shin CM, Lee HS, Chang YH, Yoon H, Park YS, Kim N, Lee DH, Ahn SH, Kim HH. Development and Validation of Models to Predict Lymph Node Metastasis in Early Gastric Cancer Using Logistic Regression and Gradient Boosting Machine Methods. Cancer Res Treat. 2023;55(4):1240-1249.
• Choi J, Kim N, Nam RH, Kim JW, Song CH, Na HY, Kang GH. Influence of location-dependent sex difference on PD-L1, MMR/MSI, and EGFR in colorectal carcinogenesis. PLoS. 2023;18(2):e0282017.
• Kim N. Sex/gender differences in gastrointestinal endoscopy from the perspective of patients and gastroenterologists. Clin Endosc. 2023 May;56(3):268-282.
• Choi Y, Choi SI, Kim N, Nam RH, Jang JY, Na HY, Shin CM, Lee DH, Min H, Kim YR, Seok YJ. Effect of Clostridium butyricum on high-fat diet-induced intestinal inflammation and production of short-chain fatty acids. Dig Dis Sci. 2023 Jun;68(6):2427-2440.
• Kim SB, Kim N, Park J, Hwang IC, Lim SH, Song DH, Choi Y, Yoon H, Shin CM, Park YS, Lee DH, Ahn S. Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow-up of 51 months. Helicobacter. 2023 Aug;28(4):e12969.
• Kim J, Choi GH, Jang OJ, Chon Y, Cho SN, Kwon D, Jeong SH. Hepatitis C Virus Seroprevalence in Persons Who Inject Drugs in Korea, 2012-2022: A Multicenter, Retrospective Study. J Korean Med Sci. 2023 Dec 11;38(48):e357.
• Ahn S, Choi J, Jeong SH. The First Korean Adult Case of Progressive Familial Intrahepatic Cholestasis Type 7 with Novel USP53 Splicing Variants by Next Generation Sequencing. Yonsei Med J. 2023 Dec;64(12):745-749.
• Shin YC, Cho EJ, Na HY, Cho JY, Han HS, Lee YJ, Kim H, Jang S, Choi GH, Jang ES, Kim JW, Jeong SH. Hepatic hemangioma: proportion and predictor of surgical treatment with emphasis on its growth rate. Korean J Intern Med. 2023 Nov;38(6):818-830.
• Jeong CY, Choi GH, Jang ES, Kim YS, Lee YJ, Kim IH, Cho SB, Yoon JH, Kim KA, Choi DH, Chung WJ, Cho HJ, Na SK, Kim YT, Lee BS, Jeong SH. A Silent Outbreak of Hepatitis E Virus (HEV) Infection or False-Positive Reaction of Anti-HEV IgM after COVID-19 Vaccination? Epidemiological Investigation of an Outbreak in a Korean Factory Complex in 2022. Sci Rep. 2023 Aug 31;13(1):14271.
• Jang ES, Choi GH, Kim YS, Kim IH, Lee YJ, Cho SB, Kim YT, Jeong SH. Prevalence, incidence, and outcomes of hepatitis E virus coinfection in patients with chronic hepatitis C. Sci Rep. 2023 Aug 21;13(1):13632.
• Lee CH, Choi GH, Choi HY, Han S, Jang ES, Chon YE, Chang Y, Kim KA, Kim DY, Yim HJ, Kim HL, Jeong SH, Kim IH. Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study. Clin Mol Hepatol. 2023 Jul;29(3):779-793.
• Kim KA, Lee S, Park HJ, Jang ES, Lee YJ, Cho SB, Kim YS, Kim IH, Lee BS, Chung WJ, Ahn SH, Kim S, Jeong SH. Next-generation sequencing analysis of hepatitis C virus resistance-associated substitutions in direct-acting antiviral failure in South Korea. Clin Mol Hepatol. 2023 Apr;29(2):496-509.
• Jaehyung Park, Nayoung Kim, Won Seok Kim, Seon Hee Lim, Yonghoon Choi, Hyeong Ho Jo, Eunjeong Ji, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee. Long-term effects of the eradication of Helicobacter pylori on metabolic parameters depending on sex, in South Korea. Gut and Liver. 2023 Jan;17(1):58-68.
• Jihye Park, Jaeyoung Chun, Hyuk Yoon, Jae Hee Cheon, Feasibility of a clinical decision support tool for ustekinumab to predict clinical remission and relapse in patients with Crohn’s disease: A multicenter, observational study, Inflammatory Bowel Disease, 2023 Apr;29(4):548-554.
• Yu Kyung Jun, Hyuk Yoon, Seong-Joon Koh, A Hyeon Kim, Kwang Woo Kim, Jun Won Park, Hyun Jung Lee, Hyoun Woo Kang, Jong Pil Im, Young Soo Park, Joo Sung Kim. Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease. 2024 Apr;21(2):244-251.
• Jihye Park, Jaeyoung Chun, Soo Jung Park, Jae Jun Park, Tae Il Kim, Hyuk Yoon, Jae Hee Cheon. Effectiveness and tolerability of methotrexate monotherapy in Crohn’s disease patients: A multicenter observational study. Therapeutic Advances in Gastroenterology. 2023 Aug;16:1-11.
• Hee Moon Koo, Yu Kyung Jun, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Young Kee Shin, Hyuk Yoon. 10 Years of Biologic Use Patterns in Patients with Inflammatory Bowel Disease: Treatment Persistence, Switching, and Dose-Intensification - A Nationwide Population-based Study. Therapeutic Advances in Gastroenterology. 2023 Sep;16:1–16
• Jin Park, Hae Young Kim, Yoon Jin Lee, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee. Distribution of Small Bowel Involvement and its Association with Clinical Outcomes in Patients with Crohn’s disease. Medicine (Baltimore). 2023 Oct 6;102(40)
• Hyuk Yoon, Young Soo Park, Jeong Eun Shin, Byong Duk Ye, Chang Soo Eun, Soon Man Yoon, Jae Myung Cha, You Sun Kim, Kyu Chan Huh, Young Sook Park, Jae Hee Cheon, Eun Suk Jung, Youngdoe Kim, Su Young Jung. Clinical importance of weight gain and associated factors in patients with moderate to severe ulcerative colitis: Results from the MOSAIK cohort in Korea. BMC Gastroenterology. 2023 Nov 21;23(1):405.
• Hyuk Yoon, Sunghyouk Park, Yu Kyung Jun, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee. Evaluation of Bacterial and Fungal Biomarkers for Differentiation and Prognosis of Patients with Inflammatory Bowel Disease. 2023 Nov 29;11(12):2882.
• Yu Kyung Jun, Hee Tae Yoon 2, So Hyun Kwon 2, Ui Hyeon Jo 3, Ji Eun Kim 4, Yoo Min Han 2 5, Min-Seon Kim 6, Jong Pil Im 2, Dong Ho Lee 1, Joo Sung Kim 2, Seong-Joon Koh, Hyunsun Park. Regulation of psoriasis, colitis, and the intestinal microbiota by clusterin. SCIENTIFIC. 2023 Sep 16;13(1):15405.
• Jun, YK/Yu, DA/Han, YM/Lee, SR/Koh, SJ/Park, H. The relationship between rosacea and inflammatory bowel disease: A systematic review and meta-analysis. DERMATOLOGY AND THERAPY. 2023 Jul;13(7):1465-1475.
• Jun, YK/Koh, SJ/Myung, DS/Park, SH/Ooi, CJ/Sood, A/Im, JP, Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting. INTESTINAL RESEARCH. 2023 Jul;21(3):353-362.
• Jun, YK/Yoon, H/Koh, SJ/Kim, AH/Kim, KW/Park, JW/Lee, HJ/Kang, HW/Im, JP/Park, YS/Kim, JS. Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease. INTESTINAL RESEARCH. 2023 Apr;21(2):244-251.
• Ho-Kyoung Lee, Nam-Eun Kim, Cheol Min Shin, Tae Jung Oh, Hyuk Yoon, Young Soo Park, Nayoung Kim, Sungho Won, Dong Ho Lee. Gut microbiome signature of metabolically healthy obese individuals according to anthropometric, metabolic and inflammatory parameters. Scientific Reports. 2024 Feb 11;14(1):3449.
• Kim E, Lee HW, Kim SS, Yoon E, Jang ES, Chang JI, Cho YY, Seo GH, Kim HJ. Tenofovir disoproxil fumarate versus tenofovir alafenamide on risk of osteoporotic fracture in patients with chronic hepatitis B: A nationwide claims study in South Korea. Aliment Pharmacol Ther. 2023 Dec;58(11-12):1185-1193.
• Shin YC, Cho EJ, Na HY, Cho JY, Han HS, Lee YJ, Kim H, Jang S, Choi GH, Jang ES, Kim JW, Jeong SH. Hepatic hemangioma: proportion and predictor of surgical treatment with emphasis on its growth rate. Korean J Intern Med. 2023 Nov;38(6):818-830.
• Park GC, Chung JW, Jang ES, Kim JW. Association between adverse outcomes of hepatitis A and acetaminophen use: A population-based cohort study. Sci Rep. 2023 Aug 31;13(1):14271.
• Jeong CY, Choi GH, Jang ES, Kim YS, Lee YJ, Kim IH, Cho SB, Yoon JH, Kim KA, Choi DH, Chung WJ, Cho HJ, Na SK, Kim YT, Lee BS, Jeong SH. Etiology and clinical characteristics of acute viral hepatitis in South Korea during 2020-2021: a prospective multicenter study. Sci Rep. 2023 Aug 31;13(1):14271.
• Park SB, Khan M, Chiliveri SC, Hu X, Irvin P, Leek M, Grieshaber A, Hu Z, Jang ES, Bax A, Liang TJ. SARS-CoV-2 omicron variants harbor spike protein mutations responsible for their attenuated fusogenic phenotype. Commun Biol. 2023 May 24;6(1):556.
• Kim, KW/Koh,SJ/Kang, HW/Park, H/Ha, H/Park, J/Kim, K/Jun, Y/Han, YM/Lee, HJ/Yoon, H/Im, JP/Park, YS/Kin, JW/Kim, JS. Atopic dermatitis is associated with the clinical course of inflammatory bowel disease. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2023 Jul-Dec;58(10):1115-1121.
• Jaehyung Park, Nayoung Kim, Won Seok Kim, Seon Hee Lim, Yonghoon Choi, Hyeong Ho Jo, Eunjeong Ji, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee. Long-term effects of the eradication of Helicobacter pylori on metabolic parameters depending on sex, in South Korea. Gut and Liver. 2023 Jan 15;17(1):58-68.
• Kyunghwan Oh, Hee Seung Hong, Nam Seok Ham, Jungbok Lee, Sang Hyoung Park, Suk-Kyun Yang, Hyuk Yoon, You Sun Kim, Chang Hwan Choi, Byong Duk Ye. Real-World Effectiveness and Safety of Ustekinumab Induction Therapy for Korean Patients with Crohn’s Disease: A KASID Prospective Multicenter Study. Intestinal Research. 2023 Jan;21(1):137-147.
• Eun Soo Kim, Sung Kook Kim, Dong Il Park, Hyo Jong Kim, Yoo Jin Lee, Ja Seol Koo, Eun Sun Kim, Hyuk Yoon, Ji Hyun Lee, Ji Won Kim, Sung Jae Shin, Hyung Wook Kim, Hyun-Soo Kim, Young Sook Park, You Sun Kim, Tae Oh Kim, Jun Lee, Chang Hwan Choi, Dong Soo Han, Jaeyoung Chun, Hyun Soo Kim. Comparison of the Pharmacokinetics of CT-P13 Between Crohn’s Disease and Ulcerative Colitis. 2023 Jul 1;57(6):601-609.
• Kwang Woo Ki, Seong-Joon Koh, Hyoun Woo Kang, Hyunsun Park, Hyeonjin Ha, Jin Park, Kyunghoon Kim, Yukyung Jun, Yoo Min Han, Hyun Jung Lee, Hyuk Yoon, Jong Pil Im, Young Soo Park, Ji Won Kim, Joo Sung Kim. Atopic dermatitis is associated with the clinical course of inflammatory bowel disease. Scandinavian Journal of Gastroenterology. 2023 Jul-Dec;58(10):1115-1121.
• Kim KA, Choi HY, Ki M, Jang ES, Jeong SH. Epidemiological trends and outcomes of primary biliary cholangitis in South Korea between 2009 and 2019 J Gastroenterol. 2023 Jul;58(7):682-692.
• Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, Kremer AE, Zigmond E, Andreone P, Gordon SC, Bowlus CL, Lawitz EJ, Aspinall RJ, Pratt DS, Raikhelson K, Gonzalez-Huezo MS, Heneghan MA, Jeong SH, Ladrón de Guevara AL, Mayo MJ, Dalekos GN, Drenth JPH, Janczewska E, Leggett BA, Nevens F, Vargas V, Zuckerman E, Corpechot C, Fassio E, Hinrichsen H, Invernizzi P, Trivedi PJ, Forman L, Jones DEJ, Ryder SD, Swain MG, Steinberg A, Boudes PF, Choi YJ, McWherter CA; ENHANCE Study Group*. Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. Hepatology. 2023 Aug 1;78(2):397-415.
• Heo J, Kim YJ, Lee SW, Lee YJ, Yoon KT, Byun KS, Jung YJ, Tak WY, Jeong SH, Kwon KM, Suri V, Wu P, Jang BK, Lee BS, Cho JY, Jang JW, Yang SH, Paik SW, Kim HJ, Kwon JH, Park NH, Kim JH, Kim IH, Ahn SH, Lim YS. Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study. Korean J Intern Med. 2023 Jul;38(4):504-513.
• Cho YK, Kim JH, Kim HS, Kim TO, Oh JH, Choi SC, Moon JS, Lee SK, Jung SW, Kim SS, Jung HK, Lee SP, Cheon GJ, Park MI, Jung HY, Ko KH, Sung IK, Lee SH, Lee JY, Lee ST, Rhee PL, Kim N, Hong SJ, Kim HJ, Kim GH, Lee KJ, Kim SK, Shin WG, Lee OY. Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitis. Aliment Pharmacol Ther. 2023;57(1):72-80.
• Lim H, Park JK, Chung H, Lee SH, Park JM, Park JH, Kim GH, Shin SK, Hong SJ, Lee KJ, Park MI, Jung HK, Kim HS, Sung JK, Jeon SW, Choi SC, Moon JS, Kim N, Park JJ, Hong SH, Kim NY, Jung HY. Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study. BMC Gastroenterol. 2023 Dec 18;23(1):447.
• Park SM, Kim KB, Han JH, Kim N, Kang TU, Swan H, Kim HJ. Incidence and risk of pancreatic cancer in patients with acute or chronic pancreatitis: a population-based cohort study. Sci Rep. 2023 Nov 2;13(1):18930.
• Park J, Kim HY, Lee YJ, Yoon H, Shin CM, Park YS, Kim N, Lee DH. Distribution of small bowel involvement and its association with clinical outcomes in patients with Crohn's disease. Medicine (Baltimore). 2023 Oct 6;102(40):e35040.
• Koo HM, Jun YK, Choi Y, Shin CM, Park YS, Kim N, Lee DH, Shin YK, Yoon H. 10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification - a nationwide population-based study. Therap Adv Gastroenterol. 2023 Sep 29;16:17562848231201728.
• Yoon H, Park S, Jun YK, Choi Y, Shin CM, Park YS, Kim N, Lee DH. Evaluation of bacterial and fungal biomarkers for differentiation and prognosis of patients with inflammatory bowel disease. Microorganisms. 2023 Nov 29;11(12):2882.
• Lee HD, Nam KH Shin CM, Lee HS, Chang YH, Yoon H, Park YS, Kim N, Lee DH, Ahn SH, Kim HH. Development and Validation of Models to Predict Lymph Node Metastasis in Early Gastric Cancer Using Logistic Regression and Gradient Boosting Machine Methods. Cancer Res Treat. 2023 Oct;55(4):1240-1249.

혈액종양내과

• Seo J, Koh J, Lee DW, Kim J, Ryu HS, Lee KH, Kim TY, Im SA. HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless of HER2 IHC results. Breast Cancer Res. 2023 Dec 14;25(1):154.
• Yang J, Kim SH, Jung EH, Kim SA, Suh KJ, Lee JY, Kim JW, Kim JW, Lee JO, Kim YJ, Lee KW, Kim JH, Bang SM, Lee JS. The effect of metformin or dipeptidyl peptidase 4 inhibitors on clinical outcomes in metastatic non-small cell lung cancer treated with immune checkpoint inhibitors. Thorac Cancer. 2023 Jan;14(1):52-60.
• Kim K, Kim H, Shin I, Noh SJ, Kim JY, Suh KJ, Kim YN, Lee JY, Cho DY, Kim SH, Kim JH, Lee SH, Choi JK. Genomic hypomethylation in cell-free DNA predicts responses to checkpoint blockade in lung and breast cancer. Sci Rep. 2023 Dec 18;13(1):22482.
• Kim S, Kim S, Kim SH, Jung EH, Suh KJ, Kim YJ, Kwon NJ, Kim H, Chung JH, Lee JS. Clinical validity of oncogenic driver genes detected from circulating tumor DNA in the blood of lung cancer patients. Transl Lung Cancer Res. 2023 Jun 30;12(6):1185-1196.
• Kim SH, Im SA, Suh KJ, Lee KH, Kim MH, Sohn J, Park YH, Kim JY, Jeong JH, Lee KE, Choi IS, Park KH, Kim HJ, Cho EK, Park SY, Kim M, Kim JH. Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16). Eur J Cancer. 2023 Dec;195:113386.
• Yhim HY, Lee J, Kim KH, Kim SA, Lee JY, Hwang HG, Hong J, Lee JO, Bang SM. Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximab-based combination chemotherapy: A population-based study in Korea. Thromb Res. 2023 Nov;231:50-57.
• Hwang HG, Lee JH, Bang SM. Incidence of Pregnancy-Associated Venous Thromboembolism: Second Nationwide Study. Thromb Haemost. 2023 Sep;123(9):904-910.
• Yoon D, Jeong HE, Choi S, Lee D, Shin JY, Bang SM. Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study. Cancer Med. 2023 Nov;12(21):20538-20543.
• Noh S, Kim SA, Lee JY, Lee JO, Bang SM. A case report of thrombotic thrombocytopenic purpura-like syndrome after Coronavirus disease 2019 vaccination. Blood Res. 2023 Jun 30;58(2):116-117.
• Jung EH, Byun JM, Shin DY, Do YR, Jo JC, Lee SM, Yoon SS. Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122). Cancer Med. 2023 Apr;12(8):9186-9193.
• Lee SW, Jung EH, Kim HJ, Min C, Yoo SH, Kim YJ, Rha SY, Yon DK, Kang B. Risk factors for delirium among patients with advanced cancer in palliative care: a multicenter, patient-based registry cohort in South Korea. Eur Rev Med Pharmacol Sci. 2023 Mar;27(5):2068-2076.
• Kim YJ, Kim SH. Advance Care Planning in South Korea. Z Evid Fortbild Qual Gesundhwes. 2023 Aug;180:68-73.
• Lim Y, Choi S, Oh HJ, Kim C, Song S, Kim S, Song H, Park S, Kim JW, Kim JW, Kim JH, Kang M, Kang SB, Kim DW, Oh HK, Lee HS, Lee KW. Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes for prediction of prognosis in resected colon cancer. NPJ Precis Oncol. 2023 Nov 20;7(1):124.
• Suh KJ, Ryu MH, Zang DY, Bae WK, Lee HS, Oh HJ, Kang M, Kim JW, Kim BJ, Mortimer PGS, Kim HJ, Lee KW. AZD8186 in Combination With Paclitaxel in Patients With Advanced Gastric Cancer: Results From a Phase Ib/II Study (KCSG ST18-20). Oncologist. 2023 Sep 7;28(9):e823-e834.
• Won SH, Hiratsuka Y, Suh SY, Bae H, Choi SE, Kim YJ, Kang B, Lee SW, Suh KJ, Kim JW, Kim SH, Kim JW, Lee KW. Mid-upper Arm Circumference as an Indicator of Quality of Life of Patients with Advanced Cancer. J Palliat Care. 2023 Jan;38(1):24-29.
• Lee KW, Zang DY, Ryu MH, Han HS, Kim KH, Kim MJ, Koh SA, Lee SS, Koo DH, Ko YH, Sohn BS, Kim JW, Park JH, Nam BH, Choi IS. A Phase 3 Randomized Clinical Trial to Compare Efficacy and Safety between Combination Therapy and Monotherapy in Elderly Patients with Advanced Gastric Cancer (KCSG ST13-10). Cancer Res Treat. 2023 Oct;55(4):1250-1260.
• Yeo M, Seo J, Lim J. The impact of the COVID-19 pandemic and the expansion of free vaccination policy on influenza vaccination coverage: An analysis of vaccination behavior in South Korea. PLoS One. 2023 Feb 15;18(2):e0281812.
• Park J, Kim HY, Na HY, Lee JS, Lee JC, Kim JW, Yoon YS, Hwang JH, Han HS, Kim J. Continued adjuvant FOLFIRINOX for BRPC or LAPC after neoadjuvant FOLFIRINOX. J Cancer Res Clin Oncol. 2023 May;149(5):1765-1775.
• Ryu H, Song C, Kim JS, Jeon JH, Cho S, Kim K, Jheon S, Kim SH, Kim YJ, Lee JS. Role of prognostic nutritional index in postoperative radiotherapy for non-small cell lung cancer. Thorac Cancer. 2023 Oct;14(28):2859-2868.
• Jung JJ, Kim EK, Kang E, Kim JH, Kim SH, Suh KJ, Kim SM, Jang M, Yun B, Park SY, Lim C, Han W, Shin HC. Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer. J Breast Cancer. 2023 Aug;26(4):353-362.
• Kim SW, Ohn JH, Kim NH, Kim ES, Lim Y, Lee J, Kim HW, Ryu J, Park HS, Suh KJ, Kim JW, Kim JW, Kim SH, Kim YJ, Lee KW, Kim JH, Lee JS, Jang HC. The Hospitalist-Oncologist co-ManagemEnt (HOME) system improves hospitalization outcomes of patients with cancer. BMC Health Serv Res. 2023 Dec 6;23(1):1367.
• Turpie AGG, Farjat AE, Haas S, Ageno W, Weitz JI, Goldhaber SZ, Goto S, Angchaisuksiri P, Kayani G, Lopes RD, Chiang CE, Gibbs H, Tse E, Verhamme P, Ten Cate H, Muntaner J, Schellong S, Bounameaux H, Prandoni P, Maheshwari U, Kakkar AK; GARFIELD-VTE investigators. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE. Thromb Res. 2023 Feb;222:31-39.
• Verstovsek S, Gerds AT, Vannucchi AM, Al-Ali HK, Lavie D, Kuykendall AT, Grosicki S, Iurlo A, Goh YT, Lazaroiu MC, Egyed M, Fox ML, McLornan D, Perkins A, Yoon SS, Gupta V, Kiladjian JJ, Granacher N, Lee SE, Ocroteala L, Passamonti F, Harrison CN, Klencke BJ, Ro S, Donahue R, Kawashima J, Mesa R; MOMENTUM Study Investigators. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study. Lancet. 2023 Jan 28;401(10373):269-280.
• Fu W, Bang SM, Huang H, Kim K, Li W, An G, Lee JJ, Cai Z, Jin J, Wang Y, Lin TL, Chim CS, Qi M, Wang J, Lu X, Song Y, Jia B, Yang X, Liu W, Zhou T, Yin L, Li Y, Zhang R, Hou J, Wang J. Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS Study. Clin Lymphoma Myeloma Leuk. 2023 Jun;23(6):446-455.e4.
• Candeloro M, Valeriani E, Monreal M, Ageno W, Riva N, Schulman S, Bang SM, Mellado M, Díaz-Peromingo JA, Moisés J, Díaz-Brasero AM, Garcia-Pagan JC, Perez-Campuzano V, Senzolo M, De Gottardi A, Di Nisio M. Clinical course and treatment of incidentally detected splanchnic vein thrombosis: an individual patient data meta-analysis. J Thromb Haemost. 2023 Jun;21(6):1592-1600.
• Yoon D, Jeong HE, Park S, You SC, Bang SM, Shin JY. Real-world data emulating randomized controlled trials of non-vitamin K antagonist oral anticoagulants in patients with venous thromboembolism. BMC Med. 2023 Sep 29;21(1):375.
• Ha H, Ko YH, Kim K, Hong J, Lee GW, Jeong SH, Bang SM, Yoon SS. Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy. Thromb J. 2023 Jun 5;21(1):63.
• Jung J, Kim K, Jung SH, Yoon SS, Lee JH, Kim JS, Shin HJ, Bang SM, Sohn SK, Suh C, Yoon DH, Kong SY, Min CK, Eom HS; Korean Multiple Myeloma Working Party. Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study. Cancer Res Treat. 2023 Apr;55(2):693-703.
• Byun JM, Shin J, Kim SA, Park H, Lee J, Shin DY, Hong J, Lee JO, Bang SM, Kim I, Yoon SS, Koh Y. A Phase II Study to Evaluate the Efficacy of Bortezomib in Combination with Thalidomide in Treatment-Naïve Waldenstrom Macroglobulinemia Patients. Cancer Res Treat. 2024 Apr;56(2):675-680.
• Kim SJ, Do YR, Lee HS, Lee WS, Kong JH, Kwak JY, Eom HS, Moon JH, Yi JH, Lee JO, Jo JC, Yang DH. A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study. Blood Res. 2023 Dec 31;58(4):194-200.
• Yhim HY, Lee J, Kim KH, Kim SA, Lee JY, Hwang HG, Hong J, Lee JO, Bang SM. Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximab-based combination chemotherapy: A population-based study in Korea. Thromb Res. 2023 Nov;231:50-57.
• Baek DW, Moon JH, Lee JH, Kang KW, Lee HS, Eom HS, Lee E, Lee JH, Lee JO, Park SK, Kim SJ, Yoo KH, Yoon SS, Koh Y, Kang HJ, Won JH, Lyu CJ, Hahn SM, Lee JH, Park JS, Jo JC, Mun YC, Yang DH, Song GY, Lim SN, Sohn SK; Korean Society of Blood and Marrow Transplantation. Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation. Blood Cancer J. 2023 Jun 26;13(1):95.
• Kim DY, Kim YR, Suh C, Yoon DH, Yang DH, Park Y, Eom HS, Lee JO, Kwak JY, Kang HJ, Hyun SY, Jo JC, Chang MH, Yoo KH, Lim SN, Shin HJ, Kim WS, Kim IH, Kim MK, Kim HJ, Lee WS, Mun YC, Kim JS. A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone. Am J Gastroenterol. 2023 Aug 1;118(8):1373-1380.
• Kim DW, Byun JM, Lee JO, Kim JK, Koh Y. Chemotherapy delivery time affects treatment outcomes of female patients with diffuse large B cell lymphoma. JCI Insight. 2023 Jan 24;8(2):e164767.
• Paik JH, Koh J, Han B, Kim S, Lee KR, Lee S, Lee JO, Kim TM, Kim WY, Jeon YK. Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression. Hum Pathol. 2023 Jan;131:47-60.
• Lee SW, Jung EH, Kim HJ, Min C, Yoo SH, Kim YJ, Rha SY, Yon DK, Kang B. Risk factors for delirium among patients with advanced cancer in palliative care: a multicenter, patient-based registry cohort in South Korea. Eur Rev Med Pharmacol Sci. 2023 Mar;27(5):2068-2076.
• Yoon WS, Chang JH, Kim JH, Kim YJ, Jung TY, Yoo H, Kim SH, Ko YC, Nam DH, Kim TM, Kim SH, Park SH, Lee YS, Yim HW, Hong YK, Yang SH. Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study). Discov Oncol. 2023 Jun 6;14(1):90.
• Galffy G, Lugowska I, Poddubskaya EV, Cho BC, Ahn MJ, Han JY, Su WC, Hauke RJ, Dyar SH, Lee DH, Serwatowski P, Estelles DL, Holden VR, Kim YJ, Vladimirov V, Horvath Z, Ghose A, Goldman A, di Pietro A, Wang J, Murphy DA, Alhadab A, Laskov M. A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer. ESMO Open. 2023 Jun;8(3):101173.
• Lee HB, Lee KH, Song SH, Kim K, Kim HK, Moon HG, Han W, Lee DW, Im SA, Jang BS, Kim YB, Yu J, Kim JH, Park YH, Shin KH, Chang JH. A Survey of Practice Patterns for Clinical Nodal Staging Prior to Neoadjuvant Chemotherapy in Breast Cancer. Oncologist. 2023 Dec 11;28(12):e1142-e1151.
• Lee K, Lee J, Choi J, Sim SH, Kim JE, Kim MH, Park YH, Kim JH, Koh SJ, Park KH, Kang MJ, Ahn MS, Lee KE, Kim HJ, Ahn HK, Kim HJ, Park KU, Park IH. Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer. Sci Rep. 2023 Jun 19;13(1):9928.
• Hwang S, Park S, Kim JH, Bang SB, Kim HJ, Ka NL, Ko Y, Kim SS, Lim GY, Lee S, Shin YK, Park SY, Kim S, Lee MO. Targeting HMG-CoA synthase 2 suppresses tamoxifen-resistant breast cancer growth by augmenting mitochondrial oxidative stress-mediated cell death. Life Sci. 2023 Sep 1;328:121827.
• Kim JS, Kim K, Jung W, Shin KH, Im SA, Kim HJ, Kim YB, Chang JS, Kim JH, Choi DH, Park YH, Kim DY, Kim TH, Choi BO, Lee SW, Kim S, Kwon J, Kang KM, Chung WK, Kim KS, Yoon WS, Kim JH, Cha J, Oh YK, Kim IA. Comparison of initial and sequential salvage brain-directed treatment in patients with 1-4 vs. 5-10 brain metastases from breast cancer (KROG 16-12). Breast Cancer Res Treat. 2023 Jul;200(1):37-45.
• Im SA, Gennari A, Park YH, Kim JH, Jiang ZF, Gupta S, Fadjari TH, Tamura K, Mastura MY, Abesamis-Tiambeng MLT, Lim EH, Lin CH, Sookprasert A, Parinyanitikul N, Tseng LM, Lee SC, Caguioa P, Singh M, Naito Y, Hukom RA, Smruti BK, Wang SS, Kim SB, Lee KH, Ahn HK, Peters S, Kim TW, Yoshino T, Pentheroudakis G, Curigliano G, Harbeck N. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer. ESMO Open. 2023 Jun;8(3):101541.
• Lee DW, Keam B, Lee KS, Ahn JH, Sohn J, Ahn JS, Lee MH, Kim JH, Lee KE, Kim HJ, Kim SY, Park YH, Ock CY, Lee KH, Han SW, Kim SB, Im YH, Chung HC, Oh DY, Im SA. A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03). Cancer Res Treat. 2023 Apr;55(2):523-530.
• Nakamura Y, Mizuno N, Sunakawa Y, Canon JL, Galsky MD, Hamilton E, Hayashi H, Jerusalem G, Kim ST, Lee KW, Kankeu Fonkoua LA, Monk BJ, Nguyen D, Oh DY, Okines A, O'Malley DM, Pohlmann P, Reck M, Shin SJ, Sudo K, Takahashi S, Van Marcke C, Yu EY, Groisberg R, Ramos J, Tan S, Stinchcombe TE, Bekaii-Saab T. Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study. J Clin Oncol. 2023 Dec 20;41(36):5569-5578.
• Kim DH, Lim Y, Ock CY, Park G, Park S, Song H, Ma M, Mostafavi M, Kang EJ, Ahn MJ, Lee KW, Kwon JH, Yang Y, Choi YH, Kim MK, Ji JH, Yun T, Kim SB, Keam B. Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma. Head Neck. 2023 Dec;45(12):3086-3095.
• Oh DY, Maqueda MA, Quinn DI, O'Dwyer PJ, Chau I, Kim SY, Duran I, Castellano D, Berlin J, Mellado B, Williamson SK, Lee KW, Marti F, Mathew P, Saif MW, Wang D, Chong E, Hilger-Rolfe J, Dean JP, Arkenau HT. Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase1b/2 study. BMC Cancer. 2023 Nov 3;23(1):1056.
• Lam LL, Pavlakis N, Shitara K, Sjoquist KM, Martin AJ, Yip S, Kang YK, Bang YJ, Chen LT, Moehler M, Bekaii-Saab T, Alcindor T, O'Callaghan CJ, Tebbutt NC, Hague W, Chan H, Rha SY, Lee KW, Gebski V, Jaworski A, Zalcberg J, Price T, Simes J, Goldstein D. INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG). BMC Cancer. 2023 Feb 22;23(1):180.
• Lee J, Park S, Jung HA, Lee SH, Seo S, Kim SB, Kim JW, Lee KW, Kang EJ, Kim JW, Choi YJ, Shim BY, An HJ, Park LC, Shin SH, Kim JJ, Oh SY, Kim MK, Ahn MJ. A phase 2 multicenter study of docetaxel-PM and trastuzumab-pkrb combination therapy in recurrent or metastatic salivary gland carcinomas. Cancer. 2023 Oct 1;129(19):2966-2974.
• Klempner SJ, Lee KW, Shitara K, Metges JP, Lonardi S, Ilson DH, Fazio N, Kim TY, Bai LY, Moran D, Yang J, Arozullah A, Park JW, Raizer JJ, Bang YJ, Shah MA. ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma. Clin Cancer Res. 2023 Oct 2;29(19):3882-3891.
• Choi Y, Kim N, Yun CY, Choi YJ, Yoon H, Shin CM, Park YS, Ahn SH, Joong Park D, Lee HS, Kim JW, Kim JW, Lee KW, Chang W, Park JH, Lee YJ, Lee KH, Kim YH, Lee DH, Kim HH. Correction: Effect of Helicobacter pylori eradication after subtotal gastrectomy on the survival rate of patients with gastric cancer: follow-up for up to 15 years. Gastric Cancer. 2023 Sep;26(5):843-845.
• Kwon HJ, Park Y, Nam SK, Kang E, Kim KK, Jeong I, Kwak Y, Yoon J, Kim TY, Lee KW, Oh DY, Im SA, Kong SH, Park DJ, Lee HJ, Kim HH, Yang HK, Lee HS. Genetic and immune microenvironment characterization of HER2-positive gastric cancer: Their association with response to trastuzumab-based treatment. Cancer Med. 2023 May;12(9):10371-10384.
• Catenacci DV, Kang YK, Uronis HE, Lee KW, Ng MC, Enzinger PC, Park SH, Gold PJ, Lacy J, Hochster HS, Oh SC, Kim YH, Marrone KA, Kelly RJ, Juergens RA, Kim JG, Alcindor T, Sym SJ, Song EK, Chee CE, Chao Y, Kim S, Oh DY, Yen J, Odegaard JI, Lagow E, Li D, Sun J, Kaminker P, Moore PA, Rosales MK, Park H. Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma. Oncology (Williston Park). 2023 Apr 25;37(4):176-183.
• Satake H, Lee KW, Chung HC, Lee J, Yamaguchi K, Chen JS, Yoshikawa T, Amagai K, Yeh KH, Goto M, Chao Y, Lam KO, Han SR, Shiratori S, Shah S, Shitara K. Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062. Jpn J Clin Oncol. 2023 Mar 7;53(3):221-229.
• Yamaguchi K, Bang YJ, Iwasa S, Sugimoto N, Ryu MH, Sakai D, Chung HC, Kawakami H, Yabusaki H, Lee J, Shimoyama T, Lee KW, Saito K, Kawaguchi Y, Kamio T, Kojima A, Sugihara M, Shitara K. Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Factor Receptor 2 Treatment-Naive Patients With Human Epidermal Growth Factor Receptor 2-Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial. J Clin Oncol. 2023 Feb 1;41(4):816-825.
• Lee YG, Kang EJ, Keam B, Choi JH, Kim JS, Park KU, Lee KE, Lee KW, Kim MK, Ahn HK, Shin SH, Kim HR, Kim SB, Kim HJ, Yun HJ. Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01). Cancers (Basel). 2023 Jan 12;15(2):471.
• Kim TH, Kwak Y, Song C, Lee HS, Kim DW, Oh HK, Kim JW, Lee KW, Kang SB, Kim JS. GLUT-1 may predict metastases and death in patients with locally advanced rectal cancer. Front Oncol. 2023 Mar 9;13:1094480.
• Oh DY, He AR, Qin S, Chen LT, Okusaka T, Vogel A, Kim JW, Suksombooncharoen T, Lee MA, Kitano M, Burris H, Bouattour M, Tanasanvimon S, McNamara MG, Zaucha R, Avallone A, Tan B, Cundom J, Lee CK, Takahashi H, Ikeda M, Chen JS, Wang J, Makowsky M, Rokutanda N, Żotkiewicz M, Kurland JF, Cohen G, Valle JW. Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer. Future Oncol. 2023 Nov;19(34):2277-2289.
• Yoo C, Javle MM, Verdaguer Mata H, de Braud F, Trojan J, Raoul JL, Kim JW, Ueno M, Lee CK, Hijioka S, Cubillo A, Furuse J, Azad N, Sato M, Vugmeyster Y, Machl A, Bajars M, Bridgewater J, Oh DY, Borad MJ. Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers. Hepatology. 2023 Sep 1;78(3):758-770.
• Harding JJ, Fan J, Oh DY, Choi HJ, Kim JW, Chang HM, Bao L, Sun HC, Macarulla T, Xie F, Metges JP, Ying J, Bridgewater J, Lee MA, Tejani MA, Chen EY, Kim DU, Wasan H, Ducreux M, Bao Y, Boyken L, Ma J, Garfin P, Pant S; HERIZON-BTC-01 study group. Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study. Lancet Oncol. 2023 Jul;24(7):772-782.
• Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, Yau T, Klümpen HJ, Chan SL, Ozaka M, Verslype C, Bouattour M, Park JO, Barajas O, Pelzer U, Valle JW, Yu L, Malhotra U, Siegel AB, Edeline J, Vogel A; KEYNOTE-966 Investigators. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023 Jun 3;401(10391):1853-1865. doi: 10.1016/S0140-6736(23)00727-4. Epub 2023 Apr 16. Erratum in: Lancet. 2023 Sep 16;402(10406):964.
• Choi J, Kim N, Nam RH, Kim JW, Song CH, Na HY, Kang GH. Influence of location-dependent sex difference on PD-L1, MMR/MSI, and EGFR in colorectal carcinogenesis. PLoS One. 2023 Feb 21;18(2):e0282017.
• Lee CK, Chon HJ, Cheon J, Lee MA, Im HS, Jang JS, Kim MH, Park S, Kang B, Hong M, Kim JW, Park HS, Kang MJ, Park YN, Choi HJ. Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14). Lancet Gastroenterol Hepatol. 2023 Jan;8(1):56-65.

내분비내과

• Lim S, Sohn M. How to cope with emerging viral diseases: lessons from South Korea's strategy for COVID-19, and collateral damage to cardiometabolic health. Lancet Reg Health West Pac. 2023 Jan;30:100581
• Kong SH, Kim JH, Park MY, Kim SW, Shin CS. Residual risks of comorbidities after parathyroidectomy in a nationwide cohort of patients with primary hyperparathyroidism. Endocrine. 2023 Jan;79(1):190-199
• Lim S, Sohn M, Florez JC, Nauck MA, Ahn J. Effects of Initial Combinations of Gemigliptin Plus Metformin Compared with Glimepiride Plus Metformin on Gut Microbiota and Glucose Regulation in Obese Patients with Type 2 Diabetes: The INTESTINE Study. Nutrients. 2023 Jan 3;15(1):248.
• Kong SH, Lee JH, Bae JM, Hong N, Kim H, Park SY, Choi YJ, Lee S, Rhee Y, KimSW, Han D, Kim JH, Shin CS. In-depth proteomic signature of parathyroid carcinoma. Eur J Endocrinol. 2023 Apr 5;188(4):385-394
• Kong SH, Jo AJ, Park CM, Park KI, Yun JE, Kim JH. Chronic airway disease as a major risk factor for fractures in osteopenic women: Nationwide cohort study. Front Endocrinol (Lausanne). 2023 Mar 21;14:1085252
• Moon JH, Jang Y, Oh TJ, Jung SY. The Risk of Type 2 Diabetes Mellitus according to Changes in Obesity Status in Late Middle-Aged Adults: A Nationwide Cohort Study of Korea. Diabetes Metab J. 2023 Jul;47(4):514-522
• Kong SH, Kim S, Kim Y, Kim JH, Kim K, Shin CS. Development and validation of common data model-based fracture prediction model using machine learning algorithm. Osteoporos Int. 2023 Aug;34(8):1437-1451
• Kim MJ, Song H, Koh Y, Lee H, Park HE, Choi SH, Yoon JW, Choi SY. Clonal hematopoiesis as a novel risk factor for type 2 diabetes mellitus in patients with hypercholesterolemia. Front Public Health. 2023 Jun 28;11:1181879
• Moon JH, Kim Y, Oh TJ, Moon JH, Kwak SH, Park KS, Jang HC, Choi SH, Cho NH. Triglyceride-Glucose Index Predicts Future Atherosclerotic Cardiovascular Diseases: A 16-Year Follow-up in a Prospective, Community-Dwelling Cohort Study. Endocrinol Metab (Seoul). 2023 Aug;38(4):406-417
• Jang HN, Oh TJ. Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy. Diabetes Metab J. 2023 Nov;47(6):743-756
• Moon JH, Lee J, Kim KH, Kim HJ, Kim H, Cha HN, Park J, Lee H, Park SY, Jang HC, Kim H. Multiparity increases the risk of diabetes by impairing the proliferative capacity of pancreatic β cells. Exp Mol Med. 2023 Oct;55(10):2269-2280
• Moon JH, Jeong S, Jang H, Koo BK, Kim W. Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study. EClinicalMedicine. 2023 Oct 28;65:102292
• Sohn M, Jung H, Lee WS, Kim TH, Lim S. Effect of Lactobacillus plantarum LMT1-48 on Body Fat in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Metab J. 2023 Jan;47(1):92-103
• Ahn CH, Oh TJ, Min SH, Cho YM. Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes. Endocrinol Metab (Seoul). 2023 Feb;38(1):1-9
• Lim LL, Lau ESH, Cheung JTK, Chan SP, Ji L, Lim S, Sirinvaravong S,Unnikrishnan AG, Luk AOY, Cortese V, Durocher A, Chan JCN. Real-world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation (JADE) register. Diabetes Obes Metab. 2023 Jan;25(1):208-221
• Koo HY, Cho EB, Kong SH, Han K, Lee KN, Yoo JE, Min JH, Chun S, Shin DW. Fracture risk in Parkinson's disease according to its severity and duration. Osteoporos Int. 2023 Jan;34(1):81-89
• Suh B, Yu H, Kim H, Lee S, Kong S, Kim JW, Choi J. Interpretable Deep-Learning Approaches for Osteoporosis Risk Screening and Individualized Feature Analysis Using Large Population-Based Data: Model Development and Performance Evaluation. J Med Internet Res. 2023 Jan 13;25:e40179
• Golfetto Miskiewicz IC, Cho HC, Lee JI, Lee J, Lee Y, Lee YK, Choi SH. Effect of atorvastatin on lipoxygenase pathway-related gene expression in an in vitro model of lipid accumulation in hepatocytes. FEBS Open Bio. 2023 Apr;13(4):606-616
• Choi JH, Yu HW, Lee JK, Kim W, Choi JY, Na HY, Park SY, Ahn CH, Moon JH, Choi SI, Lee HY, Lee WW, Cha W, Jeong WJ. BRAF^V600E and TERT promoter C228T mutations on ThyroSeq v3 analysis of delayed skin metastasis from papillary thyroid cancer: a case report and literature review. World J Surg Oncol. 2023 Feb 17;21(1):49
• Jung SY, Cho EB, Han KD, Jung JH, Yeo Y, Kong SH, Shin DW, Min JH. Risk of fracture in neuromyelitis optica spectrum disorder and multiple sclerosis: a nationwide cohort study in South Korea. Osteoporos Int. 2023 May;34(5):925-933
• Kwak SH, Han KA, Kim KS, Yu JM, Kim E, Won JC, Kang JG, Chung CH, Oh S, Choi SH, Won KC, Kim SG, Cho SA, Cho BY, Park KS. Efficacy and safety of enavogliflozin, a novel SGLT2 inhibitor, in Korean people with type 2 diabetes: A 24-week, multicentre, randomized, double-blind, placebo-controlled, phase III trial. Diabetes Obes Metab. 2023 Jul;25(7):1865-1873
• Kim KS, Han KA, Kim TN, Park CY, Park JH, Kim SY, Kim YH, Song KH, Kang ES, Kim CS, Koh G, Kang JG, Kim MK, Han JM, Kim NH, Mok JO, Lee JH, Lim S, Kim SS, Kim TH, Won KC, Lee KY, Cho JH, Han JY, Kim SH, Nah JJ, Song HR, Lee SE, Kim S;ENHANCE-D Investigators. Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study. Diabetes Metab. 2023 Jul;49(4):101440
• Kim HS, Yu JM, Jang HC, Choi EK, Park JH, Shon HS, Chung CH, Park KG, Cho JH, Kim W, Lee KH, Lee JH, Yoo SJ. Real-World Analysis of Rapid-Acting Insulin Analog Use and Its Blood Glucose Lowering Effect in Patients with Type 2 Diabetes Mellitus: Results from PASSION Disease Registry in Korea. Diabetes Metab Syndr Obes 2022;15:1495-503.
• Hwang H, Choi JY, Yu HW, Moon JH, Kim JH, Lee EK, Kim YK, Lee CY, Cho SW, Chung EJ, Ryu CH, Ryu J, Yi KH, Park DJ, Lee KE, Park YJ, Kim SJ, Jung YS. Surgical Outcomes in Patients With Low-risk Papillary Thyroid Microcarcinoma From MAeSTro Study: Immediate Operation Versus Delayed Operation After Active SurveillanceA Multicenter Prospective Cohort Study. Ann Surg. 2023 Nov 1;278(5):e1087-e1095
• Kang SM, Yun HM, Sohn M, Lim S. Vascular and metabolic effects of ipragliflozin versus sitagliptin (IVS) in type 2 diabetes treated with sulphonylurea and metformin: IVS study. Diabetes Obes Metab. 2023 Jul;25(7):1922-1931
• Lim JY, Kim YY, Kim JW, Hong S, Min K, Beom J, Yoon BH, Lee SY, Kong SH, Yoo JI, Park MS, Nho JH, Ko S, Joo MW, Kim DH, Park CH, Kim TY, Sohn S, Park SY, Hong AR, Kwon YJ, Park SB, Lee YK, Moon NH, Kim BR, Park Y, Cha Y, Ha YC. Fracture Liaison Service in Korea: 2022 Position Statement of the Korean Society for Bone and Mineral Research. J Bone Metab. 2023 Feb;30(1):31-36
• Bae JH, Lim H, Lim S. The Potential Cardiometabolic Effects of Long-Chain ω-3 Polyunsaturated Fatty Acids: Recent Updates and Controversies. Adv Nutr. 2023 Jul;14(4):612-628
• Luo Y, Xia J, Zhao Z, Chang Y, Bee YM, Nguyen KT, Lim S, Yabe D, McGill M, Kong APS, Chan SP, Deodat M, Deerochanawong C, Suastika K, Xu C, Chen L, Chen W, Li X, Zhao W, Yao X, Ji L. Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta-analysis. J Diabetes. 2023 May;15(5):419-435
• Chung SM, Moon JS, Hong JH, Hwang IC, Lim S. Comparison of the effects of gemigliptin versus glimepiride on cardiac function in patients with type 2 diabetes uncontrolled with metformin: The gemi-heart study. Diabetes Obes Metab. 2023 Aug;25(8):2181-2190
• Ji L, Luo Y, Bee YM, Xia J, Nguyen KT, Zhao W, Chen L, Chan SP, Deerochanawong C, Lim S, Yabe D, McGill M, Suastika K, Li X, Kong APS, Chen W, Zhao Z, Xu C, Deodat M, Yao X. Use of basal insulin in the management of adults with type 2 diabetes: An Asia-Pacific evidence-based clinical practice guideline. J Diabetes. 2023 Jun;15(6):474-487
• Moon S, Lee J, Yu JM, Choi H, Choi S, Park J, Choi K, Kim E, Kim H, Kim MJ, Park YJ. Association between environmental cadmium exposure and increased mortality in the U.S. National Health and Nutrition Examination Survey (1999-2018). J Expo Sci Environ Epidemiol. 2023 Nov;33(6):874-882
• Twigg S, Lim S, Yoo SH, Chen L, Bao Y, Kong A, Yeoh E, Chan SP, Robles J, Mohan V, Cohen N, McGill M, Ji L. Asia-Pacific Perspectives on the Role of Continuous Glucose Monitoring in Optimizing Diabetes Management. J Diabetes SciTechnol. 2023 May 26:19322968231176533
• Kim I, Cho HJ, Lim S, Seok SH, Lee HY. Comparison of the effects of empagliflozin and sotagliflozin on a zebrafish model of diabetic heart failure with reduced ejection fraction. Exp Mol Med. 2023 Jun;55(6):1174-1181
• Chung GE, Cho EJ, Kim MJ, Yoo JJ, Cho Y, Lee KN, Han K, Kim YJ, Yoon JH, Shin DW, Yu SJ. Association between the fatty liver index and the risk of fracture among individuals over the age of 50 years: a nationwide population-based study. Front Endocrinol (Lausanne). 2023 May 16;14:1156996
• Davies MJ, Ahmad E, Lim S, Lamptey R, Webb DR. Cancer is becoming the leading cause of death in diabetes - Authors' reply. Lancet. 2023 Jun 3;401(10391):1849-1850
• Lee JS, Sohn M, Kim K, Yoon YS, Lim S. Glucose Regulation after Partial Pancreatectomy: A Comparison of Pancreaticoduodenectomy and Distal Pancreatectomy in the Short and Long Term. Diabetes Metab J. 2023 Sep;47(5):703-714
• Sohn M, Dietrich JW, Nauck MA, Lim S. Characteristics predicting the efficacy of SGLT-2 inhibitors versus GLP-1 receptor agonists on major adverse cardiovascular events in type 2 diabetes mellitus: a meta-analysis study. Cardiovasc Diabetol. 2023 Jun 28;22(1):153
• Park D, Shin MJ, Després JP, Eckel RH, Tuomilehto J, Lim S. 20-Year Trends in Metabolic Syndrome Among Korean Adults From 2001 to 2020. JACC Asia. 2023 Jun 20;3(3):491-502
• Lee H, Kang BG, Jo J, Park HE, Yoon S, Choi SY, Kim MJ. Deep learning-based prediction for significant coronary artery stenosis on coronary computed tomography angiography in asymptomatic populations. Front Cardiovasc Med. 2023 Jun 21;10:1167468
• Luo Y, Chang Y, Zhao Z, Xia J, Xu C, Bee YM, Li X, Sheu WH, McGill M, Chan SP, Deodat M, Suastika K, Thy KN, Chen L, Shan Kong AP, Chen W, Deerochanawong C, Yabe D, Zhao W, Lim S, Yao X, Ji L. Device-supported automated basal insulin titration in adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Lancet Reg Health West Pac. 2023 Mar 24;35:100746
• Jeong SI, Kim W, Yu HW, Choi JY, Ahn CH, Moon JH, Choi SI, Cha W, Jeong WJ, Park SY, Na HY. Incidence and Clinicopathological Features of Differentiated High-Grade Thyroid Carcinomas: An Institutional Experience. Endocr Pathol. 2023 Sep;34(3):287-297
• Lim LL, S H Lau E, Pheng Chan S, Ji L, Lim S, Sirinvaravong S, Unnikrishnan AG, O Y Luk A, Cortese V, Durocher A, C N Chan J. Real-world evidence on health-related quality of life in patients with type 2 diabetes mellitus using sulphonylureas: An analysis of the Joint Asia Diabetes Evaluation (JADE) Register. Diabetes Res Clin Pract. 2023 Sep;203:110855
• Lee YK, Oh TJ, Lee JI, Choi BY, Cho HC, Jang HC, Choi SH. Complementary effects of dapagliflozin and lobeglitazone on metabolism in a diet-induced obese mouse model. Eur J Pharmacol. 2023 Oct 15;957:175946
• Hong JH, Moon JS, Seong K, Lim S. Comparison of therapeutic efficacy and safety of sitagliptin, dapagliflozin, or lobeglitazone adjunct therapy in patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea and metformin: Third agent study. Diabetes Res Clin Pract. 2023 Sep;203:110872
• Song J, Oh TJ, Song Y. Individual Postprandial Glycemic Responses to Meal Types by Different Carbohydrate Levels and Their Associations with Glycemic Variability Using Continuous Glucose Monitoring. Nutrients. 2023 Aug 13;15(16):3571
• Choi KS, Hwang I, Moon JH, Kim M. Progressive reduction in basal ganglia explains and predicts cerebral structural alteration in type 2 diabetes. J Cereb Blood Flow Metab. 2023 Dec;43(12):2096-2104
• Kim GA, Moon JH, Kim W. Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity. Clin Mol Hepatol. 2023 Oct;29(4):831-843
• Sohn M, Frias JP, Lim S. Cardiovascular efficacy and safety of antidiabetic agents: A network meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2023 Dec;25(12):3560-3577
• Oh J, Kim W, Kim GH, Kim HL, Park SD, Min KW, Hyun D, Hong JH, Lim S, Shin J; RESOLVE-INT Investigators. Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors. Adv Ther. 2023 Nov;40(11):4817-4835
• Ko HY, Bea S, Jeong HE, Park S, Cho YM, Kong SH, Shin JY. Sodium-Glucose Cotransporter 2 Inhibitors vs Incretin-Based Drugs and Risk of Fractures for Type 2 Diabetes. JAMA Netw Open. 2023 Sep 5;6(9):e2335797
• Choi JH, Lee KA, Moon JH, Chon S, Kim DJ, Kim HJ, Kim NH, Seo JA, Kim MK, Lim JH, Song Y, Yang YS, Kim JH, Lee YB, Noh J, Hur KY, Park JS, Rhee SY, Kim HJ, Kim HM, Ko JH, Kim NH, Kim CH, Ahn J, Oh TJ, Kim SK, Kim J, Han E, Jin SM, Choi WS, Moon MK. 2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association. Diabetes Metab J. 2023 Sep;47(5):575-594
• Lee JY, Kim JH, Kim YK, Lee CY, Lee EK, Moon JH, Choi HS, Yul H, Cho SW, Kim SJ, Lee KE, Park DJ, Park YJ. US Predictors of Papillary Thyroid Microcarcinoma Progression at Active Surveillance. Radiology. 2023 Oct;309(1):e230006
• Shin K, Kim J, Park J, Oh TJ, Kong SH, Ahn CH, Moon JH, Kim MJ, Moon JH. A machine learning-assisted system to predict thyrotoxicosis using patients' heart rate monitoring data: a retrospective cohort study. Sci Rep. 2023 Nov 30;13(1):21096
• Han SM, Park ES, Park J, Nahmgoong H, Choi YH, Oh J, Yim KM, Lee WT, Lee YK, Jeon YG, Shin KC, Huh JY, Choi SH, Park J, Kim JK, Kim JB. Unique adipose tissue invariant natural killer T cell subpopulations control adipocyte turnover in mice. Nat Commun. 2023 Dec 21;14(1):8512
• Kim Buomsoo, Srinivasan Karthik, Kong Sung Hye, Kim Jung Hee, Shin Chan Soo, Ram Sudha. ROLEX: A NOVEL METHOD FOR INTERPRETABLE MACHINE LEARNING USING ROBUST LOCAL EXPLANATIONS, MIS Quarterly. Sep 2023, Vol. 47 Issue 3, p1303-1332. 30p

신장내과

• Park S, Yi J, Lee YJ, Kwon EJ, Yun G, Jeong JC, Chin HJ, Na KY, Kim S. Electronic alert outpatient protocol improves the quality of care for the risk of postcontrast acute kidney injury following computed tomography. Kidney Res Clin Pract. 2023 Sep;42(5):606-616.
• Yadav SK, Park S, Lee YM, Hurh S, Kim D, Min S, Kim S, Yan JJ, Kang BC, Kim S, Yang J, Jeong JC. Application of microphysiologic system to assess neutrophil extracellular trap in xenotransplantation. J Immunol Methods. 2023 Oct;521:113537.
• Samantasinghar A, Ahmed F, Rahim CSA, Kim KH, Kim S, Choi KH. Artificial intelligence-assisted repurposing of lubiprostone alleviates tubulointerstitial fibrosis. Transl Res. 2023 Dec;262:75-88.
• Jeong HG, Kim T, Hong JE, Kim HJ, Yun SY, Kim S, Yoo J, Lee SH, Thomas RJ, Yun CH. Automated deep neural network analysis of lateral cephalogram data can aid in detecting obstructive sleep apnea. J Clin Sleep Med. 2023 Feb 1;19(2):327-337.
• Kim JH, Kang M, Kang E, Ryu H, Jeong Y, Kim J, Park SK, Jeong JC, Yoo TH, Kim Y, Kim YC, Han SS, Lee H, Oh KH. Comparison of cardiovascular event predictability between the 2009 and 2021 Chronic Kidney Disease Epidemiology Collaboration equations in a Korean chronic kidney disease cohort: the KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease. Kidney Res Clin Pract. 2023 Nov;42(6):700-711.
• Ryu J, Baek E, Son HE, Ryu JY, Jeong JC, Kim S, Na KY, Chae DW, Kim SP, Kim SH, Jhee JH, Chang TI, Choi BS, Chin HJ. Comparison of dominant and nondominant C3 deposition in primary glomerulonephritis. Kidney Res Clin Pract. 2023 Jan;42(1):98-108.
• Ryu H, Hong Y, Kang E, Kang M, Kim J, Park HC, Oh YK, Chin HJ, Park SK, Jung JY, Hyun YY, Sung SA, Ahn C, Oh KH; KNOW-CKD Study Group. Comparison of outcomes of chronic kidney disease based on etiology: a prospective cohort study from KNOW-CKD. Sci Rep. 2023 Mar 2;13(1):3570.
• Hwang JH, Oh S, Chin HJ, Kim S, Kim DK, Kim S, Park JH, Shin SJ, Lee SH, Choi BS, Lim CS. Comparison of the performance of currently used estimated glomerular filtration rate equations with 24-hour urine creatinine clearance: sample analysis of randomised controlled trial participants. BMJ Open. 2023 Aug 23;13(8):e067398.
• Ryu JY, Baek SH, Kim S. Correspondence on Letter regarding "Evidence-based hyponatremia management in liver disease". Clin Mol Hepatol. 2023 Oct;29(4):1048-1049.
• Choi JY, Chin HJ, Lee H, Jeon Y, Lim JH, Jung HY, Cho JH, Kim CD, Kim YL, Park SH. Effect of immunosuppressive agents on clinical outcomes in idiopathic membranous nephropathy. Kidney Res Clin Pract. 2023 Sep 8.
• Huh H, Kim YS, Chung W, Kim YL, Kim Y, Han S, Jung Y, Na KY, Lee KB, Oh YK, Park HC, Han SH, Yoo TH, Kim YH, Kim SW, Lee KW, Park HC, Kim SG, Kim H, Lee CH, Bae KT, Oh KH, Ahn C, Ryu HJ, Kim YC. Evaluating the Safety and effectiveness in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period. Kidney Res Clin Pract. 2023 Mar;42(2):216-228.
• Yun G, Baek SH, Kim S. Evaluation and management of hypernatremia in adults: clinical perspectives. Korean J Intern Med. 2023 May;38(3):290-302.
• Ryu JY, Baek SH, Kim S. Evidence-based hyponatremia management in liver disease. Clin Mol Hepatol. 2023 Oct;29(4):924-944.
• Han M, Wong G, Kute VB, Nakagawa Y, Wang HH, Arakama MH, Jeong JC, Cho YY, Thwin KT, Chapman J, Sapir-Pichhadze R, Mannon RB, Ahn C, Kim YH; Steering Committee Members of ASTREG-WIT-KT. Gender Disparity in Asian-Pacific Countries: An Analysis of the ASTREG-WIT-KT Registry. Transplantation. 2023 Jan 1;107(1):1-5.
• Fang X, Kim JH, Cui S, Shin YJ, Lee H, Ko EJ, Cheong HI, Kim S, Kim HS, Kim M, Yang CW, Lim SW, Chung BH. Generation of a human induced pluripotent stem cell line from a patient with dent disease. Stem Cell Res. 2023 Sep;71:103140.
• Kwon S, Kim YC, Kwon H, Cho JH, Kim CD, Son HE, Jeong JC, Jung IM, Yoo KD, Kim Y, Lee W, Lee JS, Lee H, Lim CS, Kim YS, Kim YH, Lee JP. Metformin Use and Long-term Clinical Outcomes in Kidney Transplant Recipients. Am J Kidney Dis. 2023 Sep;82(3):290-299.e1.
• Son HE, Yun G, Kwon EJ, Park S, Jeong JC, Kim S, Na KY, Paik JH, Chin HJ. Outcomes of minimal change disease without nephrotic range proteinuria. PLoS One. 2023 Aug 17;18(8):e0289870.
• Shin DJ, Li L, Cho A, Lee J, Oh S, Kwon S, Kim DK, Kim S, Oh YK, Lim CS, Kim YS, Lee JP; VENUS study investigators. Plasma Circulating Tumor Necrosis Factor Receptors at Multiple Time Points Can Predict the Outcome of Severe Acute Kidney Injury. Blood Purif. 2023;52(3):285-295.
• Yoo KD, Noh J, Bae W, An JN, Oh HJ, Rhee H, Seong EY, Baek SH, Ahn SY, Cho JH, Kim DK, Ryu DR, Kim S, Lim CS, Lee JP; Korean Association for the Study of Renal Anemia and Artificial Intelligence (KARAI). Predicting outcomes of continuous renal replacement therapy using body composition monitoring: a deep-learning approach. Sci Rep. 2023 Mar 21;13(1):4605.
• Kim H, Hyun YY, Yun HR, Joo YS, Kim Y, Jung JY, Jeong JC, Kim J, Park JT, Yoo TH, Kang SW, Oh KH, Han SH. Predictive performance of the new race-free Chronic Kidney Disease Epidemiology Collaboration equations for kidney outcome in Korean patients with chronic kidney disease. Kidney Res Clin Pract. 2023 Jul;42(4):501-511.
• Joo L, Jeong HY, Bae DH, Jee JH, Choi WH, Kim HY, Kim S, Yang DH, Gee HY, Jeon S, Roh YG, Yoo J. Prostaglandin F2α analogue, bimatoprost ameliorates colistin-induced nephrotoxicity. Biomed Pharmacother. 2023 Dec;168:115446.
• Kim M, Sohn H, Choi S, Kim S. Requirements for Trustworthy Artificial Intelligence and its Application in Healthcare. Healthc Inform Res. 2023 Oct;29(4):315-322.
• Koh HB, Kim HW, Jung CY, Lee Y, Park JT, Yoo TH, Kang SW, Lee J, Kim YH, Chae DW, Chung WK, Oh KH, Han SH; KoreaN cohort study for Outcomes in patients With Chronic Kidney Disease (KNOW-CKD) Investigators. Risk improvement and adverse kidney outcomes in patients with chronic kidney disease: findings from KNOW-CKD. J Nephrol. 2023 Apr;36(3):767-776.
• Han M, Jeong JC, Cho YY, Ahn C, Kim YH. Sex disparity in dialysis and kidney transplantation over 20 years in Korea. Kidney Res Clin Pract. 2023 Jul;42(4):512-518.
• Chang JH, Kim YC, Song SH, Kim S, Jo MW, Kim S. Shared Decision Making for Choosing Renal Replacement Therapy in Chronic Kidney Disease Patients (SDM-ART trial): study protocol for randomized clinical trial. Kidney Res Clin Pract. 2023 Nov;42(6):751-761.
• Lee YK, Kim YH, Kim DH, Kim JH, Lee JH, Park JH, Ko GJ, Hwang WM, Gil HW, Kang YS, Jin KB, Do JY, Kim SJ, Kim BS, Shin HS. Shared decision-making intervention regarding dialysis modality in patients with CKD stage 5. Medicine (Baltimore). 2023 May 12;102(19):e33695.
• Park CH, Kim HW, Park JT, Chang TI, Yoo TH, Park SK, Kim Y, Jung JY, Jeong JC, Oh KH, Kang SW, Han SH; KNOW-CKD (KoreaN Cohort Study for Outcomes in Patients with Chronic Kidney Disease) Investigators. The 2021 KDIGO blood pressure target and the progression of chronic kidney disease: Findings from KNOW-CKD. J Intern Med. 2023 Nov;294(5):653-664.
• Lee Y, Kim J, Kwon S, Jeong JC, Joo KW, Oh KH. The need for prophylactic hemodialysis to protect against nephrogenic systemic fibrosis in patients with end-stage renal disease receiving gadolinium-based contrast agents. Acta Radiol. 2023 Aug;64(8):2492-2496.
• Kwon EJ, Hwang SH, Seo S, Park J, Park S, Kim S. Efficacy of Mesenchymal-Stromal-Cell-Derived Extracellular Vesicles in Ameliorating Cisplatin Nephrotoxicity, as Modeled Using Three-Dimensional, Gravity-Driven, Two-Layer Tubule-on-a-Chip (3D-MOTIVE Chip). Int J Mol Sci. 2023 Oct 29;24(21):15726.

알레르기내과

• Shim JS, Kim H, Kwon JW, Park SY, Kim S, Kim BK, Nam YH, Yang MS, Kim MY, Kim SH, Lee BJ, Lee T, Kim SH, Park SY, Cho YJ, Park CS, Jung JW, Park HK, Kim JH, Choi JH, Moon JY, Adcock I, Chung KF, Kim MH, Kim TB; Precision Intervention in Severe Asthma (PRISM) study investigatorsa. A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM study. World Allergy Organ J. 2023 Dec 12;16(12):100848.
• Shim JS, Kim BK, Kim SH, Kwon JW, Ahn KM, Kang SY, Park HK, Park HW, Yang MS, Kim MH, Lee SM. A smartphone-based application for cough counting in patients with acute asthma exacerbation. J Thorac Dis. 2023 Jul 31;15(7):4053-4065.
• Gu BH, Choi JP, Park T, Kim AS, Jung HY, Choi DY, Lee SJ, Chang YS, Kim M, Park HK. Adult asthma with symptomatic eosinophilic inflammation is accompanied by alteration in gut microbiome. Allergy. 2023 Jul;78(7):1909-1921.
• Shim JS, Kim MH, Lee SM, Kim SH, Kwon JW, Song C, Ahn KM, Kang SY, Park HK, Park HW, Kim BK, Yang MS. An artificial intelligence algorithm-based smartphone application for daily cough monitoring. Allergy. 2023 May;78(5):1378-1380.
• Moon JY, Lee H, Kim MH, Song WJ, Lee SM, Kim SH, Kim SH, Lee BJ, Yoon HJ, Kim SH; on the behalf of Work Group for Chronic Cough, the Korean Academy of Asthma, Allergy and Clinical Immunology. Bacterial Etiology in Subacute Cough. Allergy Asthma Immunol Res. 2023 Sep;15(5):673-681.
• Jo EJ, Lee JH, Won HK, Kang N, Kang SY, Lee SE, Lee JH, Kim MY, Shim JS, An J, Yoo Y, Park SY, Kim BK, Moon JY, Park HK, Kim MH, Kwon HS, Kim SH, Kim SH, Chang YS, Kim SH, Birring SS, Lee BJ, Song WJ. Baseline Cohort Profile of the Korean Chronic Cough Registry: A Multicenter, Prospective, Observational Study. Lung. 2023 Oct;201(5):477-488.
• Losol P, Ji MH, Kim JH, Choi JP, Yun JE, Seo JH, Kim BK, Chang YS, Kim SH. Bronchial epithelial cells release inflammatory markers linked to airway inflammation and remodeling in response to TLR5 ligand flagellin. World Allergy Organ J. 2023 Jun 10;16(6):100786.
• Tomaszewski EL, Atkinson MJ, Janson C, Karlsson N, Make B, Price D, Reddel HK, Vogelmeier CF, Müllerová H, Jones PW; NOVELTY Scientific Community; NOVELTY study investigators. Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD. Respir Res. 2023 Apr 8;24(1):106.
• Kim MH, Kang DY, Nam YH, Sim DW, Kim S, Lee JK, Park JW, Park HK, Jung JW, Kim CW, Yang MS, Kim JH, Ye YM, Koh YI, Kang HR, Park SJ, Kim SH. Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR registry. World Allergy Organ J. 2023 Jan 12;16(1):100738.
• Kim MJ, Kim BR, Kim SH, Chang YS, Youn SW. Clinical Response to Low-dose Omalizumab Treatment in Chronic Spontaneous Urticaria: A Retrospective Study of 179 Patients. Acta Derm Venereol. 2023 Aug 30;103:adv11627.
• Hughes R, Rapsomaniki E, Bansal AT, Vestbo J, Price D, Agustí A, Beasley R, Fageras M, Alacqua M, Papi A, Müllerová H, Reddel HK; NOVELTY Scientific Community; NOVELTY study investigators. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum. J Allergy Clin Immunol Pract. 2023 Sep;11(9):2803-2811.
• Koh J, Woo YD, Yoo HJ, Choi JP, Kim SH, Chang YS, Jung KC, Kim JH, Jeon YK, Kim HY, Chung DH. De novo fatty-acid synthesis protects invariant NKT cells from cell death, thereby promoting their homeostasis and pathogenic roles in airway hyperresponsiveness. Elife. 2023 Nov 2;12:RP87536.
• Choe S, Lee S, Park CH, Lee JH, Kim HJ, Byeon SJ, Choi JH, Yang HJ, Sim DW, Cho BJ, Koo H, Kang MG, Jeong JB, Choi IY, Kim SH, Kim WJ, Jung JW, Lhee SH, Ko YJ, Park HK, Kang DY, Kim JH. Development and Application of an Active Pharmacovigilance Framework Based on Electronic Healthcare Records from Multiple Centers in Korea. Drug Saf. 2023 Jul;46(7):647-660.
• Kim JH, Lee H, Park SY, Kim JY, Choi SH, Kwon HS, Song WJ, Kim SH, Yu J, Song DJ, Cho YS, Lim DH, Cho YJ, Chang SI, Kim TB. Epidemiology of patients with asthma in Korea: Analysis of the NHISS database 2006-2015. World Allergy Organ J. 2023 Apr 19;16(4):100768.
• Losol P, Sokolowska M, Hwang YK, Ogulur I, Mitamura Y, Yazici D, Pat Y, Radzikowska U, Ardicli S, Yoon JE, Choi JP, Kim SH, van de Veen W, Akdis M, Chang YS, Akdis CA. Epithelial Barrier Theory: The Role of Exposome, Microbiome, and Barrier Function in Allergic Diseases. Allergy Asthma Immunol Res. 2023 Nov;15(6):705-724.
• Choi JP, Ayoub G, Ham J, Huh Y, Choi SE, Hwang YK, Noh JY, Kim SH, Song JY, Kim ES, Chang YS. Exercise With a Novel Digital Device Increased Serum Anti-influenza Antibody Titers After Influenza Vaccination. Immune Netw. 2023 Feb 27;23(2):e18.
• Kang N, Won HK, Lee JH, Shim JS, Kang SY, Park HK, Jo EJ, Lee SE, Kim MH, Kim SH, Kim SH, Chang YS, Lee BJ, Song WJ, Jo MW. Health-Related Quality of Life and Its Determinants in Chronic Cough: The Korean Chronic Cough Registry Study. Allergy Asthma Immunol Res. 2023 May;15(3):348-360.
• Losol P, Sokolowska M, Chang YS. Interactions between microbiome and underlying mechanisms in asthma. Respir Med. 2023 Mar;208:107118.
• Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, ChuppG, Bednarczyk A, Ponnarambil S, Caveney S, Almqvist G, Gołąbek M, Simonsson L,Lawson K, Bowen K, Colice G; DESTINATION study investigators. Long-term safetyand efficacy of tezepelumab in people with severe, uncontrolled asthma(DESTINATION): a randomised, placebo-controlled extension study. Lancet Respir Med. 2023 May;11(5):425-438.
• Pham DD, Lee JH, Kwon HS, Song WJ, Cho YS, Kim H, Kwon JW, Park SY, Kim S, Hur GY, Kim BK, Nam YH, Yang MS, Kim MY, Kim SH, Lee BJ, Lee T, Park SY, Kim MH, Cho YJ, Park C, Jung JW, Park HK, Kim JH, Moon JY, Bhavsar P, Adcock I, Chung KF, Kim TB. WITHDRAWN: Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM study. Ann Allergy Asthma Immunol. 2023 Jun 1:S1081-1206(23)00402-7.
• Lee JH, Yoo Y, Kim SR, Lee JH, Kim SY, An J, Park SY, Park HK, Kim S, Song WJ, Yang MS, Kwon HS, Park HK, Lee J, Hur GY, Ko GJ, Kim SH, Kim SH, Ye YM, Koh YI, Lee BJ, Cho YS, Yong HS, Kim TB. Skin Test-Guided Strategy to Select Alternative Iodinated Contrast Media in Patients With Immediate Hypersensitivity Reaction: A Prospective Confirmative Study. J Allergy Clin Immunol Pract. 2023 Nov;11(11):3454-3462.e1.

감염내과

• Choi S, Moon SM, Kwon JS, Kim SH, Park SY. Diagnostic Usefulness of Varicella Zoster Virus-Specific Immunoglobulin (Ig) A and IgG in Patients With Herpes Zoster. J Korean Med Sci. 2023 Jan 9;38(2):e7.
• HChoi SJ, Koh JY, Rha MS, Seo IH, Lee H, Jeong S, Park SH, Shin EC. KIR⁺CD8⁺ and NKG2A⁺CD8⁺ T cells are distinct innate-like populations in humans. Cell Rep. 2023 Mar 28;42(3):112236.
• Park SY, Moon SM, Kim B, Lee MJ, Song KH, Kim ES, Kim TH, Kim HB; Korea Study Group for Antimicrobial Stewardship (KOSGAP). Applicability and limitations of quality indicator-based assessment of appropriateness in antimicrobial use: a comparison with expert opinion. J Hosp Infect. 2023 Sep;139:93-98.
• Jung J, Moon SM, Kim DY, Kim SH, Lee WJ, Heo ST, Park JY, Bae S, Lee MJ, Kim B, Park SY, Jeong HW, Kim Y, Kwak YG, Song KH, Park KH, Park SH, Kim YK, Kim ES, Kim HB; Korea Study Group for Antimicrobial Stewardship. Appropriateness of antibiotic use for patients with asymptomatic bacteriuria or urinary tract infection with positive urine culture: a retrospective observational multi-centre study in Korea. J Hosp Infect. 2023 Oct;140:79-86.
• Kim B, Hwang S, Heo E, Kim HS, Jung J, Kim ES, Kim HB, Lee K, Park JS, Song J, Lee JH, Chung JY, Song KH, Yoon S. Evaluation of Vancomycin TDM Strategies: Prediction and Prevention of Kidney Injuries Based on Vancomycin TDM Results. J Korean Med Sci. 2023 Apr 10;38(14):e101.
• Kang CK, Choi B, Kim S, Sun CH, Yoon SH, Kim K, Chang E, Jung J, Choe PG, Park WB, Kim ES, Kim HB, Kim NJ, Oh MD, Im H, Kim J, Lee YH, Lee J, Chun H, Koh Y, Lee JY, Moon JH, Song KH, Jung I. Clinical impact of clonal hematopoiesis on severe COVID-19 patients without canonical risk factors. Haematologica. 2023 Jan 1;108(1):257-260.
• Escrihuela-Vidal F, Kaasch AJ, Von Cube M, Rieg S, Kern WV, Seifert H, Song KH, Liao CH, Tilley R, Gott H, Scarborough M, Gordon C, Llewelyn MJ, Kuehl R, Morata L, Soriano A, Edgeworth J, De Gopegui ER, Nsutebu E, Cisneros JM, Fowler VG, Thwaites G, López-Contreras J, Barlow G, Ternavasio-De La Vega HG, Rodríguez-Baño J, López-Cortés LE; International Staphylococcus Aureus Collaboration Study Group, The European Society of Clinical Microbiology and Infectious Diseases Study Group For Bloodstream Infections, Endocarditis And Sepsis. Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort. Clin Microbiol Infect. 2023 Apr;29(4):498-505.
• Heo E, Choi Y, Kim HS, Namgung HW, Lee E, Lee E, Lee JY, Jung J, Kim ES, Kim HB, Song KH. Current Status of Outpatient Parenteral Antimicrobial Therapy in Korea: Experience of a Single University-Affiliated Acute-Care Hospital. Infect Chemother. 2023 Jun;55(2):185-193.
• Noh H, Yoon S, Kim SH, Kim J, Seo JS, Kim JJ, Park IH, Oh J, Bae JY, Lee GE, Woo SJ, Seo SM, Kim NW, Lee YW, Jang HJ, Hong SM, An SH, Lyoo KS, Yeom M, Lee H, Jung B, Yoon SW, Kang JA, Seok SH, Lee YJ, Kim SY, Kim YB, Hwang JY, On D, Lim SY, Kim SP, Jang JY, Lee H, Kim K, Lee HJ, Kim HB, Kim SB, Park JW, Jeong DG, Song D, Choi KS, Lee HY, Choi YK, Choi JA, Song M, Park MS, Seo JY, Shin JS, Yun JW, Nam KT, Seong JK. Establishment of multicenter COVID-19 therapeutics.
• Bang E, Oh S, Cho HW, Park DH, Chang HE, Park JS, Lee H, Song KH, Kim ES, Kim HB, Suh YH, Park KU. Development of diagnostic tests for pathogen identification and detection of antimicrobial resistance on WHO global priority pathogens using modular real-time nucleic acid amplification test. Int Microbiol. 2023 Aug;26(3):563-577.
• Park JS, Choi YJ, Kwon K, Choi SJ, Moon SM, Song KH, Kim ES, Park KU, Kim HB. In-vitro Activity of Delpazolid and Comparator Agents Against Methicillin-resistant Staphylococcus aureus Involved in Bloodstream Infection. Ann Lab Med. 2023 Jul 1;43(4):389-391.
• Choi Y, Jeon EB, Kim T, Choi SJ, Moon SM, Song KH, Kim HB, Kim ES. Case Report and Literature Review of Occupational Transmission of Monkeypox Virus to Healthcare Workers, South Korea. Emerg Infect Dis. 2023 May;29(5):997-1001.
• Cheong HS, Park KH, Kim B, Eun BW, Kim HS, Kim YC, Lee H, Jeong SJ, Moon C, Kim SW, Yoon YK, Hwang IS, Park CS, Lee MS, Kim HB, Shin JY, Kwon KT. Developing Core Elements and Checklist Items for Implementing Antimicrobial Stewardship Programs in Korean General Hospitals: A Modified Delphi Survey. Infect Chemother. 2023 Mar;55(1):59-68. doi: 10.3947/ic.2022.0169. Epub 2023 Feb 15.
• Kang J, Kim HS, Yi HJ, Lee Y, Lee SH, Song KH, Park HY, Oh HS, Yoon D, Choe PG, Lee EJ, Choi CH, Sim M, Yu ES, Paik JW, Park HY. Causing trouble and being transmissible: COVID-19 survivors' experiences of stigma and discrimination in South Korea. Front Psychiatry. 2023 Mar 14;14:1103572.
• Lee CM, Choe PG, Kang CK, Lee E, Song KH, Bang JH, Kim ES, Kim HB, Kim NJ, Kim HR, Kim Y, Lee CH, Shin HM, Park SW, Park WB, Oh MD. Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19. Front Immunol. 2023 Mar 22;14:1106664.
• Kim B, Hwang S, Heo E, Kim HS, Jung J, Kim ES, Kim HB, Lee K, Park JS, Song J, Lee JH, Chung JY, Song KH, Yoon S. Evaluation of Vancomycin TDM Strategies: Prediction and Prevention of Kidney Injuries Based on Vancomycin TDM Results. J Korean Med Sci. 2023 Apr 10;38(14):e101
• Kim NH, Choi Y, Kwon K, Park JS, Park KU, Moon SM, Song KH, Kim ES, Park WB, Kim HB. Anti-Alpha-Toxin Antibody Responses and Clinical Outcomes of Staphylococcus aureus Bacteremia. J Korean Med Sci. 2023 Apr 24;38(16):e129
• Kim DM, Yu BJ, Kim DY, Seo JW, Yun NR, Kim CM, Kim YK, Jung SI, Kim UJ, Kim SE, Kim HA, Kim ES, Hur J, Lee SH, Jeong HW, Heo JY, Jung DS, Kim J, Park SH, Kwak YG, Lee S, Lim S, Chatterjee S. Clinically differential diagnosis of human granulocytic anaplasmosis and severe fever with thrombocytopenia syndrome. Sci Rep. 2023 Apr 26;13(1):6837
• Choi JP, Ayoub G, Ham J, Huh Y, Choi SE, Hwang YK, Noh JY, Kim SH, Song JY, Kim ES, Chang YS. Exercise With a Novel Digital Device Increased Serum Anti-influenza Antibody Titers After Influenza Vaccination. Immune Netw. 2023 Feb 27;23(2):e18
• Choi Y, Kang M, Shin DH, Jung J, Choi SJ, Kim NH, Moon SM, Song KH, Kim ES, Jung J, Kim HB. Antibiotic Prescription in Patients With Coronavirus Disease 2019: Analysis of National Health Insurance System Data in the Republic of Korea. J Korean Med Sci. 2023 Jun 26;38(25):e189
• Wiboonchutikula C, Kim HB, Honda H, Xin Loo AY, Chi-Chung Cheng V, Camins B, Jantarathaneewat K, Apisarnthanarak P, Rutjanawech S, Apisarnthanarak A. Antibiotic prescribing behavior among physicians in Asia: a multinational survey. Antimicrob Steward Healthc Epidemiol. 2023 Jun 29;3(1):e112
• Park HY, Lee H, Lee JY, Song KH, Kim Y, Lee SH. How Can We Deal with Psychosocial Issues in an Emerging Infectious Disease Outbreak? Lessons from a Qualitative Study for the MERS Outbreak in Korea. Infect Chemother. 2023 Sep;55(3):355-367
• Ahn JY, Ko JH, Peck KR, Bae S, Kim SH, Lee KH, Song YG, Kim YC, Park YS, Song KH, Kim ES, Jeong HW, Kim SW, Kwon KT, Choi WS, Choi JY. Immune Response Kinetics Following a Third Heterologous BNT162b2 Booster Dose After Primary 2-Dose ChAdOx1 Vaccination in Relation to Omicron Breakthrough Infection: A Prospective Nationwide Cohort Study in South Korea. Open Forum Infect Dis. 2023 Jul 13;10(7):ofad363
• Lee M, Park WB, Kim ES, Kim Y, Park SW, Lee E, Oh MD, Kim NJ, Kim HB, Song KH, Choe PG, Kang CK, Lee CM, Choi Y, Moon SM, Choi SJ, Jeon J, Bang J. Possibility of Decreasing Incidence of Human Immunodeficiency Virus Infection in Korea. Infect Chemother. 2023 Dec;55(4):451-459
• Worldwide Antimicrobial Resistance National/International Network Group (WARNING) Collaborators. Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action. World J Emerg Surg. 2023 Oct 16;18(1):50
• Park SY, Kim YC, Moon SM, Kim B, Lee R, Kim HB; Korea Study Group for Antimicrobial Stewardship (KOSGAP). Developing a framework for regular and sustainable qualitative assessment of antibiotic use in Korean medical institutions: a Delphi study. Antimicrob Resist Infect Control. 2023 Oct 18;12(1):114
• Chatterjee S, Kim CM, Kim DM, Seo JW, Kim DY, Yun NR, Jung SI, Kim UJ, Kim SE, Kim HA, Kim ES, Hur J, Kim YK, Jeong HW, Heo JY, Jung DS, Lee H, Park SH, Kwak YG, Lee S, Chatterjee RP. Coinfection With Severe Fever With Thrombocytopenia Syndrome and Scrub Typhus in Korea. Open Forum Infect Dis. 2023 Oct 17;10(10):ofad377
• Kim J, Youn D, Choi S, Lee YW, Sumberzul D, Yoon J, Lee H, Bae JW, Noh H, On D, Hong SM, An SH, Jang HJ, Kim SY, Kim YB, Hwang JY, Lee HJ, Bin Kim H, Park JW, Yun JW, Shin JS, Seo JY, Nam KT, Choi KS, Lee HY, Chang H, Seong JK, Cho J. SARS-CoV-2 infection engenders heterogeneous ribonucleoprotein interactions to impede translation elongation in the lungs. Exp Mol Med. 2023 Dec;55(12):2541-2552
• Kim IS, Kang CK, Lee SJ, Lee CH, Kim M, Seo C, Kim G, Lee S, Park KS, Chang E, Jung J, Song KH, Choe PG, Park WB, Kim ES, Bin Kim H, Kim NJ, Oh MD, Lee JE, Shin HM, Kim HR. Tracking antigen-specific TCR clonotypes in SARS-CoV-2 infection reveals distinct severity trajectories. J Med Virol. 2023 Nov;95(11):e29199
• Lee B, Ko JH, Kim YC, Baek JY, Park YS, Song KH, Kim ES, Lee KH, Song YG, Ahn JY, Choi JY, Choi WS, Bae S, Kim SH, Jeong HW, Lee YJ, Kim HJ, Choi JY, Kim B, Kim SW, Kwon KT, Peck KR, Kang ES. Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants. J Med Virol. 2023 Dec;95(12):e29329

류마티스내과

• Choi SR, Shin JY, Shin A, Choung H, Woo SJ, Park SJ, Ha YJ, Lee YJ, Lee EB, Park JK, Kang EH. Comparative risk of blindness and vision-threatening ocular comorbidities in patients with Behçet's disease versus the general population. 2023 May 2;62(5):1895-1902.
• Park EH, Kang EH, Lee YJ, Ha YJ. Impact of early age at menopause on disease outcomes in postmenopausal women with rheumatoid arthritis: a large observational cohort study of Korean patients with rheumatoid arthritis. 2023 Feb;9(1):e002722.
• Yeo J, Yoon SH, Kim JY, Lee JS, Lee EY, Goo JM, Pourzand L, Goldin JG, Kim GJ, Ha YJ. Quantitative interstitial lung disease scores in idiopathic inflammatory myopathies: longitudinal changes and clinical implications. 2023 Nov 2;62(11):3690-3699.
• Chang SH, Choi SR, Choi YS, Go DJ, Park JW, Ha YJ, Park JK, Kang EH, Lee EY, Shin K, Lee EB, Song YW, Lee YJ. Performance of cut-offs adjusted with positive control band intensity in line-blot assays for myositis-specific antibodies. 2023 Aug;43(8):1507-1513.
• Park JK, Lee YJ, Shin K, Kang EH, Ha YJ, Park JW, Kim MJ, Kim MH, Choi SR, Jung Y, Lee JH, In Jung J, Kim JY, Winthrop KL, Lee EB. A Multicenter, Prospective, Randomized, Parallel-Group Trial on the Effects of Temporary Methotrexate Discontinuation for One Week Versus Two Weeks on Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis. 2023 Feb;75(2):171-177.
• Kim HS, Park JW, Park JW, Ha YJ, Lee YK, Lee YJ, Koo KH. Anterior and Lateral Femoroacetabular Excursion Angles Are Helpful for Assessing Femoroacetabular Impingement Syndrome: A Cross-Sectional Cohort Study. 2023 Sep;39(9):2012-2022.e1.
• Park JK, Lee YJ, Kang EH, Shin K, Kim MJ, Ha YJ, Choi SR, Park JW, Kim MH, Kim JY, Jung JI, Choi Y, Winthrop KL, Lee EB. Choi SR, Shin A, Ha YJ, Lee YJ, Lee EB, Kang EH. Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study. 2023 Jul 26;25(1):129.
• Park JK, Lee YJ, Kang EH, Shin K, Kim MJ, Ha YJ, Choi SR, Park JW, Kim MH, Kim JY, Jung JI, Choi Y, Winthrop KL, Lee EB. Effect of the methotrexate discontinuation for 1 versus 2 weeks on vaccine response to seasonal influenza vaccine in rheumatoid arthritis: a noninferiority randomized controlled trial. 2023 Jul 6. doi: 10.1002/art.42644.
• Chang SH, Lee JS, Ha YJ, Kim MU, Park CH, Lee JS, Kim JW, Chung SW, Pyo JY, Lee SW, Kang EH, Lee YA, Park YB, Choe JY, Lee EY. Lung function trajectory of rheumatoid arthritis-associated interstitial lung disease. 2023 Sep 1;62(9):3014-3024.
• Kim JW, Chung SW, Pyo JY, Chang SH, Kim MU, Park CH, Lee JS, Lee JS, Ha YJ, Kang EH, Lee YA, Park YB, Lee EY, Choe JY. Methotrexate, leflunomide and tacrolimus use and the progression of rheumatoid arthritis-associated interstitial lung disease. 2023 Jul 5;62(7):2377-2385.
• Yang MK, Kim HW, Kang EH, Kim N, Choung H, Khwarg SI. Ophthalmic manifestations and visual outcomes of granulomatosis with polyangiitis: a retrospective multicentre study in Korea. 2023 May;37(7):1302-1307.
• Chung SW, Lee JH, Ha YJ, Kang EH, Lee YJ. Recurrent focal myofasciitis of Behçet syndrome mimics infectious myofasciitis: a case report. 2023 Oct 1;30(4):268-271.
• Park JW, Curtis JR, Choi SR, Kim MJ, Ha YJ, Kang EH, Lee YJ, Lee EB. Risk-Benefit Analysis of Primary Prophylaxis Against Pneumocystis Jirovecii Pneumonia in Patients With Rheumatic Diseases Receiving Rituximab. 2023 Nov;75(11):2036-2044.
• Yoo WH, Kang YM, Kim DW, Kang EH, Lee YA, Suh CH, Sung YK, Lee SH, Gu DH, Lee J, Choe JY. Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data. 2023 Apr;10(2):329-341.

노인병내과

• Kim KI. Risk Stratification of Cardiovascular Disease according to Age Groups In New Prevention Guidelines: A Review. J Lipid Atheroscler. 2023May;12(2):96-105
• Kim D, Jeong H, Kim S, Shin HG, Park KI, Lee SP, Lee HS, Lee JY, Kim KI, Kang SH, Lee JH, Jang SY, Lee JH, Kim KH, Cho JY, Park JH, Park SK, Kim S, Kim K, Lee HY. Association between office visit intervals and long-term cardiovascular risk in hypertensive patients. J Clin Hypertens (Greenwich). 2023 Aug;25(8):748-756.
• Heo KN, Seok JY, Ah YM, Kim KI, Lee SB, Lee JY. Development and validation of a machine learning-based fall-related injury risk prediction model using nationwide claims database in Korean community-dwelling older population. BMC Geriatr. 2023 Dec 11;23(1):830.
• Huh Y, Son KY, Lee JE, Kim KI, Cho B, Won CW. Health-Related Unmet Needs of Community-Dwelling Older Adults: A Nationwide Representative Descriptive Study in Korea. Ann Geriatr Med Res. 2023 Mar;27(1):66-72.
• Jung MH, Kim KI, Lee JH, Sung KC. Relative importance of potential risk factors for dementia in patients with hypertension. PLoS One. 2023 Mar 15;18(3):e0281532.

종합내과

• Kim SW, Ohn JH, Kim NH, Kim ES, Lim Y, Lee J, Kim HW, Ryu J, Park HS, Suh KJ, Kim JW, Kim JW, Kim SH, Kim YJ, Lee KW, Kim JH, Lee JS, Jang HC. The Hospitalist-Oncologist co-ManagemEnt (HOME) system improves hospitalization outcomes of patients with cancer. BMC Health Serv Res. 2023 Dec 6;23(1):1367.
• Ryu J, Park Y, Kim HW, Kim NH, Kim SH, Lee SM, Bae YS, Yoon HJ. Association between higher variability in kidney function and long-term mortality. Nephrology (Carlton). 2022 Jun;27(6):519-527.
• Ryu J, Baek E, Son HE, Ryu JY, Jeong JC, Kim S, Na KY, Chae DW, Kim SP, Kim SH, Jhee JH, Chang TI, Choi BS, Chin HJ. Comparison of dominant and nondominant C3 deposition in primary glomerulonephritis. Kidney Res Clin Pract. 2023 Jan;42(1):98-108.
• Kim SW, Ohn JH, Kim NH, Kim ES, Lim Y, Lee J, Kim HW, Ryu J, Park HS, Suh KJ, Kim JW, Kim JW, Kim SH, Kim YJ, Lee KW, Kim JH, Lee JS, Jang HC. The Hospitalist-Oncologist co-ManagemEnt (HOME) system improves hospitalization outcomes of patients with cancer. BMC Health Serv Res. 2023 Dec 6;23(1):1367.
• Ohn JH. Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis (Diabetes Metab J 2023;47:356-65). Diabetes Metab J. 2023 Sep;47(5):715-716.
• Lee S, Kim J, Ohn JH. Exploring quantitative traits-associated copy number deletions through reanalysis of UK10K consortium whole genome sequencing cohorts. BMC Genomics. 2023 Dec 18;24(1):787.
• Kim SP, Ryu J, Kim SH, Yoon HJ. Low-dose aspirin in the primary prevention of cardiovascular diseases: A retrospective, propensity score matched study. Atherosclerosis. 2023 Apr;371:54-60.
• Yang MK, Kim HW, Kang EH, Kim N, Choung H, Khwarg SI. Ophthalmic manifestations and visual outcomes of granulomatosis with polyangiitis: a retrospective multicentre study in Korea. Eye (Lond). 2023 May;37(7):1302-1307.
• Seo MR, Yeo J, Park JW, Lee YA, Lee JH, Kang EH, Ji SM, Kwon SR, Kim SK, Kim TJ, Kim TH, Kim HW, Park MC, Shin K, Lee SH, Lee EY, Cha HS, Shim SC, Yoon Y, Lee SH, Lim JH, Baek HJ; Korean Society of Spondyloarthritis Research. Korean treatment recommendations for patients with axial spondyloarthritis. J Rheum Dis. 2023 Jul 1;30(3):151-169.
• Kim HJ, Kim J, Ohn JH, Kim NH. Impact of hospitalist care model on patient outcomes in acute medical unit: a retrospective cohort study. BMJ Open. 2023 Aug 3;13(8):e069561.
• Lee SW, Park J, Kim H, Jung YW, Baek YS, Lim Y, Kim K. Atopic dermatitis and risk of gastroesophageal reflux disease: A nationwide population-based study. PLoS One. 2023 Feb 17;18(2):e0281883.
• Kim J, Han K, Jung JH, Ha J, Jeong C, Heu JY, Lee SW, Lee J, Lim Y, Kim MK, Kwon HS, Song KH, Baek KH. Physical activity and reduced risk of fracture in thyroid cancer patients after thyroidectomy - a nationwide cohort study. Front Endocrinol (Lausanne). 2023 Jul 20;14:1173781
• Jeong C, Kim J, Lee J, Lim Y, Lim DJ, Baek KH, Ha J; Catholic Medical Center Bone Research Group. Effect of Denosumab on Bone Density in Postmenopausal Osteoporosis: A Comparison with and without Calcium Supplementation in Patients on Standard Diets in Korea. J Clin Med. 2023 Nov 2;12(21):6904.